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Abstract 
Polymicrobial diseases arise when multiple microorganisms colonize a host 
and form multi-species biofilms. Within polymicrobial communities bacteria, 
fungi, viruses and/or parasites directly and indirectly interact with one another 
in a multitude of ways. The composition and the interactions between 
organisms within polymicrobial biofilms govern disease severity and patient 
outcomes. Polymicrobial infections are of significant interest because of the 
escalating development of antimicrobial resistance and the increasing 
involvement polymicrobial biofilms in chronic and systemic infections. 
The Gram-positive bacteria Staphylococcus aureus and dimorphic fungi 
Candida albicans have been shown to coexist within the human host in 
polymicrobial biofilm communities which often result in increased disease 
severity and mortality. Both of these commensals are opportunistic human 
pathogens that cause a plethora of infections ranging from relatively non-
lethal local infections to life-threatening systemic infections in 
immunocompromised individuals.  S. aureus and C. albicans have been co-
associated with a number of polymicrobial diseases including cystic fibrosis 
and polymicrobial sepsis. Furthermore, S. aureus and C. albicans dual-
infections have been associated with increased virulence and antimicrobial 
resistance. Although an effort has been made to unravel the relationship 
between S. aureus and C. albicans, metabolomics offers a powerful analytical 
tool to gain a better understanding of the interactions between this bacteria 
and fungus. To gain a better understanding of these interactions novel 
methods must be developed to modulate biofilm growth. 
Metabolomics is intended to analyse the complete small molecule component 
of a biological system. Analytically, the diversity present in these compounds 
presents huge opportunities for improvement. The overall aim of this research 
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was to develop novel metabolomics methods and to apply these methods to 
the analysis of a S. aureus/C. albicans dual species biofilm to aid in the 
understanding of the relationship between this bacteria and fungi. 
Characterisation of the S. aureus/C. albicans biofilm in comparison in to the 
mono-species was carried out using a number of techniques, including 
fluorescence microscopy, SEM imaging, qPCR and transcriptional analysis, 
which indicated that these two organisms interact with each other on a 
physical and molecular lever. Although the presence of C. albicans facilitates 
S. aureus biofilm formation in sera, the presence of the bacteria reduced the 
number of C. albicans within the dual-species biofilm compared to the fungal 
mono-species and caused ‘crinkled’ hyphae which suggested possible 
antagonistic behaviour towards the fungi.  
An untargeted liquid chromatography-mass spectrometry separation method 
was developed that effectively retained both polar and nonpolar compounds 
by serially coupling a reversed-phase liquid chromatography (RPLC) column 
to a hydrophilic interaction liquid chromatography (HILIC) column via a T-
piece. Two independent pumps were incorporated into the system to allow 
independent gradient control of the two columns. The high dilution between 
the columns, achieved by the difference in flow rates, enabled the retention 
and separation of both polar and nonpolar standards and numerous polar and 
non-polar metabolites extracted from beer. Good peak shapes and retention 
time reproducibility was achieved across all compound classes analysed. 
Next, a targeted ion-chromatography mass-spectrometry method was 
developed for the analysis of central carbon metabolism intermediates, 
specifically those involved in glycolysis, the tricarboxylic acid (TCA) cycle 
and the Electron Transport Chain (ETC). A total mix of all of the energy 
metabolites standards analysed were able to be separated and detected using 
IC-MS, with the exception of DHAP, G3P, oxaloacetate, acetyl-CoA, 
4 
 
succinyl-CoA, NAD and NADP. The method displayed good reproducibility 
and limits of detection. 
The complexity of the extracted biofilms proved challenging to the IC-MS. 
Sample variation and low intensities in some sample groups (particularly the 
S. aureus samples) resulted in lower detection than expected. The 
RPLC/HILIC method provided hundreds of metabolite detections, but 
suffered in comparison to the conventional HILIC method, likely due to far 
greater optimisation of the original technique, leading to the utilisation of the 
routine pHILIC method in place of the serially combined method.  
Untargeted metabolomics analysis highlighted significant changes in a 
number of metabolic pathways including purine, pyrimidine, methionine and 
cysteine metabolism between the S. aureus and C. albicans mono- species 
and the dual-species biofilms. The differences detected within individual 
pathways suggest a difference in behaviour when the microorganisms are 
cultured with one another. The dramatic downregulation of a large portion of 
essential metabolites within purine, pyrimidine, cysteine and methionine 
pathways is indicative of the bacteria struggling to proliferate and form strong 
biofilms in sera. Down-regulation of many of the pathways in the dual-
species biofilm compared to the C. albicans mono-species biofilm suggests 
that the presence of S. aureus within the biofilm could be having an adverse 
effect on the C. albicans.  
The results and conclusions herein provide greater understanding of the 
clinically important interaction between S. aureus and C. albicans. 
Microscopic and molecular characterisation enabled visualisation of the dual-
species biofilm. The development and application of metabolomics 
techniques highlighted changes in metabolism between the mono- and dual-
species biofilms, indicating that the relationship between S. aureus & C. 
albicans may not be completely synergistic, as previously suggested. 
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Although the metabolomics methods developed during this study performed 
well, with regards to the separation of simple standard mixes and the complex 
beer sample, were not suitable for biofilm analysis. Through continued 
sample preparation and chromatographic optimisation these novel methods 
could offer relatively simple alternatives to more time consuming and 
complex chromatographic procedures.  
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1.1 Polymicrobial infections: bacteria, fungi and biofilms 
Polymicrobial diseases are acute and chronic diseases that are caused by 
various combinations of bacteria, fungi, viruses and parasites (Brogden, 
Guthmiller, & Taylor, 2005). A host can become infected with multiple 
microorganisms in a number of ways. In synergistic polymicrobial infections 
a microorganism can generate a niche that is favourable for infection and 
colonization by pathogens, which is often seen between some periodontal 
pathogens (Palmer et al., 2001). Other polymicrobial infections occur when 
the presence of one microorganism predisposes the host to colonisation or 
infection by a second microorganism. For example, respiratory tract viruses 
can destroy respiratory epithelium. This can create adhesions which can 
enable bacteria to adhere to the surface causing superinfections (Peltola & 
Mccullers, 2004). In additive polymicrobial infections two or more non-
pathogenic microorganisms can cause infections such as bacteraemia, 
abdominal abscesses, lung abscesses, odontogenic infections, brain abscesses 
and liver infections (Myres et al., 2002). Through culture independent 
community analysis methodologies, several diseases that were previously 
characterised as being mono-microbial are now recognised as polymicrobial 
infections, including diseases of the oral cavity, otitis media, diabetic foot 
wound infections and chronic infections in the cystic fibrosis lung. The 
composition of microbial populations predicts disease severity and outcomes. 
1.1.1 Polymicrobial interactions 
There are a number of bacterial-fungal interactions that can occur when these 
micro-organisms come into contact with one another, both direct and indirect. 
These interactions can influence behaviour, growth, virulence and survival 
(De Sordi & Mühlschlegel, 2009; Anton Y Peleg, Hogan, & Mylonakis, 
2010). Interactions include the secretion of molecules into the environment 
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for the purpose of signalling (Short, Murdoch, & Ryan, 2014). Bacteria can 
use these diffusible  molecules to monitor aspects of their environment, such 
as population density, termed quorum sensing, and they modulate their 
behaviour accordingly (De Sordi & Mühlschlegel, 2009; Short et al., 2014). 
For a compound to be classified as an intercellular signal, it has to adhere to 
guidelines set out by Monds & O’Toole (2008): the compound has to be 
secreted and identified by the receiving organism; the organism has to possess 
a receptor to sense the signal and a mechanism to respond specifically to it; 
the concentration of the signal to elicit a response cannot be toxic to the cell; 
the response is separate from the metabolism of the signal; the purified signal 
can  reproduce the response; and the signal network is adaptive at the level of 
the community (Monds & O’Toole, 2008). Some types of signal molecules 
produced for intracellular signalling can be recognized and influence other 
non-producing species through ‘eavesdropping’ (Fugère et al., 2014; Riedel et 
al., 2001). There are various types of inter-kingdom cross talk (De Sordi & 
Mühlschlegel, 2009). In one-way sensing, an organism senses and responds to 
a signal produced by another organism. One organism can use the signal 
produced by another organism to regulate its own gene, known as co-opting 
for a signal. An organism can also alter the production or stability of a signal 
from another organism, known as modulation of a signal. In two-way 
communication, multiple signals are exchanged between organisms (Cugini, 
Kolter, & Hogan, 2008). 
Another indirect interaction is the modification of the environment, whereby 
one organism causes a change in the surrounding environment, e.g. pH. 
Changes in pH can modulate hyphae formation in C. albicans (Buffo, 
Herman, & Soll, 1984).  
As well as diffused molecules bacteria and fungi can have physical 
interactions. Bacteria can attach to hyphae and yeast cells (Harriott & Noverr, 
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2009; A. Y. Peleg et al., 2008; Tampakakis, Peleg, & Mylonakis, 2009). 
Bacterial biofilms can also be found on the surface of the fungal hyphae (D. 
A. Hogan & Kolter, 2002). Physical interactions have been associated with 
reduced fungal viability. This could be due to the bacteria secreting 
antifungals into the environment, through direct transfer of bacterial toxins 
into fungal cells or through the depletion of nutrients (Anton Y Peleg et al., 
2010).  
The nature of polymicrobial interactions are species and environment 
dependent. Interspecies interactions can be symbiotic. Cross feeding of 
metabolites from the enzymatic breakdown of a carbon source or the presence 
of different species within a niche can provide protection against the host’s 
immune response or anti-microbial agents (Harriott & Noverr, 2010). 
Interspecies interactions can also be antagonistic, e.g. one organism can 
secrete lethal quantities of antibiotics, antifungals or bacteriocins that cause 
harm to another organism. Cross kingdom interactions can also benefit one 
organism, without damage to another organism through the secretion of 
molecules termed ‘cues’. ‘Coercion’ can also occur, through which one 
organism manipulates another organisms to benefit itself, without serious 
damage to the other (Short et al., 2014). 
S. aureus and C. albicans have been shown to coexist within the human host 
in polymicrobial biofilm communities which often result in increased disease 
severity and mortality (Adam, Baillie, & Douglas, 2002; Baena-Monroy et al., 
2005; Tawara, Honma, & Naito, 1996).  
1.1.2 Staphylococcus aureus 
Staphylococcus aureus (S. aureus) are non-motile, Gram-positive cocci with a 
diameter of 0.5 – 1.5 µM (Harris, Foster, & Richards, 2002). These 
facultative anaerobes are a human commensal that asymptomatically colonize 
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20% of the normal population, transiently colonize 60% of the population, 
while 20% of the population are rarely or never colonized (Williams, 1963). 
S. aureus primarily colonize anterior nares and are also found on the skin, 
rectum, pharynx, vagina, axillae and gastrointestinal (GI) tract  (Wertheim et 
al., 2005).  
S. aureus can grow by aerobic respiration or fermentation and cell division 
occurs in more than one plane to produce grape-like clusters (Tzagoloff & 
Novick, 1977). Staphylococci are tolerant to high salt concentrations and also 
show resistance to elevated temperatures (W. E. Kloos & Lambe, 1991). S. 
aureus are coagulase positive, i.e. can produce  a blood clotting enzyme (W. 
E. Kloos & Musselwhite, 1975). S. aureus form golden colonies when grown 
on a solid media, which can be used to differentiate the bacteria from 
coagulase negative staphylococci (CoNS), which produce white or translucent 
colonies (Howard & Kloos, 1987).  
The cell membrane, comprised of a phospholipid bi-layer, is surrounded by a 
cell wall (Fig. 1-1). The cell wall encasing S. aureus is a 20 – 40 nM thick 
protective coat, mainly composed of peptidoglycan and teichoic acid (a 
phosphate-containing polymer), which account for 50% and 40% of cell wall 
mass, respectively (Knox & Wicken, 1973; Shockman & Barrett, 1983). The 
remaining 10% of the cell wall is made up of surface proteins, exoproteins 
and peptidoglycan hydrolases (Harris et al., 2002). Peptidoglycan enables the 
construction of a tight multi-layered network that is capable of withstanding 
the high osmotic pressure of staphylococcus (B. Wilkinson, 1997), while the 
teichoic acid aids in the acquisition and localisation of metal ions and the 
activities of autolytic enzymes (B. Wilkinson, 1997). The remaining 
components are involved in surface attachment and S. aureus virulence 
(Harris et al., 2002). As well as the cell membrane and the cell wall, over 90% 
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of clinical strains of S. aureus have capsular polysaccharides (Arbeit, 
Karakawa, Vann, & Robbins, 1984; Thakker, Park, Carey, & Lee, 1998).  
 
Figure 1-1 Diagram of structure of S. aureus cell. 
 
1.1.2.1 S. aureus virulence factors and biofilm formation 
S. aureus possess a plethora of virulence factors which enable the bacteria to 
infect hosts successfully and increase disease severity through suppression 
and evasion of host immune response and increase its pathogenicity (Bien, 
Sokolova, & Bozko, 2011). These virulence factors include the production of 
adhesions, the secretion of toxins and the formation of biofilms (Bien et al., 
2011). 
S. aureus secrete cytotoxins, superantigens, proteases, lipase and coagulase. 
The cytolytic toxins produced by S. aureus cause cell leakage and lysis 
through the formation of ß-barrel pores in cell membranes (Foster, 2005; 
Kaneko & Kamio, 2004). Each toxin targets specific mammalian cell types. 
For example, leukocytes are targeted by leukocidin and Panton-Valentine 
leukocidin (PVL) while α-haemolysin (Hla) exhibits specificity towards 
platelets and monocytes (Kaneko & Kamio, 2004; Menestrina, Dalla Serra, & 
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Prévost, 2001). Superantigens, which cause nonspecific T-cell activation and 
massive cytokines release, include enterotoxins which cause food poisoning, 
toxic shock toxin-1 which causes toxic shock syndrome (TSS) and exfoliative 
toxin which causes degradation and exfoliation of the epidermis. 
Adhesins enable S. aureus to adhere to surfaces within the host and initiate 
the formation of a biofilm. The bacteria can adhere to host plasma or 
extracellular matrix (ECM) components, such as collagen, fibrinogen and 
fibronectin using a group of covalently anchored peptidoglycan proteins 
collectively known as microbial surface component recognising adhesive 
matrix molecules (MSCRAMMs) (Foster & Höök, 1998; Maresso & 
Schneewind, 2008; Marraffini, DeDent, & Schneewind, 2006; Speziale et al., 
2009). These proteins, which include staphylococcal protein A (SasA), 
collagen-binding protein, clumping factor A and B (ClfA and ClfB), and 
fibronectin-binding proteins A and B (FnbpA and FnbpB), mediate the initial 
attachment stage of biofilm formation, a key virulence factor which is 
essential for host colonization (Archer et al., 2011; Bien et al., 2011; Foster & 
Höök, 1998; Lowy, 1998; Yarwood, Bartels, Volper, & Greenberg, 2004). A 
second group of adhesins, collectively known as secreted expanded-repertoire 
adhesive molecules (SERAMs), are partially bound to the cell wall (Clarke & 
Foster, 2006). This group of proteins modulate the host immune system 
(Chavakis, Wiechmann, Preissner, & Herrmann, 2005; Hammel, Nemecek, 
Keightley, Thomas, & Geisbrecht, 2007). The expression of the capsule 
exopolysaccharides and polysaccharide intracellular adhesin (PIA) are other 
import S. aureus virulence factors. Capsule polysaccharides encase many 
pathogenic strains of S. aureus and provide protection from the host immune 
response by  decreasing the susceptibility of the bacteria to phagocytosis 
(Thakker et al., 1998; B. J. Wilkinson & Holmes, 1979). PIA, composed of 
poly-N-acetyl-glucosamine, is important for staphylococcal aggregation 
during biofilm formation (Götz, 2002). 
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The ability to form biofilms is a characteristic shared by most bacteria species 
and is an important mechanism required for host colonization and infection 
(McDougald, Rice, Barraud, Steinberg, & Kjelleberg, 2011; Stewart & 
William Costerton, 2001) Through a highly regulated multi-step process 
planktonic bacteria adhere to a biotic or abiotic surface and secrete adhesions 
to cement themselves to the surface as well as bind themselves to other 
bacterial cells (Götz, 2002). 
Biofilm formation undergoes several stages of development (McDougald et 
al., 2011; Moormeier, Bose, Horswill, & Bayles, 2014; O’Toole, Kaplan, & 
Kolter, 2000). The first stage of biofilm formation is attachment of the 
bacteria to a surface (McDougald et al., 2011). Contact with a surface causes 
a change in gene expression that initiates MSCRAMMs biosynthesis along 
with other cell surface proteins (Foster & Höök, 1998; Gabriela Bowden et 
al., 2002; McCrea et al., 2000; J. M. Patti, Allen, McGavin, & Hook, 1994; 
Peschel, Vuong, Otto, & Gotz, 2000). After initial attachment, the next stage 
in biofilm formation is maturation. During maturation PIA is synthesised and 
secreted by S. aureus. Bacterial cells are stuck together through the 
electrostatic interaction of positively charged PIA and the negatively charged 
teichoic acids on the cell surface (Gross, Cramton, Götz, & Peschel, 2001; 
Otto, 2008).  
The mature biofilm is surrounded by ECM consisting of exopolysaccharides, 
teichoic acids, extracellular genomic DNA (eDNA), proteins and nucleic 
acids (Flemming & Wingender, 2010; Gross et al., 2001; Rice et al., 2007). 
The ECM creates a scaffold to support biofilm structure, acts as a protective 
barrier against external stressors, e.g. antimicrobials, as well as exhibiting 
digestive properties to enable large nutrients to be metabolized and distributed 
amongst the bacteria within the biofilm (Costerton, Lewandowski, Caldwell, 
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Korber, & LappinScott, 1995; Flemming & Wingender, 2010; Hall-Stoodley, 
Costerton, & Stoodley, 2004; Monds & O’Toole, 2009; Otto, 2008) 
Once a biofilm has matured, dispersion of planktonic cells from the biofilm 
allows the bacteria to migrate and colonize other areas within the host 
(McDougald et al., 2011). Dispersal cues can be cell density dependent, or 
environmental, including nutrient availability (McDougald et al., 2011). 
1.1.3 Candida albicans 
Candida albicans is a dimorphic fungus which is able to morphologically 
transform from unicellular yeast cells into a filamentous invasive hyphae 
form (Sudbery, Gow, & Berman, 2004). The ability to morphologically 
switch is crucial for C. albicans ability to adhere to surfaces and for host 
tissue colonization during infection (Saville, Lazzell, Monteagudo, & Lopez-
ribot, 2003). C. albicans is the most abundant fungal species of healthy 
human microbiota and is found in the GI tract, reproductive tract, oral cavity 
and skin (Achkar & Fries, 2010; Ganguly & Mitchell, 2011; Kennedy & 
Volz, 1985; Kumamoto, 2002, 2011). However, C. albicans is also one of the 
few fungal species that can cause disease (Nobile & Johnson, 2015). C. 
albicans is an opportunistic pathogen that can cause fungal infections when 
there are alterations in host microbiota (use of antibiotics), host immune 
response (during stress or infection by another microbe) or favourable 
variations in the environment (changes in nutrient content) (Nobile & 
Johnson, 2015).  
1.1.3.1 C. albicans biofilm formation and infection 
Infections arise when C. albicans adheres to a surface and forms a biofilm. 
The developmental stages of biofilm formation in C. albicans are similar to 
most other microorganisms, consisting of four temporal stages; attachment, 
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early stage growth (initiation), maturation and dispersal (Chandra et al., 2001; 
Douglas, 2003; Hawser & Douglas, 1994; Nobile & Mitchell, 2006; Uppuluri 
et al., 2010). During the attachment stage, spherical yeast cells adhere to a 
surface. These yeast cells then proliferate to form a basal layer of anchoring 
cells. The biofilm then enters a stage of maturation in which pseudohyphae 
(ellipsoid cells joined end to end) and hyphae (chains of cylindrical cells) are 
formed, alongside the production of ECM. After maturation, yeast-form cells 
are dispersed from the biofilm to seed new sites within the host (Chandra et 
al., 2001; Douglas, 2003; Hawser & Douglas, 1994; Nobile & Mitchell, 2006; 
Uppuluri et al., 2010). 
The ability to form biofilms is an important virulence factor in C. albicans. 
Sherry et al. (2014) categorized C. albicans isolates as either high biofilm 
formers (HBF) or low biofilm formers (LBF) based on biomass quantification 
(Sherry et al., 2014). HBF were more resistant to antifungal treatment with 
amphotericin B (Amp B) and resulted in higher mortality rates in an infection 
model (Sherry et al., 2014). Anti-microbial resistance in C. albicans biofilms 
are due to the up-regulation of efflux pumps, the presence of recalcitrant 
persister cells and the presence of ECM. 
The two major classes of efflux pumps; the ATP-binding cassette transporter 
superfamily and the major facilitator class, modulate drug exportation from 
cells (Anderson, 2005; Cowen, 2008; Ramage, Bachmann, Patterson, Wickes, 
& López-Ribot, 2002). In planktonic cells efflux pumps are upregulated in 
response to antifungal drugs. However in C. albicans efflux pumps are 
upregulated within the first few hours of surface contact and remain 
upregulated throughout biofilm development (Mateus, Crow, & Ahearn, 
2004; Mukherjee, Chandra, Kuhn, & Ghannoum, 2003; J. E. Nett, Lepak, 
Marchillo, & Andes, 2009; Nobile et al., 2012; Ramage et al., 2002; Yeater et 
al., 2007). This automatic upregulation contributes to the increased antifungal 
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resistance of C. albicans biofilms. Persister cells also contribute to drug-
resistance in biofilms. 
Persister cells are a sub-set of metabolically dormant yeast cells that exhibit 
phenotypic variation within the biofilm and are extremely resistant to anti-
microbial drugs (LaFleur, Kumamoto, & Lewis, 2006). Drug resistance 
exhibited by persister cells is the result of the metabolically dormant state of 
the cells, rather than being dictated by cell membrane composition and efflux 
pump expression (Knot, Suci, Miller, Nelson, & Tyler, 2006; LaFleur et al., 
2006). Although persister cells are an important component of drug resistance 
in C. albicans, little is known about their formation and roles in C. albicans 
biofilms. ECM is another major contributor to C. albicans antifungal 
resistance.  
The ECM secreted by C. albicans is predominantly composed of proteins and 
glycoproteins (55%), carbohydrates (25%), lipids (15%) and nucleic acids 
(5%) (Zarnowski et al., 2014).  As well as acting as a physical barrier to 
antimicrobial drugs, ECM also contains constituents that contribute to drug 
resistance (Al-Fattani & Douglas, 2006; J. Nett et al., 2007; J. E. Nett, 
Sanchez, Cain, & Andes, 2010). For example, the addition of polysaccharides 
β-1,3-glucans to C. albicans planktonic cells increased tolerance of the cells 
to fluconazole and the addition of β-1,3-glucanase to C. albicans biofilms 
increased biofilm susceptibility to fluconazole treatment (Mitchell et al., 
2013; J. Nett et al., 2007). Extracellular DNA may also indirectly contribute 
to anti-microbial resistance (Martins et al., 2010). One study reported that 
treating biofilms with DNase enhanced the disruption of C. albicans biofilms 
when treated with caspofungin and Amp B (Martins, Henriques, Lopez-Ribot, 
& Oliveira, 2012). C. albicans ECM contains over 500 proteins, mainly 
predicted to be enzymes, including hydrolysing enzymes, which can 
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breakdown molecules as a protective response or to access a nutrient resource 
(Zarnowski et al., 2014).  
C. albicans infections can range in severity from superficial mucosal and 
dermal infections, such as thrush and nappy rash, to severe systemic fungal 
infections of tissues and organs with mortality rates of up to 40% (Calderone 
& Fonzi, 2001; Rex et al., 2004; Wisplinghoff et al., 2004). C. albicans can 
have serious implications for immunocompromised individuals (AIDS 
patients and those undergoing anticancer or immunosuppression therapies) 
and healthy individuals with implanted medical devices (Weig, Gross, & 
Muhlschlegel, 1998). Urinary and central venous catheters, pacemakers, 
mechanical heart valves, joint prostheses, contact lenses and dentures are all 
susceptible to C. albicans infections (Cauda, 2009; Donlan, 2002; Kojic & 
Darouiche, 2004; Seddiki et al., 2013). C. albicans infections account for 
15% of all sepsis cases, are the 4th most common cause of clinically acquired 
bloodstream infections and are the most common fungal species isolated from 
medical device infections (Pfaller & Diekema, 2007; Saldanha Dominic, 
Shenoy, & Baliga, 2007; Wenzel, 1995; Wisplinghoff et al., 2004).  
Fungal biofilms are more resistant to antifungals, therefore higher doses are 
required for treatment, along with removal of any infected medical device 
(Andes et al., 2012; Cornely et al., 2012; Lortholary et al., 2012; Mermel et 
al., 2009). Unfortunately, the cost and danger of device removal, along with 
the complications associated with high doses of antifungal drugs (e.g. kidney 
and liver damage), often means that treatments are not possible for critically 
ill patients. Multiple antifungal-resistant forms of C. albicans are being 
increasingly encountered in clinical settings (Ramage et al., 2002).  
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Although infections by C. albicans and S. aureus single-species biofilms are 
well documented, microbes are often found in complex polymicrobial 
communities.   
1.1.4 The role of Candida-Staph polymicrobial biofilms in disease 
It is estimated that 27-56% of hospital acquired bloodstream infections are 
polymicrobial with S. aureus as the third most common microorganism 
isolated in conjunction with C. albicans (Klotz, Chasin, Powell, Gaur, & 
Lipke, 2007). The clinical outcomes of polymicrobial sepsis compared with 
monomicrobial sepsis are grave, with significantly higher mortality rates 
(Pulimood, Ganesan, Alangaden, & Chandrasekar, 2002). These pathogens 
have been co-associated with a number of polymicrobial  diseases including 
ventilator-associated pneumonia, cystic fibrosis, superinfection of burn 
wounds, urinary tract infections and denture stomatitis (Dahlén, Blomquist, & 
Carlén, 2009; Ekwempu, Lawande, & Egler, 1981; Siegman-Igra, Schwartz, 
& Konforti, 1988; A. J. Smith et al., 2003; Valenza et al., 2008). 
Using an in vivo model of systemic intraperitoneal infection, co-inoculation of 
C. albicans and S. aureus had a synergistic effect on mortality in mice (E. 
Carlson, 1982). Infection with sub-lethal doses of either species in isolation 
resulted in no mortality in mice. However, co-infection with both these 
pathogens at the same doses resulted in a mortality rate of 100%. Heat-
inactivation of either C. albicans or S. aureus before co-infection reversed 
this effect (E. Carlson, 1982). Each species could influence gene expression in 
vivo, resulting in increased virulence and resistance to host defences as was 
reported in vitro (Peters et al., 2010a).  
C. albicans in conjunction with other bacterial species have been isolated 
from several types of oral infections, including oropharyngeal candidiasis 
(OPC) (or thrush) and denture stomatitis. OPC affect the soft and hard palate, 
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buccal mucosa, the floor of the mouth and the tongue and appears as red 
patches or white curd-like lesions. Fluorescent in situ hybridisation (FISH) 
and 16S RNA analysis revealed the presence of bacterial species, including 
Lactobacillus/Enterococcus species and Staphylococcus species (Dongari-
Bagtzoglou, Kashleva, Dwivedi, Diaz, & Vasilakos, 2009). Denture stomatitis 
is an inflammatory process of the oral mucous that leads to the formation of 
lesions.  S. aureus was the most common bacteria isolated with C. albicans 
from the oral mucosa and dental prosthesis in patients with denture stomatitis 
(Baena-Monroy et al., 2005).  
Polymicrobial biofilms are prevalent in chronic wounds, such as diabetic foot, 
pressure and venous leg ulcers (Bertesteanu et al., 2014). Aerobic or 
facultative anaerobes including S. aureus, coagulase-negative staphylococci, 
P. aeruginosa, E. coli, Enterobacter spp. and Candida spp. can cause delayed 
wound healing and infection in both acute and chronic wounds, especially 
surgical wounds (Duerden, 1994; Mangram, Horan, Pearson, Silver, & Jarvis, 
1999). The presence of bacteria within wounds can induce excessive 
inflammatory response and tissue damage, which can lead to abscesses, 
cellulitis, osteomyelitis or limb loss (Bertesteanu et al., 2014).   
Due to the severity of dual-infections, various studies have been carried out to 
investigate the relationship between S. aureus and C. albicans in dual-species 
biofilms. 
1.1.5 S. aureus and C. albicans dual-species biofilms  
Dual-infections involving C. albicans and S. aureus result in increased 
mortality in mice (Eunice Carlson, 1983; Eunice Carlson & Johnson, 1985a, 
1985b). Carlson (1983) found that the presence of C. albicans stimulated 
toxin production in different strains of S. aureus and increased mouse 
mortality and morbidity when combined with sublethal doses of C. albicans 
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(Eunice Carlson, 1983). Carlson and Johnson (1985) went on to study this 
disease synergism in further detail (Eunice Carlson & Johnson, 1985a). 
Carlson and Johnson found that S. aureus was always associated with C. 
albicans growth even when the two microorganisms were injected at different 
sites on a mouse model (Eunice Carlson & Johnson, 1985a). Furthermore, 
they discovered that the bacteria was always found within the fungal biofilm 
rather than at the peripherals and that mixed infections were only found at the 
fungal injection sites, which suggested fungal growth was essential for 
bacterial growth and that the fungus may have played a protective role in the 
dual-infection (Eunice Carlson & Johnson, 1985a).  
S. aureus does not form strong biofilms in serum (Harriott & Noverr, 2009).  
Harriott and Noverr (2009) found that sera did not affect the initial attachment 
of the bacteria but was unable to support subsequent biofilm formation 
(Harriott & Noverr, 2009). CFU assays, along with fluorescence microscopy 
and antimicrobial testing revealed that C. albicans and S. aureus form a 
polymicrobial biofilm in serum and increase S. aureus resistance to 
antimicrobials compared to S. aureus monocultures (Harriott & Noverr, 
2009). Although the presence of C. albicans increased S. aureus vancomycin 
resistance, the presence or absence of S. aureus had no effect on the 
susceptibility of C. albicans to Amp B (Harriott & Noverr, 2009). When C. 
albicans was killed off in the polymicrobial biofilms using very high 
concentrations of Amp B, S. aureus became susceptible to vancomycin. This 
trend was observed when C. albicans and S. aureus were cultured using a 
using a 0.4µm polyester (PET) Transwell membrane, which physically 
separated the microorganisms but allowed free movement of small molecules 
between the membrane (Harriott & Noverr, 2009). However, when S. aureus 
was cultured with C. albicans matrix, S. aureus  antimicrobial resistance 
increased and were comparable to the results obtained when the bacteria and 
fungi were cultured together (Harriott & Noverr, 2009). Harriott and Noverr 
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concluded that C. albicans facilitated S. aureus biofilm formation in serum 
and that C. albicans ECM played a role in the increased resistance of S. 
aureus in polymicrobial biofilms, either by limiting the penetration of the 
drug, allowing S. aureus to up-regulate drug resistance genes or that the 
matrix material itself altered the growth and gene expression of S. aureus 
resulting in the up-regulation of anti-microbial genes (Harriott & Noverr, 
2009). As well as antimicrobial resistance and biofilm formation, the use of 
fluorescence microscopy revealed that S. aureus adhered to C. albicans 
hyphae (Harriott & Noverr, 2009). 
In a further study, Harriott and Noverr (2010) investigated the mechanism of 
C. albicans-induced vancomycin resistance during biofilm formation by 
analysing C. albicans mutant strains deficient in regulators of morphogenesis 
(Harriott & Noverr, 2010). As S. aureus preferentially adhered to C. albicans 
hyphae, they investigated mutants with various ECM and hyphae formation 
deficiencies (Harriott & Noverr, 2010). A mutant that was indistinguishable 
from the wild-type strain supported polymicrobial biofilm formation and 
vancomycin resistance (Harriott & Noverr, 2010). Other mutants with short or 
no hyphae and no ECM did not support S. aureus polymicrobial biofilm 
formation or vancomycin resistance. Adjusting the initial concentrations C. 
albicans mutants which formed very poor biofilms to concentrations similar 
to the wild-type C. albicans did not make a difference with regards to 
polymicrobial biofilm formation, so it was concluded that the lack of hyphae, 
and not the lack of cell number dictated phenotype (Harriott & Noverr, 2010). 
Interestingly, S. aureus cell numbers increased when it was cultured with a C. 
albicans mutant defective in adherence, but could still produce hyphae 
(Harriott & Noverr, 2010). Harriott and Noverr then went on to investigate 
the role of different adhesins, in particular the members of the ALS family of 
adhesions that mediate aggregation with bacteria and other yeasts (S. A. Klotz 
et al., 2007). However, they concluded that it may be a unique combination of 
Chapter 1  44 
these adhesions, rather than a single adhesion that is required for adherence 
(Harriott & Noverr, 2010). Overall, it was concluded that surface-associated 
adhesions and the ECM facilitate S. aureus polymicrobial biofilm formation 
and subsequent vancomycin resistance, although nonspecific interactions 
could also play a role in polymicrobial biofilm formation (Harriott & Noverr, 
2010).  
Peters et al. (2010) elucidated the nature and spatial relationship of the 
interactions between C. albicans and S. aureus using confocal scanning laser 
microscopy (CLSM), characterised proteomic changes and identified 
differentially regulated metabolic, stress and virulence proteins during 
polymicrobial biofilm growth  (Peters et al., 2010a). Similar to Harriott and 
Noverr (2009), the imaging analysis revealed that S. aureus adhered to C. 
albicans hyphae and not the round yeast cells (Harriott & Noverr, 2009; 
Peters et al., 2010a). Preference for binding to the hyphae of C. albicans has 
been reported in a number of other species including Streptococcus pyogenes, 
Acinetobacter baumannii and P. aeruginosa (Bamford et al., 2009; 
Cunningham, 2000; D. A. Hogan & Kolter, 2002; A. Y. Peleg et al., 2008). 
However, many of these interactions result in fungal and/or bacterial killing 
during co-culture. Unlike Harriott and Noverr, Peters found that the bacteria 
were dispersed throughout the entire biofilm, whereas Harriott found that the 
bacteria adhered to C. albicans hyphae in the uppermost region of the biofilm. 
Peters cultured the biofilms on glass coverslips using RPMI-FBS media, 
whereas Harriott cultured biofilms on permanox chamber slides using 50% 
FBS in water, which could be responsible for the differences observed by 
Peters et al. (Harriott & Noverr, 2009; Peters et al., 2010a).  The C. albicans – 
S. aureus interaction was found to be non-lethal through a LIVE/DEAD cell 
viability assay. Through proteomic analysis it was observed that candidal 
germination may induce S. aureus virulence and biofilm formation through 
the downregulation of CodY expression which is a transcriptional repressor of 
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a variety of S. aureus virulence factors (Levdikov, Blagova, Joseph, 
Sonenshein, & Wilkinson, 2006). Interestingly, several stress-related proteins 
were upregulated in S. aureus when it was cultured with C. albicans. 
Similarly, stress response proteins were upregulated in C. albicans when it 
was cultured with S. aureus, suggesting the presence of one of the 
microorganisms elicits a stress response in the other microorganism (Peters et 
al., 2010a).  
In another study, Peters et al. (2012) investigated the role that Als3 played in 
mediating the adherence of S. aureus to C. albicans hyphae (Peters, 
Ovchinnikova, et al., 2012). Peters compared various adherence mutants as 
well as a strain lacking the hyphal cell wall protein Hwp1 and determined the 
level of staphylococcal binding to C. albicans hyphae using scanning electron 
microscopy, confocal microscopy, adherence ELISA and atomic force 
microscopy (AFM). The findings suggested that strains lacking Als3 
displayed reduced ability to adhere to S. aureus. However, some adhesin 
mutants showed increased S. aureus binding when compared to the parental 
strain (Peters, Ovchinnikova, et al., 2012). The authors suggest that this could 
be the result of increased expression of other known adhesins or through the 
exposure of other adhesive moieties on the surface of C. albicans resulting in 
increased S. aureus adherence. Other molecules or biofilm matrix components 
could also play a role or could be due to non-specific attachment (Peters, 
Ovchinnikova, et al., 2012). Strains expressing Als3 exhibited stronger 
binding forces to S. aureus. Significantly, Peters observed S. aureus cells 
beneath epithelial barriers of co-infected mouse tongues. These findings 
suggest a mechanism of infection by which C. albicans hyphae penetrate host 
tissue enabling S. aureus to breach the biological barriers and initiate 
infection (Peters, Ovchinnikova, et al., 2012).  
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Dual-species infections are notoriously difficult to treat due to increased 
antimicrobial resistance and disease severity. Although an effort has been 
made to unravel the relationship between S. aureus and C. albicans, 
metabolomics offers a powerful analytical tool to gain a better understanding 
of the interactions between this bacteria and fungus. 
1.2 Metabolomics 
Metabolites are small organic molecules that are chemically changed during 
metabolic reactions. They are necessary for the correct growth, maintenance 
and function of cells (Dettmer, Aronov, & Hammock, 2007; Haggarty & 
Burgess, 2017). Although metabolic analysis had been carried out previously, 
Oliver et al. were the first to describe the full complement of small molecules 
synthesised by an organism as the metabolome (Oliver, Winson, Kell, & 
Baganz, 1998). The metabolome can be defined on all levels of complexity 
such as organisms, tissues, cells or cell complements (Fiehn, 2002). 
Conceptually, metabolomics is the study of metabolic reactions through the 
identification and quantitation of all the metabolites, the metabolome, within 
a biological system (Blow, 2008; Fiehn, 2002). Metabolomics is at the end of 
the ‘omics’ cascade (Fig. 1-2) and, unlike genes and proteins, the functions of 
which are subject to epigenetic regulation and post-translational 
modifications, respectively, metabolites are changed as a direct result of 
biochemical activity (Dettmer et al., 2007; G. J. Patti, Yanes, & Siuzdak, 
2012a). As metabolites are the direct products of biochemical reactions their 
concentrations can provide a quantitative, rather than qualitative, description 
of cellular regulation and control. The direct correlation of metabolite 
concentrations to metabolic activity provides an insight into the phenotype 
and changes in phenotype as a result of cellular response to genetic or 
environmental stimuli (Dettmer et al., 2007; Fiehn, 2002; Haggarty & 
Burgess, 2017; G. J. Patti et al., 2012a).  The ability to utilize metabolomics 
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to quantitatively describe the cellular state of a biological system has led to its 
recognition as an important tool in cell and systems biology (Johnson & 
Gonzalez, 2012; G. J. Patti, Yanes, & Siuzdak, 2012b). 
 
 
Figure 1-2 The ‘omics’ cascade and their related molecules. 
 
In order to gain an insight into the biology and physiology of a biological 
system using metabolomics, it is essential to detect and quantify as many of 
the metabolites as possible within that system (García-Cañaveras, López, 
Castell, Donato, & Lahoz, 2016). The number of metabolites varies 
dramatically between different biological systems, e.g. an estimated 2000 are 
present in mammals compared to 200 000 in the plant kingdom (Saito & 
Matsuda, 2010; Weckwerth, 2003). The mass of metabolites can range from 
50 – 2500 Daltons (Da) with low picomolar concentrations to molar 
concentrations (Forcisi et al., 2013; Wang, Liu, Hu, Li, & Wan, 2015). As 
well as number, mass and abundance, stereochemistry leads to different 
biological functions. Metabolites can also vary in polarity, pKa, solubility and 
charge (J. Chen et al., 2008; Forcisi et al., 2013; Saito & Matsuda, 2010; 
Wang et al., 2015; Weckwerth, 2003). García-Cañaveras et al. described the 
metabolomics concept as ‘the unbiased determination of all the metabolites 
present in a sample independently of their chemical structure’(García-
Cañaveras et al., 2016). Global (or untargeted) metabolomics aims to provide 
an unbiased insight into the metabolome through the detection and 
quantitation of as many metabolites as possible within a given biological 
sample. 
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Unlike global (untargeted) metabolomics, the ambitious goal of which is to 
detect and quantify all of the small molecules within a biological sample, 
targeted metabolomics has the comparatively more modest goal of detecting 
and quantifying a pre-defined group of chemically characterised compounds 
from known biochemical pathways (Lu, Bennett, & Rabinowitz, 2008; 
Nielsen & Oliver, 2005; Roberts, Souza, Gerszten, & Clish, 2012). A typical 
targeted metabolomics experiment generally aims to analyse dozens to 
hundreds of metabolites in a quantitative or semi-quantitative manner with the 
use of internal standards (Lu et al., 2008; Roberts et al., 2012).   
Targeting a particular pathway, specific part of metabolism or a group of 
metabolites can provide a powerful tool for systems biology and 
biotechnology (Cakir et al., 2006; Fiehn, 2002; Kümmel, Panke, & 
Heinemann, 2006; Nielsen & Oliver, 2005; Stitt & Fernie, 2003). 
Measurement of specific classes of metabolites or selected key metabolites 
can aid in the elucidation of metabolic networks, which opens the door for 
many types of data analysis such as identification of reporter reactions, 
network-embedded thermodynamic analysis, kinetic modelling and novel 
associations between analytes to be identified (Cakir et al., 2006; Kümmel et 
al., 2006; Roberts et al., 2012). 
Through targeting a specific metabolite or a specific group of metabolites, all 
other supplementary compounds can be ignored (Fiehn, 2002). As the 
compounds to be analysed are known, and have been chemically defined, 
sample preparation methods for their extraction and purification can be 
optimized and the analytical platform used can be tuned for their separation 
and detection (Fiehn, 2002; Roberts et al., 2012). 
Due to the number and complexity of metabolites in existence sophisticated 
instrumentation is required for their detection, quantitation and identification.  
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1.3 Analytical methods 
1.3.1 Mass spectrometry 
Metabolites exhibit wide ranging chemical diversity and concentrations. This 
diversity leads to a need for sensitive instrumentation for their detection and 
identification. The two most popular platforms that researchers rely on for 
metabolomics analyses are nuclear magnetic resonance (NMR) and mass 
spectrometry (MS).  
Mass spectrometry is a technology in which analyte ions are separated and 
detected based on their mass-to-charge (m/z) ratios. The m/z ratio is then used 
to calculate the compounds molar mass, which in turn is used for 
identification. Although there are a large number of different mass 
spectrometers available, the basic components of a MS are the same (Fig. 1-
3).  
 
Figure 1-3 Schematic diagram of the major components of a mass spectrometer. 
 
A sample is introduced to the MS source at the inlet. The compounds within 
the sample are ionised to produce charged molecules in the gaseous phase. 
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Ion optics, operated under a vacuum, focus and accelerate ions through the 
MS to the mass analyser. As the ions move through the MS they can be 
excluded or included in the final analysis based on their m/z values using 
quadrupoles. A variety of detection systems are used to detect resolved ions. 
A computer is used for instrument control and data acquisition. Instrument 
software automatically generates the m/z ratios for all of the detected ions 
which are displayed as mass spectra, an example of which can be seen in Fig. 
1-4. 
 
Figure 1-4 An example of a mass spectrum. Detection: ESI-FTMS, negative mode. 
 
As the MS detects ions in the gas phase, ionisation of the compounds within a 
sample is the first stage of MS analysis.  
1.3.1.1 Electrospray Ionisation (ESI) 
There are numerous techniques available for the production of analyte ions, 
and the method adopted is dependent on the type of analysis a researcher 
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wishes to carry out. For example, to determine the spatial distribution of 
metabolites within a sample, matrix assisted laser desorption ionisation 
(MALDI) (Karas, Bachmann, & Hillenkamp, 1985; Tanaka et al., 1988) or 
desorption electrospray ionisation (DESI) (Takats, 2004) could be used.  
Unlike MALDI and DESI, in which metabolites are ionised from the surface 
of a sample, electrospray ionisation (ESI) is predominantly used to ionize 
analytes that are in the liquid phase. Developed by Dole et. al (1968), ESI is a 
soft ionisation technique carried out at atmospheric pressure that produces 
mainly intact molecular ions (Dole, Mack, & Hines, 1968; L. . Mack, Kralik, 
Rheude, & Dole, 1970). It is compatible with continual flow systems and 
therefore is often utilized at the LC-MS interface to enable the transport of 
analytes in solution into the MS, through desolvation of charged analyte 
species. Fig. 1-5 depicts a simplified diagram of the ESI process, which can 
be divided into three stages; droplet formation, droplet shrinkage and gaseous 
ion formation (Gaskell, 1997; Kebarle & Tang, 1993).  
 
Figure 1-5 Schematic of electrospray ionisation (ESI), operating in positive mode. 
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ESI can operate in both positive and negative modes, producing protonated 
and deprotonated ions, respectively. The simplest ES ion source configuration 
is a two electrode system. A solution is flowed through a metal capillary, 
which is held at a potential. The counter electrode is the inlet capillary and the 
lens elements and detector of the MS. A high potential difference (~±3-6kV) 
is maintained between the ESI probe and the MS (Van Berkel & Kertesz, 
2007). Positively charged analyte ions are primarily produced when the 
analyte molecules interact with charged species present in the solution, which 
include H+, Na+ and K+, to produce [M+nH]n+, [M+nNa]n+ or [M+nK]n+, 
respectively. In negative mode, the deprotonated molecular ion is commonly 
observed at [M-nH]n-, although adducts may also still be observed such as 
[M+Cl]- or [M+HCOO]- (Van Berkel & Kertesz, 2007; Yamashita & Fenn, 
1984). As ions accumulate at the surface of the liquid, the liquid is drawn 
down a filament and forms a ‘Taylor cone’ (Taylor, 1964). When the 
electrostatic force applied to the capillary exceeds the surface tension of the 
liquid, droplets break away from the main body of the liquid and travel along 
the pressure and potential gradient towards the MS inlet with the spray 
emission aided by coaxial nitrogen gas. A number of parameters influence the 
diameter of the droplets produced including the applied potential, the solvent 
properties and the flow rate (Wilm & Mann, 1994).  
As a droplet travels along the pressure gradient towards the MS inlet solvent 
evaporation occurs, causing a reduction in droplet size. When the magnitude 
of the charge is great enough to overcome the surface tension holding the 
droplet together, the ‘Rayleigh limit’, the droplet will break apart, ‘Coulomb 
explosion’. The droplet continues to deplete in size through evaporation and 
fission, respectively, to form droplets that contain a single ion. The non-
solvated ions result from further evaporation of solvent. This mechanism for 
the production of ions is known as the charged residue model (CRM) (Fig. 1-
6A). A second mechanism for the production of gas-phase ions is the ion 
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evaporation model (IEM) (Fig. 1-6B), in which a charged ion is expelled from 
a small highly charged droplet. The solvated ion experiences two opposing 
forces as it tries to leave the droplet. The solvent within the droplet creates a 
charge that pulls the ion back into the droplet, while at the same time the 
repulsive forces by excess droplet charge pushes the ion away from the 
droplet (Konermann, Ahadi, Rodriguez, & Vahidi, 2013). The ion is initially 
attached to the droplet via a solvent bridge, which eventually ruptures when 
the ion is released (Ahadi & Konermann, 2011) (Fig. 1-6B). 
 
 
Figure 1-6 The production of gas-phase charged species through the (A) charged residue 
(CRM) and (B) ion evaporation (IEM) models (Van Berkel & Kertesz, 2007). 
 
The newly produced desolvated ions then travel to the inlet of the MS where 
they can be detected. There are a large number of mass analysers 
commercially available today; therefore the instrumentation discussed in this 
chapter will focus on the mass spectrometers that have been utilized in this 
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research; a quadrupole mass analyser (along with hexapoles and octapoles 
which are used for the transfer of ions through the MS) and an Orbitrap mass 
analyser, which was used for analyte detection and quantitation. 
1.3.1.2 Mass analysers 
1.3.1.2.1 Quadrupole mass analysers  
Quadrupole mass analysers are composed of a square array of four circular 
rods, which are perfectly parallel (Holzscheiter, 1995; Paul & Raether, 1955). 
The rods are grouped into two pairs of opposing rods with the same polarity 
applied to each of the rods within that pair (Fig. 1-7). Direct current (DC) and 
radio frequency (RF) voltages are applied to the rods to produce a 
quadrupolar field (Mallet & Down, 2009). The total electric field is made up 
of the generated quadrupolar field superimposed on a constant field resulting 
from the potentials applied to the rods (de Hoffmann & Stroobant, 2002).  
The positively or negatively charged ions entering the quadrupole travel along 
the z-axis and are attracted to the negatively or positively charged rods, 
respectively.  
 
Figure 1-7 Quadrupole parallel cylindrical rods with opposing charges. 
Ions travelling along the z-axis in the space between the rods will maintain 
their velocity, but are subjected to accelerations along the x- and y-axes as a 
result of the forces induced by the electric field. As long as the ion does not 
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hit one of the rods its trajectory will remain stable and the ion will be detected 
(de Hoffmann & Stroobant, 2002). The x-direction is a high-pass mass filter; 
only ions with high masses will be transmitted to the end of the quadrupole as 
ions with low m/z gain energy from the RF field and oscillate with increasing 
amplitude until they encounter one of the x-electrodes. Conversely, the y-
direction acts as low-pass mass filter. In the y-direction, as a result of the 
defocusing effect of the DC component, heavy ions become unstable. 
However, the trajectories of some lower mass ions can be corrected (when 
their amplitude increases) by the RF component which stops these ions from 
colliding with the y-electrodes.  
Within the quadrupole there are regions along the x- and y-axes that are stable 
and the ions travelling within these regions will have a stable trajectory. 
Mathieu equations are used to determine where ions will be stable in the x- 
and y-axes (Equation 1 & 2): 
au = 

	
        (1) 
qu =	 		        (2) 
Where: au/qu = related to the x- & y-coordinate of the ion travelling through the 
quadrupole, z = no. of charges on the ion, e = charge of electron, U = DC voltage applied 
to the rods, V = amplitude of the RF voltage, M = the mass of the ion, ω = the angular 
frequency constant, r0 = radius of the quadrupole. 
To determine where ions will be stable in both the x- and y-axes 
simultaneously, individual stability diagrams of each axis are overlaid to 
determine the stability areas within the quadrupole. A specific area is 
commonly used in MS, area A (Fig. 1-8).  
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Figure 1-8 Stability diagram produced from the Mathieu equation. u can be either x or y. 
The direct potential part is shown for positive U and negative U. 
 
Ions with different m/z ratios require different voltages to keep them in the 
stable region. The direct potential (U) applied to the rods and the RF voltage 
(V) are two variables that are altered to manipulate the position of ions within 
the quadrupole. An ion in an unstable region will be ejected from the 
analyser; hence by altering the U/V (RF/DC) ratio individual m/z can be 
transmitted to the end of the quadrupole to the exclusion of all others. 
Scanning along a U/V ratio constant allows successive detection of different 
masses (as long as the line goes through the stability area of that ions mass 
(Fig. 1-9)). The higher the U/V ratio is within the stable area of a specific ion 
the greater the resolution. This allows the quadrupole to focus, store or eject 
ions based on their m/z ratios.  
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Figure 1-9 Stability areas for three ions with different masses (m1<m2<m3<m4). The red 
line represents the U/V ratio. 
 
Quadrupole mass analysers include Q-time of flight (TOF), triple quads and 
bench-top single quads. However, due to their relatively low resolution 
capabilities, quadrupoles are not often used as the sole mass analyser within 
an MS, instead they are often utilized for ion focusing and selection before 
fragmentation and/or detection. Figure 1-10 illustrates the position of a 
quadrupole mass analyser within an Orbitrap FusionTM. 
 
Figure has been removed due to Copyright restrictions. 
Figure 1-10 Position of the quadrupole mass analyser within an Orbitrap FusionTM (Image 
taken from https://www.planetorbitrap.com. Accessed on 12th June 2017). 
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1.3.1.2.2 The Orbitrap 
Invented in 1999, the Orbitrap is a Fourier transform mass analyser that has 
been commercially available since 2005 (Hu et al., 2005;  a Makarov, 2000). 
This orbital trapping mass analyser utilizes a spindle-shaped central electrode 
surrounded by two symmetrical outer electrodes that precisely complement 
the shape of the inner electrode ( a Makarov, 2000).  
The outer electrodes are electrically separated from one another and are used 
to establish an ion trapping field and also act as receiver plates for image 
current detection (Hu et al., 2005;  a Makarov, 2000). Ions that successfully 
enter the orbital trap oscillate around the centre electrode and the image 
current from these oscillating ions are detected by the receiver plates as a 
time-domain signal. The signal detected from coherent ions is then used to 
generate a mass spectrum through fast Fourier transforms.  
Although there is a wide range of MS instruments that implement the 
Orbitrap mass analyser, with various layouts and levels of complexities (Fig. 
1-11), there remains a common feature amongst all of them. The mass 
analyser is always preceded by a gas-filled curved quadrupole, known as a C-
trap, that traps ions before injection into the mass analyser (Hu et al., 2005; A. 
Makarov & Scigelova, 2010;  a Makarov, 2000). 
 
Figure has been removed due to Copyright restrictions. 
Figure 1-11 Schematics illustration the diversity of the Orbitrap range. The (A) Fusion; 
(B) QExative Plus and (C) LTQ Orbitrap XL differ in layout and complexities, but all the 
instruments comprise of a C-trap and Orbitrap mass analyser (Image taken from 
https://www.planetorbitrap.com. Accessed on 12th June 2017). 
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In the C-trap, ions enter RF-only bent quadrupole and get stored there during 
which time they lose energy ( a Makarov, 2000). The RF voltage is then 
ramped down and a high-voltage pulse is applied across the trap, ejecting ions 
orthogonally to its curved axis. As the original thread of ions disperses into 
short packets of different m/z, dedicated bent ion optics focuses these packets 
onto the aperture of the analyser. 
Ion packets enter the Orbitrap analyser at an offset from its equator and 
experience strong radial and axial fields. The axial components of the field 
forces axial acceleration, and hence, so-called excitation by injection, while 
the radial component sets ions on a circular orbit around the central electrode. 
As the voltage on this electrode increases during the injection process, the 
radius of the ion packet rotation gets squeezed down.  
Because of the strong dependence of the rotational frequencies on the ion 
energies, angles and initial positions, each ion packet soon spreads over the 
angular coordinate and forms a thin rotating ring. After voltages are stabilized 
the differential amplifier detects a current induced by these rings on the split 
outer electrodes of the trap. 
Due to the complexity of the metabolome and sheer number of metabolites in 
existence many have the same mass, but have different chemical 
compositions or different chemical structures. To allow these metabolites to 
be detected and identified, a separation step based on the metabolites differing 
chemical properties is required before detection. Liquid (LC) or gas (GC) 
chromatography are often the analytical platforms of choice for analyte 
separation before MS detection. 
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 1.3.2 Chromatography 
In chromatography, analytes within a mixture are pushed through a column 
using a mobile phase (MP) and separated based on their affinity (or attraction) 
for the packing material, i.e. the stationary phase (SP) within the column. In 
gas chromatography (GC) metabolites and a carrier gas are transported 
through a column which is gradually heated using a temperature controlled 
oven. The metabolites interact with the stationary phase within the column 
and are separated due to their volatilities (Mozzi, Ortiz, Bleckwedel, De 
Vuyst, & Pescuma, 2013).  Within LC systems analyte molecules are eluted 
through a column in a liquid MP using a pump (Pal & Sharma, 2010). The 
column is filled with a chemically specific SP (Pal & Sharma, 2010). The SP 
can be composed of various types of material depending on the LC technique 
used. As analytes elute through the column they interact with the SP. It is the 
interactions between the analyte molecules, the SP and the MP that 
determines how long each analyte is retained on the column (Xiang, Liu, & 
Lee, 2006).  The detected analytes are plotted onto a chromatogram (Fig. 1-
12).  
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Figure 1-12 Simple diagram of chromatogram. 
 
From the example chromatogram (Fig. 1-11), the retention time (RT) for each 
analyte, tr, is the time it takes for the analyte to reach the detector after it has 
been injected onto the column. The dead time, t0, is the time it takes for 
unretained analytes and MP to reach the detector. The RT of each analyte can 
be taken as the time from injection of the sample, tR1, or as an adjusted RT 
from the elution of the dead volume, t’R1, which can be calculated using 
Equation 3. 
t’R1 = tR1 – t0        (3) 
The retention volume, VR, is the volume of MP required to elute a specific 
analyte from a column and can be calculated using Equation 4. 
VR = tR x F        (4)  
Where F = to the MP flow rate. 
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Analytes moving through a column spread into a Gaussian peak, with a 
standard deviation of σ (Fig. 1-13). The breadth of peaks can be measured at 
half the height of the peak (w1/2) or at the baseline, between two tangents 
drawn from the inflection points at either side of the peak, i.e. the steepest 
part of the peak. 
 
 
Figure 1-13 Diagram of Gaussian peak. 
 
Resolution (Rs), i.e. the ability of a chromatographic method to separate 
analyte peaks, is the most important function of an HPLC system. Resolution 
can be calculated from the ratio of the difference in retention of the two 
analyte peaks over the average width of the two peaks (Fig. 1-14 & Equation 
5). 
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 Rs = 
	
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  or Rs = 
	
	
  or   Rs = 
∆

 (5) 
Where tR1 & tR2 = the RT of the apices of the peaks, wb1 and wb2 = the full width at base of 
the peaks, ∆tR = the difference in RT of tR2 & tR1 and wav= the average of the widths at the 
base of the analyte peaks. 
Most publications utilise full width at half maximum (FWHM) to calculate 
resolution. In a peak with a Gaussian distribution the peak width (W) = 4σ 
and FWHM (W1/2) = 2.354σ (Fig. 1.13). When these are substituted into 
Equation 5, resolution can be calculated using Equation 6. 
 Rs = 1.18 
	
/	/
      (6) 
 
Figure 1-14 A simple diagram of two peaks which are not baseline resolved. tR1 & tR2 = 
the RT of the apices of the peaks and wb1 and wb2 = the full width at base of the peaks. 
 
Resolution can be effected by the retention factor (or capacity), the selectivity 
(or separation factor) and the efficiency of a chromatographic system (Fig. 1-
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15). Figure 1-16 describes the relationship between selectivity and efficiency 
in a chromatographic system. The relationship of efficiency, selectivity, 
capacity to resolution can be expressed as the Fundamental Resolution 
Equation (Equation 7). 
 
 
Figure 1-15 Diagram illustration the factors that affect resolution in chromatography; 
retention, selectivity and efficiency. Retention is a measure of how well the SP attracts an 
analyte. The stronger the interaction between the SP and the analyte, the longer the analyte 
is retained. Selectivity describes how well the system distinguishes between analytes. 
Efficiency is a measurement of how well the system can elute analytes off the SP. An 
efficient chromatographic system will produce narrow peaks. 
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Figure 1-16 Diagram illustration the relationship between selectivity and efficiency. (A) A 
chromatographic system that displays good selectivity and high efficiency will produce 
narrow well separated peaks. A system that displays good selectivity, but low efficiency, 
will produce broad peaks that are separated. (B) A chromatographic system that has bad 
selectivity, but good efficiency will produce narrow peaks that are not resolved. A system 
that displays bad selectivity and low efficiency will often produce one broad peak over the 
RT where two peaks should be detected. 
 
   (7) 
The retention factor (or capacity), k, is a measurement of an analytes retention 
on the column (Fig. 1-14). Equation 8 summarises how the retention factor is 
calculated. k is equal to the RT of the analyte on the column to the RT of the 
unretained compounds. 
k = 			   =  

	
       (8) 
k can be altered by altering the solvent strength of the MP. This is a relatively 
simple way to increase or decrease the level of interaction between the 
analytes and the SP, which in turn can increase or decrease k. k ignores 
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variables such as flow rate variations and column dimensions, so is useful for 
comparing the RT of specific analytes between HPLC systems. 
The selectivity (or separation factor), α, is a measurement of the 
chromatographic systems ability to ‘chemically’ distinguish between sample 
components. α is measured as a ratio of the retention factors (k) of the 
analytes in question and can be visualised as the distance between the apices 
of two peaks (Fig. 1-14 & Equation 9). 
α = 


 = 


        (9) 
High values of α indicate a good separation of the apex of each peak. By 
definition the selectivity is always greater than one, as if α = 1, the peaks 
would be co-eluting. The greater the selectivity value the further apart the 
peaks are on the chromatogram. As α is dependent on the chemical properties 
of the analytes, the chemistry of the MP and/or the SP and/or the analytes in 
solution can be altered to optimise the selectivity of the system. 
Some of the parameters that can be altered include the organic solvent used in 
the MP, e.g. acetonitrile (ACN) over methanol (MeOH) or isopropanol (IPA); 
the MP pH, which will alter the degree of ionization of some metabolites 
(altering hydrophobicity); different solvent strengths and additives, e.g. ion 
pairing agents, can alter selectivity as well as retention; column temperature 
(and hence MP temperature) can also have a small effect on certain analytes 
especially on ionisable and chiral compounds. Altering the selectivity can 
have a dramatic effect on resolution, i.e. small changes in selectivity can 
result in large improvements on resolution.   
Column efficiency is the ability of the chromatogram to produce thin peaks 
(limited band broadening) and can be determined using the Plate Theory 
which was developed by Martin and Synge (1941) or by the Rate Theory 
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(Martin & Synge, 1941; Mayer & Tompkins, 1947; Muzenda, 2012). Martin 
and Synge (1941) introduced the theory of applying the ‘theoretical plate’ 
concept of distillation to a liquid-liquid chromatographic column (Martin & 
Synge, 1941). Within each theoretical plate complete equilibration of the 
analytes between the SP and the MP occurs. It was concluded that greater 
separation occurs with the greater the number of theoretical plate and as plate 
height (H or HETP) becomes smaller. Columns often act as if they have 
different numbers of plates for different analytes present in the sample. The 
number of plates on a column can be calculated using Equation 10. 
N = 16  
2
        (10) 
Where tR= the retention time and wb = base width of the peak. 
For asymmetric peaks the equation is altered slightly (Equation 11). 
 N = 41.7 
! 	.# $
% &# '.(
       (11) 
The Rate Theory takes into consideration the mechanism of band broadening, 
the effect of rate elution on band broadening, the availability of different 
paths an analyte can follow through a column and the diffusion of a solute 
along the length of the column. 
When determining theoretical plate height using Rate Theory, longitudinal 
diffusion (LD), equilibration time and the resistance to mass transfer have to 
be considered. The Van Deemter Equation takes these variables into 
consideration (Equation 12). The Van Deemter Equation can be used to 
determine the optimum flow rate to achieve the smallest theoretical plate 
height using a Van Deemter plot (Fig. 1-17). 
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H = A +  &)* + Cux       (12)  
Where A = multiple paths, &)* = longitudinal diffusion, Cux = equilibration time. 
 
Figure 1-17 An example of a Van Deemter plot. Where Cux = the equilibration time, A = 
Eddy diffusion and +,- = longitudinal diffusion. 
 
LD occurs as a solute moves through the column; solute continuously diffuses 
away from its centre. The higher the flow rate the less time the solute has to 
diffuse. The plate height due to LD can be calculated using Equation 13. 
HLD = 
.
/  = 
012
)*
 = 
&
)*
       (13) 
Where σ2 = variance resulting from LD, L = length of column, γ = irregular diffusion 
pattern, Dm = the diffusion coefficient of solute in MP. 
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Resistance to mass transfer (or nonequilibrium) is the time required for the 
solute to equilibrate between the MP and the SP. As the analyte travels 
through the column, some of the analyte is stuck to the SP while the 
remainder in the MP moves further down the column, resulting in band 
broadening. The slower the flow rate the more complete the equilibration is 
and the less band broadening occurs. The plate height due to finite 
equilibration time can be calculated according to Equation 14. 
Hmass transfer = Cux = (Cs + Cm)ux     (14) 
Where, Cs and Cm are the rates of mass transfer through the SP and MP, respectively. 
There are specific equations for Cs and Cm depending on the type of chromatography used.  
 
Efficiency can be improved by decreasing the SP thickness, reducing the 
column radius and increasing the MP temperature. 
A solute can take a multitude of flow paths through a column (Eddy 
Diffusion). Determining A through Equation 15, takes this phenomenon into 
account with regards to chromatographic efficiency. 
A = 2λdp        (15) 
Where λ = the dimensionless constant characteristic of the SP packing material and dp = 
particle diameter. 
 
Eddy diffusion can be minimised by eliminating the column packing, 
reducing the particle size or packing the column with particles of similar size. 
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The Van Deemter Equation can be used to calculate the height (H) or height 
equivalent to a theoretical plate (HETP), and because H = /	3 ,  the number of 
theoretical plates within the chromatographic system. 
To improve the efficiency of a chromatographic system the particle diameter 
can be reduced, the column diameter can be reduced, changing the column 
temperature, reducing the thickness of the liquid film, optimizing the flow 
rate of the MP or lengthening the column. 
There are various types of HPLC systems which can be used to separate 
various types of analytes. (1) Adsorption chromatography separates analytes 
based on their polarity (Mozzi et al., 2013). There are two classes of 
adsorption chromatography – (i) normal phase (NPLC) in which the SP is 
polar (e.g. silica) and the MP is non-polar (e.g. chloroform). The least polar 
analytes elute first and the most polar are retained for longer; and (ii) reversed 
phase (RPLC) in which the SP is non-polar (e.g. C18) and the MP is polar (e.g. 
acetonitrile (ACN)). The most polar analytes elute first and the least polar are 
retained for longer (Mozzi et al., 2013). (2) Ion exchange chromatography 
separates analyte ions based on the strength of their charge (Mozzi et al., 
2013). The SP has an ionically charged surface, opposite to the charge of the 
target ions, with which the target ions are attracted. The stronger the charge 
on the target ion the longer it will be retained. Ion exchange chromatography 
can only be used for ionic or ionisable samples (Mozzi et al., 2013). (3) Size 
exclusion chromatography separates analytes by their solvated molecular size 
(Mozzi et al., 2013). Controlled pore sizes in the packing material allow for 
the penetration and retention of analytes under a specified size with the 
exclusion and elution of larger analytes (Mozzi et al., 2013).  
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Although reverse phase (RPLC) is better suited for the analysis of nonpolar 
compounds, due to its ease of use and wide ranging applicability, it is the 
most commonly used method in LC for metabolic analysis.  
1.3.2.1 Reverse phase liquid chromatography (RPLC) 
In RPLC the MP is more polar than the SP. The SP is typically hydrophobic 
and chemically bonded to the surface of a silica support (Fig. 1-18). 
 
Figure 1-18 Schematic representation of RPLC stationary phase. 
 
The MP in RPLC is composed of water (polar) and an organic solvent which 
acts as a modifier to vary the retention of analytes by lowering the polarity of 
the MP. Hydrophobic analytes are repelled by the polar MP into the non-polar 
SP where they reside for a time until ‘partitioning’ out into the MP. The 
hydrophobicity of an analyte is the primary indicator of how long the analyte 
will be retained in RPLC. Hydrophobicity is often expressed as LogP which is 
a measure of the way an analyte in its neutral form partitions between two 
immiscible solvents (usually water and octanol) under standard conditions. 
The LogP of a compound can be determined using Equation 15. The higher 
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the value of LogP (-1 to 1), the more hydrophobic the molecule is.The more 
hydrophobic an analyte is the greater its retention on column. 
logPoct/water = log ! 4567)869:;674567)8);<6;<5=	:$   (15) 
A compounds structure can also indicate how well it will be retained in 
RPLC. Generally retention increases with: - (1) decreasing water solubility; 
(2) increasing carbon numbers; (3) branched chain compounds; (4) increasing 
compound saturation. Neutral polar and charged species are the least well 
retained using RPLC, followed by weak acids and bases which all elute early, 
and ionic compounds tend to elute with the void volume of the column.  
The MP in RPLC consists of a water/aqueous solution and an organic 
modifier. As water is the most polar solvent, it is chromatographically the 
weakest as it repels hydrophobic analytes into the SP more than any other 
solvent which results in long RT. As the organic modifier added lowers the 
polarity of the MP, the hydrophobic analyte will no longer be as strongly 
repelled and will spend less time in the SP. As organic modifiers reduce RT, 
they are classed as chromatographically ‘strong’. The more organic modifier 
that is added the more analyte RT will decrease. Examples of some common 
organic modifiers are listed in Fig. 1-19. 
 
Figure 1-19 A comparison of common elution solvents used in RPLC. 
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Although not the optimum method, RPLC can be used to analyse ionisable 
compounds, however the pH of the MP has to be considered. All acids and 
bases have a unique ionisation constant (Ka) which specifies their degree of 
ionisation in an aqueous solution. The greater the degree of ionisation, the 
greater the influence the species has on the hydrogen ion (H+) concentration 
of a solution, and hence, the ‘stronger’ the acid or base. For example a strong 
acid that completely ionises in a solution increases the H+ concentration and 
therefore lowers the pH of that solution. A strong base will completely ionise 
removing H+ ions which in turn raises the pH of that solution.  When an acid 
or a base is dissolved in water an equilibrium is established: 
  HA ⇌	A-	+	H+		 	 (acid)	
	 	 B	+	H2O	⇌	HB+	+	OH-	 (base) 
 
The	 dissociation	 constants	 of	 acids	 and	 bases	 can	 be	 determined	 using	
the	following	equation	Equation	17	&	18.	
	
Ka	=	4%
a84bc8
4b%8 	 	 (acid)     (17) 
 Kb = 
4b&c84dba8
4&8   (base)     (18) 
 
Weaker acids and bases will only partially dissociate in solution. The partial 
acid or base dissociation constant is defined as the negative logarithm of the 
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dissociation coefficient of the neutral and charged forms of the compound 
(Equation 19 & 20). 
 
 pKa = -log10Ka   (acid)    (19) 
 pKb = -log10Kb   (base)    (20) 
 
The addition of acid to aqueous solution of a basic analyte will increase the 
concentration of the charged analyte in solution as the concentration of H+ 
increases and the addition of a base will increase the concentration of the 
neutral form of the base. Conversely, the addition of a basic solution to an 
acidic analyte will increase the concentration of the charged analyte and the 
addition of an acid will increase the neutral form of the acid. If the MP is at 
the exact pKa of an analyte, that analyte will exist 50% in its ionised form and 
50% in its non-ionised form. The pH of the MP dictates if the average extend 
of ionisation is hydrophobic or hydrophilic (Fig. 1-20). As pH is related to the 
degree of ionisation of analytes, and the degree of ionization dictates analytes 
hydrophobicity, the MP pH can be used to control retention.  
 
Figure 1-20 Schematic illustrating the acid and base equilibrium. 
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Buffers can be added to the MP to control pH to resist small changes that may 
occur in the HPLC system. The definition of a buffer is a weak acid or base in 
co-solution with its salt, e.g. acetic acid and sodium acetate. The compounds 
that are used to make buffering agents can also be used on their own to alter 
the pH of the MP and as ion pairing agents. 
To improve the retention of strongly acidic or basic analytes salt modifiers or 
ionic liquids, ion-pairing agents, can be added to the mobile phase. Ion 
pairing agents contain an ionic functional group and a hydrophobic portion. 
Neutral ion pairs are formed by the electrostatic interaction of the ion pairing 
agent with any counter ions in solution (Equation 21), forming pseudo-neutral 
complexes (Fig. 1-21A).  
A+ + B- <=> A.B       (21) 
Where A+ = the cationic analyte of interest, B- = the anionic pairing agent and A.B = the 
neutral ion pair formed. (Note: if the analyte is anionic, then similar analysis can be 
performed using a cationic pairing agent). 
 
Another possible interaction is the hydrophobic portion of the ion-pairing 
agents partitioning into the alkyl bonded stationary phase of the column 
forming transitory ion-exchange sites (Fig. 1-21B). The use of ion-pairing 
agents has increased the coverage of RPLC by facilitating the retention of 
some polar analytes but these agents can yield inconsistent and irreproducible 
results, have lengthy equilibrium times, can limit gradient runs, irreversibly 
modify and reduce column life-times and have significant ion suppression 
effects on mass spectrometry instrumentation, leading to a far more restricted 
range of available ion pairs than for chromatography as a whole (Garcı́a, 
Hogenboom, Zappey, & Irth, 2002). 
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Figure 1-21 Neutral ion pairs formed in (a) solution between the ion pairing agent 
(octanesulfonic acid) and a counter ion (phenylpropanolamine) and (b) the formation of 
transitory ion-exchange sites by the partitioning of the ion pairing agent into the stationary 
phase. The charged region of the ion-pairing agent attracts counter analyte ions in solution.  
 
Traditionally, polar and ionic analytes do not retain well on RPLC columns 
without the addition of non-volatile ion-pairing agents to the MP (Bennett, 
Kimball, & Gao, 2009; Buescher, Moco, Sauer, & Zamboni, 2010; Kimball & 
Rabinowitz, 2006; Lu et al., 2010, 2014, 2008; Luo, Groenke, Takors, 
Wandrey, & Oldiges, 2007; Rabinowitz & Kimball, 2007). The addition of 
some ion pairing agents, such as tributylamine (TBA) enables the retention of 
polar and charged analytes. However, these reagents can cause irreversible 
contamination of MS instrumentation, therefore may not be suitable for use in 
some laboratories (Buescher et al., 2010). Some of the most important 
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compound classes in metabolomics are polar and ionic: carbohydrates, 
organic acids, amino acids and nucleotides chromatograph poorly on RP 
HPLC without the aid of ion-pairing agents, but retain and separate well with 
some Hydrophilic interaction liquid chromatography (HILIC) columns. 
1.3.2.2 Hydrophilic interaction liquid chromatography (HILIC) 
First applied to HPLC by Yu & Hartwick (1989), hydrophilic interaction 
liquid chromatography (HILIC) is an alternative to NPLC, and similar to 
NPLC, the elution order of HILIC is inverted to RPLC (Alpert, 1990; Yu & 
Hartwick, 1989). Analytes that have little to no retention on RPLC tend to 
exhibit good retention on HILIC.  HILIC utilizes a NP polar stationary phase 
with a RP mobile phase containing at least 50% organic solvent (usually 
ACN) in water (Alpert, 1990). The polar SP retains the strongly polar 
compounds which are then eluted using the organic solvent/water MP 
(Kahsay, Song, Van Schepdael, Cabooter, & Adams, 2014). Typical eluents 
for HILIC consists of 40 – 97% ACN in water or a volatile organic buffer. 
Due to the high organic concentration in the MP, HILIC is favourable for use 
with MS detection and shows a 10 – 1000 fold increase in sensitivity for 
hydrophilic analytes.  
The HILIC SP is hydrophilic and often charged at least in some region of the 
pH scale. Various columns can be used in HILIC, including bare silica gel, 
silica-based cyano-, diol-, amino-, amido, carbamate-, polyol-, or zwitterionic 
sulfobetaine and other polar SP chemically bonded on a silica gel support 
(Guo & Gaiki, 2005; Jandera, 2011). Figure 1-22 shows some examples of the 
HILIC SPs available. Compounds interact with the SP and retention is 
generally stronger for more hydrophilic compounds.  
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Figure 1-22 Structures of (A) unmodified silica hydride (SH); (B) modified SH (C8); (C) 
amino; (D) diol and (E) cyano stationary phases that can be bonded to silica gel. 
 
The sulfoalkylbetaine zwitterionic SP (Fig. 1-23) was introduced by Irgum’s 
group for HILIC separations of inorganic salts, small organic ionic 
compounds and peptides (Jiang, Fischer, Girmay, & Irgum, 2006; Jiang & 
Irgum, 1999; Viklund & Irgum, 2000). The active layer is bonded onto a 
wide-pore silica gel or polymer support. The active SP contains both strongly 
acidic sulfonic acid groups and strongly basic ammonium groups separated by 
a short alkyl chain, which acts as a spacer. The two oppositely charged groups 
enable the simultaneous separation of anionic and cationic analytes.  
 
 
Figure 1-23 Structure of the sulfoalkylbetaine stationary phase. 
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The sulfoalkylbetaine SP strongly absorbs water. A water enriched liquid 
layer will be absorbed on the surface of polar adsorbens or bonded phases. 
This creates a water-rich adsorbed diffuse liquid-multilayer (Alpert, 1990) 
(Fig. 1-24). Separation in HILIC is achieved by the partitioning of analytes 
from the eluent into the hydrophilic environment, in a process that is typically 
exothermic (Guo & Gaiki, 2005).  Polar interactions, such as hydrogen-
bonding and dipole-dipole interactions, which are governed by the 
acidity/basicity of the analytes and dipole moments and the polarizability of 
the analytes, respectively, are the primary factors that determine retention in 
HILIC. Electrostatic interactions can also affect the retention of analytes 
carrying a charge, which may require the addition of salts or buffers to the 
MP for analyte elution. 
 
Figure 1-24 Simple diagram depicting partitioning in HILIC. 
 
In HILIC chromatography analytes elute in an order of decreasing 
hydrophobicity. Ikegami et al. (2008) carried out a comparison of the 
separation efficiencies of 9 different HILIC columns, including a bare silica, 
amino-silica, polymer-coated silica, cyano-silica and ZIC-HILIC (Ikegami, 
Tomomatsu, Takubo, Horie, & Tanaka, 2008). ZIC-HILIC can be applied to a 
wide range of analytes but the optimal flow-rate was lower than the other 
columns, so is not suitable for fast elution. The level of organic solvent in the 
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MP has the biggest influence on retention (Guo & Gaiki, 2005). Generally the 
elution time decreases as the water content in the MP increases (Fig. 1-25). 
Typically increasing the column temperature decreases retention. Unlike 
RPLC, the type of salt used in the buffer and its concentration has an effect on 
retention in HILIC (Guo & Gaiki, 2005). Guo & Gaiki (2005) found that 
increasing the salt concentration increased the retention of some analytes. The 
increase in retention of analytes occurred regardless of functional group. This 
suggests that increase of retention as a function of increasing the salt 
concentration in the MP may be a result of the partitioning process rather than 
any specific interactions between the SP and analyte functional groups (Guo 
& Gaiki, 2005). A high level of organic content in the MP leads to a higher 
salt concentration in the aqueous layer. This results in an increase in volume 
or hydrophilicity of the liquid layer, leading to longer retention of analytes 
(Alpert, 1990; Guo & Gaiki, 2005).   
 
Figure 1-25 A comparison of common elution solvents used in HILIC. 
 
HILIC has many advantages including: that good peak shapes can be obtained 
for bases, it can be easily coupled to MS especially in ESI mode, it can 
enhance MS sensitivity and the order of the solutes is different and generally 
opposite (complementary) to that of RPLC (McCalley, 2007). One drawback 
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encountered when using HILIC is that the separation mode is not as well 
understood and so a change in condition could have an unexpected outcome 
on separation (McCalley, 2010). Another drawback when using HILIC is the 
lack of retention seen for analytes that are neutral and non-polar (McCalley, 
2010). Negatively charged ions are often not retained either due to the 
repulsion of the ion from the negatively charged groups on the column (e.g. 
silanol groups) (McCalley, 2010). Originally applied to carbohydrates, amino 
acids and peptides, HILIC now has various applications including the analysis 
of small molecules, metabolites, toxins and drugs of abuse (Dell’Aversano, 
Hess, & Quilliam, 2005; Gheorghe et al., 2008; Hsieh, 2008; Hsieh & Chen, 
2005; Jandera, 2011). 
1.3.2.3 Ion exchange chromatography (IEX) 
Ion exchange chromatography (IEX) (a branch of LC) is utilized for the 
separation and detection of charged or ionisable analytes (Boyd, Adamson, & 
Myers, 1947; Ketelle & Boyd, 1947; Mayer & Tompkins, 1947; Moore, 
Spackman, & Stein, 1958). Analytes are separated in IEX based on 
differences in their net surface charge. The SP or medium used in IEX is 
charged and the separation mechanism is based on the reversible adsorption 
of charged analytes to ion exchange groups of opposite charge. The analyte 
ions interact with charged functional groups on the SP until they are displaced 
by competing eluent ions. The basic exchange process can be described by: 
F+E- + A- = F+A- + E- 
Where F+ = the functional group, E- = the eluent ion and A- = the analyte ion. 
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In addition to ion exchange interaction other types of bonding may occur such 
as van der Waals forces and non-polar interactions. However, the effects of 
this non-specific binding are usually very small. If there are no other 
interactions present the RT of an ion is proportional to its charge, 
polarizability and ionic radius (Nesterenko & Paull, 2017). 
A typical IEX run begins with equilibration of the IEX SP with the eluent 
buffer. After equilibration, a sample is injected onto the column. Oppositely 
charged analytes interact with the charged SP at varying degrees depending 
on differences in their overall charge, charge density and surface charge 
distribution. Neutral and analytes with the same charge as the SP will not be 
retained. Retained analytes are eluted off of the column using a gradient 
which increases the ion concentration in the MP. These ions displace the 
bound analytes from the column as they compete for sites. As the eluent 
concentration increases higher charged analytes are eluted off the column. 
Once the analytes have been eluted, a final high ionic strength wash is used to 
remove any ionically bound analytes before re-equilibration. 
Although efficient separations of anions and cations had been carried out 
previously, the term ion chromatography appeared in 1975 when Small et al. 
separated small organic ions on an ion exchange column improving on 
previous methods through the development of conductimetric detection after 
post-column suppression of the eluent conductivity (Small, Stevens, & 
Bauman, 1975).  
SPs utilised in IEX are made from porous or non-porous matrices. Porous 
matrices are beneficial as high porosity provides the maximum surface area 
for exchange sites, whereas non-porous matrices are good for high resolution 
separations where diffusion effects are not wanted. The matrices are 
physically stable to withstand high salt or pH concentrations and are 
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composed of an inert material to ensure low levels of non-specific 
interactions. Organic polymer-based ion-exchangers are commonly used in 
anion exchange chromatography (AEX) and include highly crosslinked 
poly(styrene-divinylbenzene) (PS-DVB), poly(methacrylate) (PMA), 
poly(vinyl alcohol) (PVA) and poly(styrene-ethylvinylbenzene) (PS-EVB) 
(Nesterenko & Paull, 2017). PMA, PVA, PS-DVB and PS-EVB-based anion 
exchangers are reasonably stable in alkaline eluents. These anion exchangers 
are functionalised with quaternary ammonium groups (account for over 95% 
of all AEX in IC) (Nesterenko & Paull, 2017). There are two main types of 
ammonium quaternary columns available; ‘Type I’ in which a trialkyl-
ammonium head is connected to the surface using an alkyl spacer (‘carbonate-
type selectivity’) and ‘Type II’ which contain two alkyl substituents and one 
hydroxyalkyl substituent at the nitrogen (‘hydroxyl-type selectivity’). For 
cation exchange chromatography (CEX) silica-based ion-exchangers are 
commonly used with three main types of functionalities; sulfonic acid for 
strong acid CEX; weak acid CEX, including carboxylic and phosphoric 
groups; and complexation-type ion-exchangers (Haddad, Nesterenko, & 
Buchberger, 2008; Nesterenko & Paull, 2017; Terborg et al., 2012). 
IEX mediums are considered strong or weak depending on the extent to 
which the ionisation state of the functional group varies with pH. For 
example, a strong ion exchanger has no variation in ion exchange capacity 
with a change in pH, i.e. this exchanger does not take up or lose protons with 
changing pH therefore remains fully charged over a broad pH range. This 
enables easy optimisation and development of methods as the charge 
characteristics of the SP do not change with pH, there are no intermediate 
forms of interaction so the mechanism is simple and the column capacity 
remains constant. Weak ion exchangers offer different selectivity compared to 
strong exchangers. However, as they can gain or lose protons with changing 
pH, the ion capacity changes with pH.  
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As has been mentioned previously, binding analytes are eluted from the 
column using either a salt or pH gradient. The type of compounds that are 
being analysed and the instrument used will dictate how the analytes is eluted. 
Many eluents utilised in IEX are water based and can range from dilute 
electrolyte solutions to complex multicomponent buffer solutions (Nesterenko 
& Paull, 2017). Some common eluents utilised in AEX include hydroxide (Na 
or K), carbonate/bicarbonate (Na or K), aliphatic carboxylic acids (e.g. citric 
or formic acid) and aromatic sulfonic acids (Nesterenko & Paull, 2017). The 
two main types of eluents used in CEX are dilute inorganic or organic acids. 
Conductivity or supressed conductivity is the common detection mode for 
IEX. Conductivity detection measures the resistance (or impedance) between 
two electrodes within a flow cell. The response of a conductivity cell for AEX 
can be described using Equation 22. 
 ∆e =	 fgafhaig'jakl        (22) 
Where ∆G = conductance signal, λs- & λg- = limiting ionic conductances of the analyte and 
the eluent ions, respectively, Cs = the concentration of the analyte anion and K= the cell 
constant, which takes the physical dimensions of the cell into account. 
 
Conductivity detection without suppression can result in very high 
background noise and very weak analyte signals. Supressed conductivity 
reduces the background conductivity of the eluent by exchanging eluent ions 
with counter ions across an ion exchange membrane or through a high 
capacity IEX resin (Nesterenko & Paull, 2017; Small et al., 1975). Developed 
by Dionex Inc. (now part of Thermo Scientific) eluent suppressors convert 
highly conductive hydroxide and carbonate eluents into pure water and 
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carbonic acid, respectively through the exchanging eluent cations (e.g. K+ or 
Na+) with hydronium ions. Figure 1-26 illustrates the process through which 
K+ counter ions are suppressed before conductivity detection. Briefly, analyte 
ions elute with K+ counter ions and flow through a cell containing two 
electrodes. The electrodes are positioned beside two cation-exchange 
membranes. The electrodes electrolyse water into hydronium and hydroxide 
ions. As the eluent passes through the centre of the cell between each 
electrode and CEX membrane, hydronium ions diffuse across the membrane 
next to the anode neutralising the hydroxide eluent to water. At the same time 
the K+ diffuse across the other membrane and provide counter ions for the 
hydroxide ions which are being generated at the cathode. This lowers the 
background conductivity to almost zero by transferring the KOH across the 
membrane so that it does not reach the detector.  
 
Figure 1-26 Schematic representation of a membrane-based suppressor showing chemical 
suppression of a potassium hydroxide eluent. 
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Once metabolites have been separated and detected using an LC-MS system, 
the detected metabolites have to be identified. 
1.3.3 Identification 
Before any biological relevance can be drawn from a metabolomics study, the 
MS raw data files have to be processed using computer software, so that 
analytes can be identified and their abundances compared. 
Instrument specific data output files are converted to universally recognised 
data files (e.g.  XML & MZmine). The converted files are then run through 
software where peaks are detected based on a predetermined set of rules, 
which may include ion abundance, peak shape, signal-to-noise thresholds and 
RT. The peak picking software carries out this processing across all replicate 
samples and using a defined set of rules detects, combines and filters features 
based on relative standard deviation (RSD) of related peaks. The features 
from each chromatographic run are then combined into one dataset, which 
then allows further analysis.  
After data processing, metabolite identification and annotation is carried out 
using compound databases such as the Kyoto Encyclopaedia of Genes and 
Genomes (KEGG), PubChem, ChemSpider and MassBank which aid in the 
annotation and identification of analytes (Horai et al., 2010; Kanehisa & 
Goto, 2000; S. Kim et al., 2016; Pence & Williams, 2010). 
A standard method for reporting metabolomics analysis was suggested by the 
Chemical Analysis Working Group (CAWG) as part of the Metabolomics 
Standards Initiative (MSI) (Sumner et al., 2007). To ensure good practices in 
the field of metabolomics the CAWG set out a number of minimum reporting 
standards which included sample preparation, experimental analysis, quality 
control, metabolite identification and data processing. Sumner et al. proposed 
Chapter 1  87 
four levels of metabolite identification (Table 1-1). Although this created a 
simple standardised method for reporting metabolite identification, it did not 
address the identification of metabolites in the absence of an authentic 
chemical standard (Sumner et al., 2014).  
Table 1-1 List of the minimum metadata relative to metabolite identification required for 
each MSI level (Sumner et al., 2007). 
MSI Level Description  
1 
Identification of compound using at least two 
independent orthogonal data relative to an authentic 
standard compound analysed under identical conditions. 
2 
Putatively annotated compounds (without authentic 
chemical standard) based on physiochemical 
properties&/or spectral similarities with public or 
commercial libraries. 
3 
Putatively characterised compound classes- either 
through physiochemical characterisation or by similarity 
to spectra of compounds of a known chemical class. 
4 
Unknown compound- although unidentified or 
unclassified compound can still be differentiated and 
quantified based on spectral data. 
 
More recently, Sumner et al. (2014) proposed a quantitative and alphanumeric 
metabolite identification reporting method (Sumner et al., 2014). 
The proposed quantitative  system would give a numerical score to each of 
the techniques used in the analysis and then the score is multiplied by 2 or 1.5 
depending on whether the compound was matched to an authentic chemical 
standard or to literature values/spectral libraries, respectively (Sumner et al., 
2014). Using a quantitative approach, a minimum score value for a confident 
identification can be set and takes into account the identification of a 
metabolite through a variety of methods (Sumner et al., 2014).  
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The alphanumeric system uses a string of letters and numbers to summarise 
the data that composed the bases of the identification. Basic codes are 
employed to detail how the metabolite was matched (e.g. Rt = retention time 
match, MS1 = full scan MS match, MS2 = tandem MS match, subscript ‘a’ = 
matched to authentic chemical standard, subscript ‘PL’ = matched to public 
library, etc.).  
The alphanumeric metabolite identification, although more complex than the 
MSI level system for identification, is more descriptive and is more intuitive 
than the quantitative method. As such, the Sumner alphanumeric method for 
describing metabolite identification has been utilised throughout this thesis 
and subsequent publications arising from this research. 
1.4 Aims and Hypothesis 
The number and complexity of metabolites in existence leads to a need for 
novel chromatographic methods to extend the coverage of the metabolome. 
We hypothesise that the development of these novel metabolomics 
methodologies will extend the coverage of the metabolome in a simple and 
efficient manner. We further hypothesise that S. aureus and C. albicans 
interact with one another on a molecular level and that the application of the 
developed metabolomics methods to the analysis of S. aureus and C. albicans 
biofilms will highlight significant metabolic differences between the mono- 
and dual-cultured biofilms which will provide further insight into the 
relationship between this prokaryote and eukaryote within their dual-species 
biofilm.  
The overall aim of this research is to develop novel metabolomics methods 
and to apply these methods to the analysis of a S. aureus/C. albicans dual 
species biofilm to aid in the understanding of the relationship between this 
bacteria and fungi. 
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1. We aim to carry out microscopic and molecular characterisation of a 
dual-species S. aureus/C. albicans biofilm. 
2. Develop an untargeted 2D LC-MS method for the identification of 
polar and nonpolar compounds within one analytical run. 
3. Develop a targeted IC-MS metabolomics method for the analysis of 
central carbon metabolism intermediates in a single chromatographic 
run. 
4. Apply the developed metabolomics methods to the analysis of single 
and dual species S. aureus and C. albicans biofilms. 
 
 
 
 
Chapter 2. Materials and methods 
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2.1 Bacterial and fungal biofilm characterisation 
2.1.1 Bacterial and fungal strains and growth 
Candida albicans laboratory strain SC5314 (ATCC MYA-2876) was used in 
this study. C. albicans was sub-cultured on Sabouraud’s dextrose (SAB) agar 
(Fluka Analytical, India) and grown at 37°C for 48 h and maintained at 4°C. 
Broths were prepared by inoculating yeast peptone dextrose (YPD) medium 
(Sigma Life Sciences, USA), followed by incubation at 37°C, at 188 rpm, for 
16-18 h. 
Staphylococcus aureus Newman strain (NCTC 8178/ATCC) was cultured on 
Luria Bertani (LB) agar (Sigma Life Sciences, USA) and incubated for 48 h at 
37°C before being maintained at 4°C. Overnight cultures were incubated 
aerobically in LB broth (Sigma Life Sciences, USA) in a shaking incubator 
set to 37°C, at a speed of 188 rpm, for 16-18 h. 
2.1.2 Biofilm formation 
Overnight cultures of C. albicans and S. aureus were centrifuged at 3000 rpm 
for 5 minutes (Heraeus Megafuge 16R, Thermo Fisher Scientific, Germany) 
and washed twice using sterile phosphate buffered saline (PBS) (Fisher 
Chemicals, Leicestershire, UK). C. albicans and S. aureus were standardised 
to 106 cells/mL in an appropriate culture medium. Culture media with no 
inoculum were used as negative controls. 
2.1.3 Biofilm characterisation 
For biofilm characterisation, pure and co-cultures of the S. aureus and C. 
albicans strains were first grown in four different media. Trypic soy broth 
(TSB), brain-heart infusion (BHI), RPMI and 50% foetal bovine serum (FBS) 
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(all Sigma-Aldrich) were selected. Growth curves and crystal violet (CV) 
staining were used to determine the most appropriate culture medium. 
2.1.4 Growth curves 
Pure and co-cultures of the S. aureus and C. albicans strains were grown in 
flat-bottomed 96 well microtitre plates at 37 °C for 24 hours in each of the 
four media. Their growth rates were analysed spectrophotometrically by 
reading the absorbance every hour at 590 nm in a microtitre plate reader 
(FluoStar Omega, BMG Labtech). The well plate was agitated before each 
reading to re-suspend the cells in the media. All absorbance values were blank 
corrected based upon the negative control where no growth had occurred.  
2.1.5 Biomass assays 
Biofilms were carefully washed with PBS and allowed to air dry. 100 µL of 
0.05% crystal violet (CV) solution was added to each biofilm and incubated at 
room temperature for 20 mins to allow uptake of the dye. Following 
incubation, The CV solution was discarded and the biofilms were washed 
with running tap water to remove any unbound dye, and 200 µL of 100% 
ethanol applied to de-stain each biofilm. The contents of the wells were mixed 
thoroughly by pipetting and 100 µL from each well were transferred to a new 
flat-bottomed 96 well-plate for OD measurement. The biomass was quantified 
spectrophotometrically by reading the absorbance at 570 nm in a microtitre 
plate reader (FluoStar Omega, BMG Labtech). All absorbance values were 
blank corrected based upon the negative control where no biofilms were 
formed.   
For biofilm visualisation the pure and co-cultures were grown within 12 well 
flat-bottomed tissue culture plates for 24 h. The biofilms were carefully 
washed with PBS and allowed to air dry. 1 mL of 0.05% crystal violet (CV) 
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solution was added to each biofilm and incubated at room temperature for 20 
mins to allow uptake of the dye. Following incubation, the CV solution was 
discarded and the biofilms were washed with running tap water to remove any 
unbound dye. The stained biofilms were allowed to air dry and were then 
digitally imaged (Canon IXUS 22 HS). 
2.1.6 Fluorescence microscopy 
Biofilms were grown in 12 well flat-bottomed tissue culture plates for 24 h on 
Thermanox Cell Culture coverslips. The cover slips were carefully washed in 
sterile water and placed in clean wells of a new well-plate containing 100% 
methanol. The fixed biofilms were stored at 4 °C overnight, washed carefully 
in sterile water and placed in a clean well-plate. 1 mL of 1.5 µL/mL of 
calcufluor white and 2.5 µL/mL of SYTO 9 were added to each well and left 
in the dark for 20 min.  
2.1.7 Scanning electron microscopy (SEM) 
Biofilms were grown in 12 well flat-bottomed tissue culture plates for 24 h on 
Thermanox Cell Culture coverslips. The cover slips were carefully washed in 
PBS and placed in clean wells of a new well plate. The coverslips were rinsed 
in a 2% gluteraldehyde/2% paraformaldehyde/0.15M sodium cacodylate for 5 
mins (x3) and then stored in the fixative at 4 °C until SEM could be carried 
out. The fixed and dried samples were sputter-coated with gold and viewed 
under a JEOL JSM-6400 scanning electron microscope. 
2.1.8 Cell numbers 
The effect of the presence of S. aureus and C. albicans on cell numbers in the 
co-cultured biofilms were analysed using real-time quantitative PCR. 
Biofilms were grown in 12 well flat-bottomed tissue culture plates for 24 h on 
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Thermanox Cell Culture coverslips. The cover slips were carefully washed in 
PBS and each coverslip placed in a bijoux containing 1 mL of PBS. For qPCR 
the biofilm sonicate was used for DNA extraction using the MasterPure Gram 
Positive DNA Purificiation Kit (Epicentre®, Cambridge, UK), following 
manufacturer’s instructions. The extracted DNA underwent quality checks 
using the NanoDrop spectrophotometer (Fischer Scientific, Loughborough). 
Briefly, 1 µL of extracted DNA was added to a mastermix containing 12.5 µL 
SYBR® GreenER™, 9.5 µL UV-treated RNase-free water and 1 µL of 10 µM 
forward/reverse primers for the bacterial or fungal species. Three independent 
replicates from each parameter were analysed in triplicate using MxProP 
Quantitative PCR machine and MxProP 3000 software (Stratagene, 
Amsterdam, Netherlands). Samples were quantified to calculate the colony 
forming equivalent (CFE) based upon a previously established standard curve 
of bacterial and fungal colony forming units ranging from 1 × 103 to 108 
cfu/mL (Appendix I). The R2 values for these standard curves ranged from 
0.980 to 0.999. 
2.1.9 Gene expression analysis of biofilm associated genes 
The effect of the presence of S. aureus on C. albicans SC5314 adhesion 
(ALS3) and filamentation (HWP1) was analysed by quantitative 
transcriptional analysis. Standardised cells (1 × 106 cells/mL) were grown in 
12 well flat-bottomed tissue culture plates for 24 h. The supernatant was 
removed and RNA was extracted using the TRIzol® method (Invitrogen, 
Paisley, UK) . After DNase treatment (QIAGEN, Crawley, UK) and 
purification (RNeasy MinElute Cleanup Kit; QIAGEN), cDNA was 
synthesised using a High-Capacity RNA-to-cDNA™ Kit (Life Technologies, 
Paisley, UK), and quantitative PCR (qPCR) was performed using a SYBR® 
GreenER™ assay (Life Technologies). The primers (Table 2-1) and 
conditions used for real-time qPCR throughout this study are described 
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elsewhere (Sherry et al., 2014). Each parameter was analysed in triplicate 
using an MxProP Quantitative PCR machine and MxProP 3000 software 
(Stratagene, Amsterdam, The Netherlands). Gene expression was normalised 
to the housekeeping gene act-1 according to the 2−∆∆CT method, and the 
percentage of gene expression was expressed as the log10 mean ± standard 
deviation (Livak & Schmittgen, 2001). 
 
Table 2-1 A list of the Forward (F) and Reverse (R) Primers used to quantify Candida 
albicans (C. albicans) and Staphylococcus aureus (S. aureus) cell numbers in the mono- 
and dual-species biofilms, and the Forward (F) and Reverse (R) Primers used to determine 
expression of the surface protein Als3 (ALS3) and hyphal wall protein (HWP1) in C. 
albicans. 
Species-specific Primers Sequence (5’-3’) 
C. albicans F - ACTTCTGTAAGAGTGCTGGTTC 
 R - TGTCGTAATCAAACTCGGTAGC 
S. aureus F - ATTTGGTCCCAGTGGTGTGGGTAT 
 R - GCTGTGACAATTGCCGTTTGTCGT 
C. albicans Biofilm genes  
ALS3 F - CAACTTGGGTTATTGAAACAAAAACA 
 R - AGAAACAGAAACCCAAGAACAACCT 
HWP1 F - GCTCAACTTATTGCTATCGCTTATTACA 
 R - GACCGTCTACCTGTGGGACAGT 
C. albicans Housekeeping gene  
ACT1 F - AAGAATTGATTTGGCTGGTAGAGA 
 R - TGGCAGAAGATTGAGAAGAAGTTT 
 
2.1.10 Statistical analysis 
Graph production, data distribution, and statistical analysis were performed 
using GraphPad Prism (version 5; La Jolla, CA, USA). Student t-tests were 
used to analyse experiments comparing independent sample data. Statistical 
significance was achieved if P < 0.05. All statistical analysis was carried out 
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using data obtained from three independent biological replicates for each 
sample group (n = 3). Error bars depict the standard deviation of the sample 
group. 
2.2 Serially combined method 
2.2.1 Chemicals and reagents 
HPLC gradient grade water was purchased from VWR (Chicago, USA). 
Absolute ethanol and acetonitrile were purchased from Fisher Scientific 
(Leicestershire, UK). Ammonium carbonate, deoxycholic acid, cholic acid, 
dyhydrocholic acid, chenodeoxycholic acid acid, DL-isocitric acid trisodium 
salt hydrate , cis-aconitic acid, a-ketoglutaric acid disodium salt hydrate, 
sodium succinate dibasic, sodium fumarate dibasic, DL-malic acid and 
sodium pyruvate were all purchased from Sigma-Aldrich (Bornem, Belgium). 
All chemicals were of analytical-reagent grade. 
2.2.2 Standards 
All of the standards were prepared to a concentration of 10 µM in water with 
the exception of the bile acids. Stock standard solutions of Deoxycholic acid, 
cholic acid, dehydrocholic acid and Chenodeoxycholic acid were prepared in 
100 % hot ethanol. The standards were then diluted at a 1:1 ratio with H2O 
and then diluted 1:100 in 100 % H2O, to a final concentration of 10 µM. (The 
structures of these compounds can be found in Fig. 2-1). 
10 µL of each sample was injected onto the column in triplicate over three 
days (n= 9).. 
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Figure 2-1 Chemical structures of the test compounds. A selection of polar TCA 
intermediates (succinic acid, 2-oxoglutaric acid, isocitric acid, cis-aconitic acid, pyruvic 
acid, fumaric acid and malic acid) and nonpolar bile acids (deoxycholic acid, 
chenodeoxycholic acid, cholic acid and dehydrocholic acid) were utilised to determine the 
suitability of the system for the retention and separation of polar and nonpolar metabolites 
(Haggarty et al., 2015). 
 
2.2.3 Beer samples 
Samples of a bitter style branded ale were extracted at a ratio of 1:3:1 
chloroform:methanol:beer. 250 µL samples were dried using N2 and 
resuspended in 200 µL of 10% acetonitrile in water. 
10 µL of each sample was injected onto the column in octuplicate. 
To evaluate the long term reproducibility of the method, analysis of the 
combined method was carried out in three batches over five days, while the 
individual column analyses were done over a single day (n= 23). 
2.2.4 Instrumentation 
A Thermo Scientific Ultimate 3000 RSLC system (Thermo Scientific, CA, 
USA) was used. Column temperature was maintained at 25°C. The system 
was coupled with a Thermo Scientific Exactive Orbitrap system equipped 
with a HESI II interface (Thermo Scientific, Hemel Hempstead, UK). 
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Acquisition was carried out in positive and negative switching mode. The 
capillary temperature was 275 °C with a data acquisition mass range of 70-
1400 m/z. Thermo Xcalibur™ (version 2.2.42) was used for instrument 
control and data acquisition. Fragmentation for annotation of beer metabolites 
was performed on an identically configured Thermo Scientific Q-Exactive 
with a normalised collision energy of 50 and isolation width of 1 Da.  
For the first separation a Hypersil GOLD (100 x 1.0 mm, 1.9 µm) (Thermo 
Scientific, Hemel Hempstead, UK) was used and the second separation was 
performed with a SeQuant® ZIC®-pHILIC column (150 x 4.6 mm, 5 µm) 
(Merck KGaA, Darmstadt, Germany).  The two columns were coupled in 
series through a T-piece. The third port of the T-piece was connected to the 
second pump. A scheme of the instrumental set-up is given in Fig. 2-2. All 
metabolites were detected in negative mode except where stated. 
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Figure 2-2 Schematic diagram of the RPLC/pHILIC/ESI-FTMS. The first gradient pump (Pump 1), running at 65 µL/min, delivered a high aqueous mobile 
phase for the analytes as they were injected onto the RP column. The second gradient pump (Pump 2) was joined via a t-piece to the system to deliver a high 
concentration of organic solvent (>80% ACN) before introduction of the sample to the HILIC column. Pump 2 was run at a higher flow rate of 350 µL/min 
to increase the organic concentration of the eluent before the HILIC column. One injection from each sample passed through both the RP and HILIC 
columns before detection by the mass spectrometer. By incorporating two gradient pumps into the system individual control of the mobile phase 
compositions was achieved (Haggarty et al., 2015). 
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2.2.5 Chromatographic conditions 
The RPLC mobile phase was a combination of LC-MS-grade water (solvent 
A) and acetonitrile (ACN) (solvent B). The HILIC mobile phase was a 
mixture of LC-MS-grade water + 20 mM ammonium carbonate, pH 9, 
(solvent A), ACN (solvent B) and the solvent from the RP column. The 
following RP gradient was applied at a rate of 65 µL/min: a concentration of 
5%B was held for 2 min and then increased to 95%B over 15min, where it 
was held for 5 min, followed by equilibration at 5%B, held for 15.5 min. The 
HILIC gradient was applied at a rate of 350 µL/min: a 90%B was held for 5 
min and then decreased to 20% B in 15 min and then decreased to 5% B and 
held for 5 min, followed by reconstitution of the starting conditions within 0.1 
min and re-equilibration with 90%B for 12.5 min. This resulted in a total 
analysis time of 37.5 min. A summary of the chromatographic conditions can 
be found in Table 2-2. 
2.2.6 Evaluation of reproducibility 
Retention times were obtained for each peak using the Quan Browser 
software, part of the Thermo XcaliburTM (version 2.2.42) suite. A total of nine 
replicates were used to determine retention time reproducibility for the 
organic and bile acid standards. As the extracted beer was a more complex 
sample, a total of twenty-three replicates were used to evaluate retention time 
reproducibility. Retention times were averaged and the standard deviation was 
calculated. Relative standard deviations were obtained for each compound 
and expressed as percentages. 
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Table 2-2 Summary of the chromatographic conditions for the combined RPLC/pHILIC method (Haggarty et al., 2015). Pump 1 was running a reverse 
phase (RPLC) gradient through a Thermo Hypersil GOLD (100 x 1.0 mm, 1.9 µm) column at a flow rate of 65 µL/min. Pump 2 was running a hydrophilic 
interaction liquid chromatography (HILIC) gradient through a SeQuant® ZIC®-pHILIC (150 x 4.6 mm, 5 µm) at a flow rate of 350 µL/min. Solvent A 
consisited of water (H2O) for Pump 1 and H2O + 20 mM ammonium carbonate for Pump 2. Solvent B consisted of acetonitrile (ACN) for both Pump 1 and 
Pump 2. 
 
Pump 1 (RPLC)   Pump 2 (HILIC) 
Solvent A H2O  Solvent A H2O + 20 mM ammonium carbonate 
Solvent B ACN  Solvent B ACN 
Column Thermo Hypersil GOLD (100 x 1.0 mm, 1.9 µm)  Column SeQuant® ZIC®-pHILIC (150 x 4.6 mm, 5 µm) 
    
 
    
Gradient Time (min) B% Flow (mL/min)  Gradient Time (min) B% Flow (mL/min) 
 
0 5 0.065  
 
0 90 0.350 
 
2 5 0.065  
 
5 90 0.350 
 
17 95 0.065  
 
20 20 0.350 
 
22 95 0.065  
 
20.1 5 0.350 
 
22.1 5 0.065  
 
25 5 0.350 
   
0.065  
 
25.1 90 0.350 
 
37.5 5 0.065  
 
37.5 90 0.350 
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2.2.7 Extracellular-metabolite extraction 
Medium controls (50% FBS with MilliQ water) and biofilm supernatants 
were transferred into reaction tubes (1.5 mL, Greiner bio-one GmbH, 
Germany) containing ice cold chloroform:methanol:water (1:3:1 v:v:v) at a 
ratio of 1:40 (sample:extraction solvent). The reaction tubes were vortexed at 
maximum speed for 15 seconds (Vortex Genie 2, Scientific Industries, NY, 
USA) and stored at -80oC prior to analysis. 
2.2.8 Intracellular-metabolite extraction 
Cell culture cover slips were removed from the wells and placed in bijoux 
containing ice cold 10 mM ammonium bicarbonate. The bijoux were 
sonicated at maximum speed for 10 minutes at 4oC (XUB5, 4.5 L, Grant 
Instruments, Cambridgeshire, UK). The supernatants, including the debris, 
were removed and placed in clean reaction tubes. The biofilm suspensions 
were centrifuged at 3000 rpm for 5 minutes at 4oC, the supernatants were 
removed, and 1 mL of a 1 mL:1 g extraction solvent (ChCl3:MeOH:H2O 1:3:1 
v:v:v) : 0.1 mm acid washed glass beads (Sigma Aldrich, USA) were added to 
each pellet. Bead beating was carried out at 3000 rpm for 10 minutes at 4oC 
(Disrupter Genie, Scientific Industries, NY, USA). The samples were 
centrifuged at 13000 rpm for 5 minutes at 4oC, the supernatants were removed 
and stored at -80oC analysis. 
2.2.9 Metabolic data analysis and statistical analysis 
Organic acid and bile acids were matched to authentic pure standards by 
retention time and accurate mass and can therefore be classified under the 
alphanumeric metabolite coding scheme as HRMS1a, Rta as described in 
Sumner et al. (2014). Beer metabolites were matched to compounds 
putatively by accurate mass or accurate mass and fragment spectrum match to 
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the MassBank library (Horai et al. 2010) and may be classified as HRMS1 or 
HRMS1MS2 PL respectively (Sumner et al. 2014). 
For biofilm samples, raw mass spectrometry data was processed using our 
standard pipeline (Creek, Jankevics, Burgess, Breitling, & Barrett, 2012; 
Gloaguen et al., 2017), consisting of XCMS (C. A. Smith, Want, O’Maille, 
Abagyan, & Siuzdak, 2006) (for peak picking), MzMatch (Scheltema, 
Jankevics, Jansen, Swertz, & Breitling, 2011) (for filtering and grouping) and 
in-house R-scripts (for further filtering, post-processing and identification). 
Peaks were visualised using PeakML viewer (Scheltema et al., 2011). Core 
metabolite identifications were validated against a panel of unambiguous 
authenic pure standards (Sigma-Aldrich) using high resolution accuate mass 
and RT (error of 5% was allowed), and could therefore be classified as 
HRMS1a, Rta, as described by Sumner et al. (2014). Additional putative 
identifications were assigned by accurate mass along with a RT prediction 
algorithm (error of 35% allowed) (Creek et al., 2011) and as such were 
classified as HRMS1PL (Sumner et al., 2014). 
Once identified and filtered, detected peak intensities were logged (base 2) 
and quantification was performed on sets of biological replicates by applying 
differential statistics to generate P values. Metabolites with apparently 
different levels were assessed using Bayes moderated t-tests (Smyth, 2004). 
Benjamini and Hochberg false discovery rate adjustment for multiple testing 
was applied (Hochberg & Benjamini, 1990) and the resulting data was used to 
query the KEGG database for pathway analysis (Kanehisa & Goto, 2000). For 
LC-MS analysis, five independent biological replicates were used.  
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2.3 Ion chromatography – mass spectrometry 
2.3.1 Chemicals and reagents 
HPLC gradient grade water was purchased from VWR (Chicago, USA). 
Absolute ethanol and acetonitrile were purchased from Fisher Scientific 
(Leicestershire, UK). All of the central carbon metabolism standards were 
purchased from Sigma-Aldrich (Bornem, Belgium). All chemicals were of 
analytical-reagent grade. 
2.3.2 Standards 
Each individual standard was prepared to a concentration of 1 mM in 
ultrapure Milli-Q water, with the exception of acetyl-CoA, CoA, succinyl-
CoA, FAD, ATP and ADP which were made up to a concentration of 100 
µM.  
A glycolysis mix (Table 2-3) was created by diluting the 1 mM stocks of 
glucose, glucose 6-phosphate, fructose 6-phosphate, dihydroxyacetone 
phosphate, glyceraldehyde 3-phosphate, 3-phosphoglycerate, 2-
phosphoglycerate, phosphoenolpyruvate, pyruvate at a 1:10 ratio and the 1 
mM stock of fructose 1,6-bisphosphate at a ratio of 1:100, resulting  in a final 
concentration of 100 µM for each standard and 10 µM of fructose 1,6-
bisphosphate. 
A TCA mix (Table 2-4) was created by diluting 1 mM stocks of citric acid, 
isocitric acid, cis-aconitic acid, 2-oxoglutaric acid, succinic acid, fumaric 
acid, malic acid and oxaloacetic acid at a 1:10 ratio, resulting in a final 
concentration of 100 µM of each standard. 
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A coenzyme and nucleoside phosphate mix (Table 2-5) was created by the 
addition of each of the stock solutions of nicotinamide adenine dinucleotide 
phosphate (NADP+), nicotinamide adenine dinucleotide (NAD+), flavin 
adenine dinucleotide (FAD), adenosine diphosphate (ADP), and adenosine 
triphosphate (ATP) at a 1:10 ratio. This resulted in a mix containing 100 µM 
of NADP+ and NAD+, and 10 µM of FAD, ADP and ATP. 
A total energy mix was made by diluting each of the standards at a 1:10 ratio, 
with the exception of fructose 1, 6-bisphosphate, which was diluted at a ratio 
of 1:100. This resulted in a mix containing 100 µM of glucose, glucose 6-
phosphate, fructose 6-phosphate, dihydroxyacetone phosphate, 
glyceraldehyde 3-phosphate, 3-phosphoglycerate, 2-phosphoglycerate, 
phosphoenolpyruvate, pyruvate, citric acid, isocitric acid, cis-aconitic acid, 2-
oxoglutaric acid, succinic acid, fumaric acid, malic acid and oxaloacetic acid, 
NADP+, NAD+, ADP and ATP, and 10 µM of fructose 1, 6-bisphosphate, 
ADP, ATP and FAD. 
Table 2-3 A list of the glycolysis standards elemental formulae, molecular weights (MW) 
and m/z values ([M-H]). 
Glycolysis  
  
Metabolite Formula MW [M-H] 
Glucose C6H12O6 180.0634 179.0562 
Glucose-6-phosphate  C6H13O9P 260.0297 259.0225 
Fructose-6-phosphate  C6H13O9P 260.0297 259.0225 
Fructose-1,6-biphophate  C6H14O12P2 339.9961 338.9889 
Glyceraldehyde-3-phosphate  C3H7O6P 169.9980 168.9908 
3-Phosphoglyceric acid C3H7O7P 185.9929 184.9857 
2-Phosphoglyceric acid C3H7O7P 185.9929 184.9857 
Phosphoenolpyruvic acid C3H5O6P 167.9824 166.9752 
Pyruvic acid C3H4O3 88.0160 87.0088 
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Table 2-4 A list of the TCA standards elemental formulae, molecular weights (MW) and 
m/z values ([M-H]). 
TCA cycle 
   
Metabolite Formula MW [M-H] 
Citric acid C6H8O7 192.0270 191.0198 
Isocitric acid C6H8O7 192.0270 191.0198 
cis-Aconitic acid C6H6O6 174.0164 173.0092 
2-Oxoglutaric acid C5H6O5 146.0215 145.0143 
Succinyl-CoA C25H40N7O19P3S 867.1313 866.1241 
Succinic acid C4H6O4 118.0266 117.0194 
Fumaric acid C4H4O4 116.0110 115.0038 
Malic acid C4H6O5 134.0215 133.0143 
Oxaloacetic acid C4H4O5 132.0059 130.9987 
Acetyl-Coenzyme A (CoA) C23H38N7O17P3S 809.1258 808.1186 
Coenzyme A (CoA) C21H36N7O16P3S 767.1152 766.108 
 
 
Table 2-5 A list of the coenzymes and nucleoside phosphates standards elemental 
formulae, molecular weights (MW) and m/z values ([M-H]). 
Coenzymes and nucleoside phosphates 
   
Metabolite Formula MW [M-H] 
Nicotinamide adenine dinucleotide phosphate (NADP+) C21H28N7O17P3 743.0755 742.0683 
Nicotinamide adenine dinucleotide (NAD+) C21H28N7O14P2 664.1170 663.1098 
Flavin adenine dinucleotide (FAD) C27H33N9O15P2 785.1571 784.1499 
Adenosine diphosphate (ADP) C10H15N5O10P2 427.0294 426.0222 
Adenosine triphosphate (ATP) C10H16N5O13P3 506.9958 505.9886 
 
 
2.3.3 Instrumentation 
A Thermo Scientific Dionex™ ICS-2100 Integrated IC System (Thermo 
Scientific, CA, USA) was used. The IC system was coupled to a Thermo 
Scientific Orbitrap FusionTM TribridTM Mass Spectrometer (Thermo 
Scientific, CA, USA) using a HESI interface (Thermo Scientific, Hemel 
Hempstead, UK). The spray voltage was 2500V, with a transfer tube 
temperature of 333 °C. Acquisition was carried out in negative polarity mode. 
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The capillary temperature was 275 °C with a data acquisition mass range of 
70 – 1000 m/z. The analytes were detected using the Orbitrap detector with a 
resolution of 60 000. The ICS-2100 IC System was controlled using Thermo 
Chromeleon® software (version 6.80). Thermo XcaliburTM (version 
3.1.66.10) was used for mass spectrometer instrument control and data 
acquisition.  
A Thermo Dionex™ IonPac™ AS11-HC-4µm (2 x 250 mm) column 
(Thermo Scientific, Hemel Hempstead, UK) was utilized in this study. The 
ICS-2100 system was coupled to the mass spectrometer via an external pump 
running at a flow rate of 70 µL/min. The make-up flow consisted of 100% 
MeOH.  
2.3.4 Chromatographic conditions 
Column temperature was maintained at 35 °C. Ultrapure (18.2 MΩ·cm at 25 
°C)  Milli-Q (Merck Millipore, MA, USA) water was further purified using a 
Thermo Scientific™ Dionex™ ICW-3000 Online Water Purifier (Thermo 
Scientific, CA, USA) before introduction to the ICS-2100 system. A 
hydroxide (OH-) mobile phase was produced using a Thermo Scientific™ 
Dionex™ Potassium Hydroxide Eluent Generator Cartridge (EGC 500 KOH) 
(Thermo Scientific, CA, USA). The following OH- gradient was applied at a 
rate of 230 µL/min: an equilibration at a concentration of 1 mM was held for 
7 min at the beginning of each chromatographic run. A concentration of 1 
mM was held for 3 min and then increased to 31 mM over 20 min. The 
concentration was then increased to 36 mM over 10 min, then increased to 50 
mM over 10 min and increased to 100 mM over 10 min and held 7 min, 
followed by a decrease to 5 mM within 0.1 min. This resulted in a total 
analysis time of 67.1 min. A summary of the chromatographic conditions can 
be found in Figure 2-3 & Table 2-6. 
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Figure 2-3 Summary of the chromatographic conditions used for the targeted ion 
chromatography – mass spectrometry (ICMS) analysis of energy metabolite standards and 
extracted biofilm (intracellular) and spent media (extracellular) samples. A hydroxide (OH-
) gradient increasing from 1 – 100 mM over 60 min, with a re-equilibration of 1 mM for 7 
min, was carried out for each chromatographic run, resulting in a total analysis time of 67.1 
min. 
 
Table 2-6 Summary of the chromatographic conditions used for the targeted ion 
chromatography – mass spectrometry (ICMS) analysis. The eluent consisted of a 
hydroxide (OH-) gradient flowing at a rate of 230 µL/min. The column used was a Thermo 
Dionex™ IonPac™ AS11-HC-4µm (2 x 250 mm). 
  
  
Eluent OH- (Thermo Dionex™ EGC 500 KOH) 
Column Thermo Dionex™ IonPac™ AS11-HC-4µm (2 x 250 mm) 
    
Gradient Time (min) Concentration (mM) Flow (mL/min) 
 
-7 1 0.230 
 
0 1 0.230 
 
3 1 0.230 
 
23 31 0.230 
 
33 36 0.230 
 
43 50 0.230 
 53 100 0.230 
 60 100 0.230 
 
60.1 5 0.230 
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2.3.5 Evaluation of reproducibility and limits of detection 
Retention times for the energy metabolite standards were obtained by 
conducting a mass search for each individual standard peak using Thermo 
ScientificTM ToxID Automated Compound Screening Software (version 
2.1.2.17). The average retention time for each energy metabolite was used to 
create an automatic processing method to screen each sample for all energy 
metabolites, using Quan Browser software, part of the Thermo XcaliburTM 
(version 2.2.42) suite. Retention times were averaged and the standard 
deviation was calculated. Relative standard deviations were calculated for 
each compound and expressed as percentages. 
The stock solution of the total energy mix was serially diluted to determine 
the limits of detection (LoD) for each metabolite when using the system 
(Table 2-7). An automatic processing method was created using the Quan 
Browser software (Thermo Scientific, CA, USA). The expected retention time 
and [M-H] for each metabolite were used to detect each analyte within the 
total mix dilutions. The peak areas were measured using an Xcalibur 
processing method and reported for each of the metabolite standards at each 
of the dilutions.  
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Table 2-7 Summary of the energy metabolite concentrations used to determine the limits 
of detection (LoD) of the IC-MS system. Each metabolite’s elemental formula (EF) is 
listed along with its final concentration (nmoles) in the total mix for each of the dilutions 
used (Dilution Factor). 
  Dilution Factor 
Metabolite EF 1 1/5 1/10 1/15 1/25 1/50 1/100 1/500 
  Concentration (nmol) 
Glucose C6H12O6 100000 20000 10000 6666.67 4000 2000 1000 200 
Glucose-6-phosphate C6H13O9P 100000 20000 10000 6666.67 4000 2000 1000 200 
Fructose-6-phosphate C6H13O9P 100000 20000 10000 6666.67 4000 2000 1000 200 
Fructose-16-biphosphate C6H14O12P2 10000 2000 1000 666.67 400 200 100 20 
3-phosphglycerate C3H7O7P 100000 20000 10000 6666.67 4000 2000 1000 200 
2-phosphoglycerate C3H7O7P 100000 20000 10000 6666.67 4000 2000 1000 200 
Phosphoenolpyruvate C3H5O6P 100000 20000 10000 6666.67 4000 2000 1000 200 
Pyruvate C3H4O3 100000 20000 10000 6666.67 4000 2000 1000 200 
Citrate C6H8O7 100000 20000 10000 6666.67 4000 2000 1000 200 
Isocitrate C6H8O7 100000 20000 10000 6666.67 4000 2000 1000 200 
cis-Aconitate C6H6O6 100000 20000 10000 6666.67 4000 2000 1000 200 
2-Oxoglutarate C5H6O5 100000 20000 10000 6666.67 4000 2000 1000 200 
Succinate C4H6O4 100000 20000 10000 6666.67 4000 2000 1000 200 
Fumarate C4H4O4 100000 20000 10000 6666.67 4000 2000 1000 200 
Malate C4H6O5 100000 20000 10000 6666.67 4000 2000 1000 200 
Oxaloacetate C4H4O5 100000 20000 10000 6666.67 4000 2000 1000 200 
FAD C27H33N9O15P2 100000 20000 10000 6666.67 4000 2000 1000 200 
ADP C10H15N5O10P2 10000 2000 1000 666.67 400 200 100 20 
ATP C10H16N5O13P3 10000 2000 1000 666.67 400 200 100 20 
 
 
2.3.6 Extracellular-metabolite extraction 
Medium controls (50% FBS with MilliQ water) and biofilm supernatants 
were transferred into reaction tubes (1.5 mL, Greiner bio-one GmbH, 
Germany) containing ice cold chloroform:methanol:water  
(ChCl3:MeOH:H2O) (1:3:1 v:v:v) at a ratio of 1:40 (sample:extraction 
solvent). The reaction tubes were vortexed at maximum speed for 15 seconds 
(Vortex Genie 2, Scientific Industries, NY, USA) and stored at -80oC prior to 
analysis. 
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2.3.7 Intracellular-metabolite extraction 
Cell culture cover slips were removed from the wells and placed in bijoux 
containing ice cold 10 mM ammonium bicarbonate. The bijoux were 
sonicated at maximum speed for 10 minutes at 4oC (XUB5, 4.5 L, Grant 
Instruments, Cambridgeshire, UK). The supernatants, including the debris, 
were removed and placed in clean reaction tubes. The biofilm suspensions 
were centrifuged at 3000 rpm for 5 minutes at 4oC, the supernatants were 
removed, and 1 mL of a 1 mL:1 g extraction solvent (ChCl3:MeOH:H2O 1:3:1 
v:v:v) : 0.1 mm acid washed glass beads (Sigma Aldrich, USA) were added to 
each pellet. Bead beating was carried out at 3000 rpm for 10 minutes at 4oC 
(Disrupter Genie, Scientific Industries, NY, USA). The samples were 
centrifuged at 13000 rpm for 5 minutes at 4oC, the supernatants were removed 
and stored at -80oC analysis. 
2.3.8 Metabolite identification and statistical analysis 
All of the energy metabolite were matched to authentic pure standards by 
retention time and accurate mass and can therefore be classified under the 
alphanumeric metabolite coding scheme as HRMS1a, Rta as described by 
Sumner et al. (2014). 
For biofilm samples, raw mass spectrometry data was processed using Quan 
Browser software, part of the Thermo XcaliburTM (version 2.2.42) suite. Core 
metabolite identifications were validated against a panel of unambiguous 
authentic pure standards (Sigma-Aldrich) using high resolution accurate mass 
and RT (error of 3 ppm was allowed), and could therefore be classified as 
HRMS1a, Rta, as described by Sumner et al. (2014).  Detected peak intensities 
were logged (base 2), and quantification was performed on sets of biological 
replicates. For IC-MS analysis, five independent biological replicates were 
used with standard deviation calculated and recorded for each compound.
 
 
 
 
Chapter 3. S. aureus and C. albicans 
dual-species biofilm characterisation 
The work presented within this chapter (sections of which have been 
submitted for publication) was carried out with the assistance of Ryan 
Kean at the University of Glasgow Dental School. 
  
 
 
 
 
Chapter 3  113 
3.1 Introduction  
Staphylococcus aureus and Candida albicans frequently coexist within the 
human host as complex biofilm communities (Adam et al., 2002; Baena-
Monroy et al., 2005). S. aureus and C. albicans are leading pathogens in 
bloodstream and systemic infections, and cause morbidity and mortality in 
hospitalized patients. These two organisms are of significant interest because 
of the escalating development of antimicrobial resistance and the increasing 
awareness of the involvement of polymicrobial biofilms in chronic and 
systemic infections (Perlroth, Choi, & Spellberg, 2007). These prokaryote and 
eukaryote have been shown to co-aggregate together; existing within a 
dynamic and interactive state (Peters, Jabra-rizk, et al., 2012; Peters, 
Ovchinnikova, et al., 2012; Shirtliff, Peters, & Jabra-Rizk, 2009). It appears 
that in an analogous manner to C. albicans and oral streptococci biofilms, 
yeast cells have the capacity to modulate the action of antibacterial agents and 
staphylococci, which can also affect the activity of antifungal agents in these 
biofilms (Adam et al., 2002). For example, it has been reported that the 
presence of C. albicans along with S. aureus protects the bacteria against 
vancomycin treatment up to concentrations as high as 1600mg/mL, which has 
been suggested to be a multifactorial process (Harriott & Noverr, 2009, 
2010). Importantly, their interaction has been associated with enhanced 
pathogenic behaviour, disease severity and morbidity (Nair, Biswas, Götz, & 
Biswas, 2014). 
The ability of these microorganisms to co-colonize or co-infect has been 
demonstrated in a clinical setting. In denture stomatitis patients, an archetypal 
polymicrobial disease, a high incidence of mixed colonization by both species 
has been demonstrated (Baena-Monroy et al., 2005). While not life-
threatening, this is a disease of chronic inflammation, suggesting a degree of 
synergy between S. aureus and C. albicans. It is not uncommon to find these 
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two organisms preferentially isolated from sonicated vascular catheters, 
which is coincidental with positive blood cultures (Sherertz et al., 1990). 
Furthermore, mixed bacterial–fungal biofilms have been shown to be 
associated with a multitude of other conditions including infections of 
endotracheal tubes, biliary stents, silicone voice and orthopaedic prostheses 
and acrylic dentures (Peters, Jabra-rizk, et al., 2012). Collectively, these 
clinical observations give credence in the study of the interactions between 
these two important nosocomial bloodstream pathogens. The importance of 
this has already led to significant commentary on their interactions and its 
implications for disease (Nair et al., 2014; Shirtliff et al., 2009).  
Experimentally, there have been some interesting mechanistic observations. It 
has been shown that S. aureus preferentially adheres to hyphal elements of C. 
albicans, relying on the adhesion to the aglutanin-like sequence 3 protein 
(Als3p) from C. albicans to adhere to its hyphae, though it is likely that other 
proteins are involved (Peters et al., 2010a; Peters, Ovchinnikova, et al., 2012). 
It is thought that adhesion to the hyphae, one of C. albicans most influential 
virulence factors, may assist S. aureus in penetrating into the host, a manner 
analogous to injection from a needle-stick injury. This has been demonstrated 
in mice studies, where in mixed infections those mice infected with C. 
albicans ∆als3 strains along S. aureus were unable to invade the tongue, 
whereas the wild type infections demonstrated co-infection (Peters, 
Ovchinnikova, et al., 2012). The ramifications of this enhanced invasive 
capacity have been shown historically to impact mortality, where synergism 
between the co-infection intraperitoneally in a mouse model was shown to 
lead to 100% mortality, whereas mono-species infections caused no mortality 
whatsoever (Eunice Carlson, 1983).  Whether or not the relationship between 
the two organisms is physical or chemical remains to be determined, although 
there is evidence that growth related synergy is an important factor in their 
co-habitation of micro-niches (Eunice Carlson & Johnson, 1985a). The 
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physical relationship between the organisms is important, but not 
fundamental, as recent studies have indicated that morphogenesis, i.e. the 
presence of hyphae, is not a critical factor in their pathogenic potential as 
demonstrated in some intricate mice studies using C. albicans genetically 
locked into the yeast state (Nash, Peters, Palmer, Fidel, & Noverr, 2014).  
However, these studies do suggest that the physical aspects of the interaction 
may be host site specific.  
One key feature of this study was the implication for the role of inflammation 
and its role in disease outcomes (Nash et al., 2014). This could suggest that in 
addition to the physical cellular interactions, chemical signalling between the 
microorganisms may play an important additional role in alerting the host. 
Understanding this may be crucial in improving clinical management. 
Chemically mediated signalling is suggestive of quorum sensing, which could 
potentiate both positive and negative interactions between these two 
microorganisms, which inadvertently potentiates host immunity. Interestingly, 
C. albicans produces a quorum sensing molecule farnesol that has been 
shown to impact cell membrane integrity, viability and susceptibility to 
clinically important antibiotics (Jabra-Rizk, Meiller, James, & Shirtliff, 2006). 
In the context of orthopaedic research similar data has been observed, with 
farnesol also eliciting negative effects on osteoblastogenesis (Unnanuntana, 
Bonsignore, Shirtliff, & Greenfield, 2009). Therefore, this supports the idea 
that the interaction between the two microorganisms may have detrimental 
effects on the host. If the work in Streptococcus gordonii and C. albicans is 
extrapolated, then it can be surmised that a bidirectional relationship is likely 
to exist between S. aureus and C. albicans (Bamford et al., 2009).  
The aim of this study was to test the hypothesis that S. aureus and C. albicans 
intimately interact with one another through chemical and protein mediated 
interactions. The goal was to investigate the relationship between S. aureus 
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and C. albicans, utilising a variety of macroscopic, microscopic and 
molecular techniques. The results obtained from the analysis of the 
polymicrobial biofilm were compared to those obtained from the individual 
bacterial and fungal biofilms in the hope that the differences recorded would 
enable elucidation of the physical and molecular interactions between these 
two nosocomial pathogens to be determined.   
3.2 Material and methods  
The materials and methods are the same as those described in Chapter 2. 
Transcriptional analysis was attempted for a number of S. aureus 
MSCRAMM proteins. However, very low quantities of RNA were collected, 
which resulted in insufficient levels of cDNA production. 
3.3 Results  
3.3.1 Growth curves 
Four different types of media were investigated to determine the optimum 
growth conditions for the mono-species S. aureus and C. albicans cultures 
and the dual-species cultures (Fig. 3-1). Trypticase soy broth (TSB) favours 
the growth of the co-culture and S. aureus (Fig. 3-1 A). There are 
considerably lower levels of growth of C. albicans in TSB, apparent after 6 
hours of incubation, when the growth curves begin to plateau; where there is a 
significant difference (p = 0.002) between the co-culture and C. albicans 
growth (Fig. 3-1 A). This significant difference in growth between the co-
culture and C. albicans continues for the duration of the 24 hour incubation 
period (p < 0.0001).  
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Brain-heat infusion is preferential for the growth of bacteria, and as such 
higher levels of growth were recorded for S. aureus and the co-culture (Fig. 3-
1 B). After 24 hours of incubation the organisms appeared to still be growing 
at an exponential rate, signified by the absence of a curve plateau (Fig. 3-1 B). 
There is a significant difference in the growth profile of the C. albicans 
cultures and the co-cultures (p = 0.001). 
C. albicans and the co-culture grew at similar rates in the Roswell Park 
Memorial Institute (RPMI) media, but the media does not support the growth 
of S. aureus (Fig. 3-1 C). There was a significant difference (p = 0.0002) 
between S. aureus and co-culture growth profiles after 8 hours of growth, 
when the growth began to plateau (Fig. 3-1 C). This significant difference in 
the growth rates of S. aureus and the co-culture continued for the remainder 
of the 24 hour incubation period (p < 0.0001). 
The levels of growth when the mono- and dual-species cultures were 
incubated in 50% foetal bovine serum (FBS) were lower than those recorded 
for TSB, BHI and RPMI (Fig. 3-1 D and A-C). However the growth levels 
between S. aureus, C. albicans and the co-culture were all comparable to one 
another, with no significant difference recorded after 10 hours of incubation, 
when the growth curves begin to plateau  (p = 0.111 for C. aureus vs. co-
culture, and p = 0.216 for S. aureus vs. co-culture) (Fig. 3-1 D). No 
significant differences in the growth levels were detected between S. aureus, 
C. albicans and the co-cultures (p = 0.117 and p = 0.085, respectively) for the 
remainder of the 24 incubation (Fig. 3-1 D).  
50% FBS was chosen as the culture media for further the mono- and dual-
species biofilm analysis as the media equally supported the growth of the 
mono- and dual-species cultures. 
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Figure 3-1 A comparison of the growth curves of C. albicans, S. aureus and their co-
culture in various media. (A) trypticase soy broth (TSB), (B) brain-heart infusion (BHI), 
(C) RPMI and (D) 50% foetal bovine serum (FBS). Absorbance measured at 590 nm every 
hour over 24 hour incubation at 37°C. Error bars ± standard deviation (S.D). (n=3). 
 
3.3.2 Biomass assay 
The results obtained from the biomass assay suggest that although the level of 
growth between S. aureus, C. albicans and their co-culture are similar when 
cultured in 50% FBS, their ability to form biofilms is quite different (Fig. 3-
2). FBS does not support S. aureus biofilm formation as a mono-species (Fig. 
3-2 A and B (b)). S. aureus were present after 24 hours of growth, but an 
average absorbance of 0.057 suggested that the bacteria had formed very poor 
biofilms. C. albicans readily formed strong biofilms after 24 hours of growth, 
with an average absorbance of 1.120; - approximately a 20 fold increase in 
biomass compared to the S. aureus mono-species (Fig. 3-2). The dual-species 
biofilm displayed the greatest biomass, with an average absorbance of 1.476 
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(Fig. 3-2A). The biomass of the co-culture was significantly increased 
(p=<0.0001) in comparison to both mono-species biofilms (Fig. 3-2 A). When 
the biofilms were stained using crystal violet (CV) the differences in biomass 
between the three cultures could be seen easily (Fig. 3-2 B).  
 
Figure 3-2 Biomass comparison of C. albicans, S. aureus and their co-culture in 50% FBS 
by crystal violet (CV) staining. (A) Bar chart and (B) Macroscopic image. Well plate lay 
out was as follows: top row = C. albicans; middle row = S. aureus; bottom row = co-
culture. CV stained and absorbance measured at 530 nm after 24 hours growth at 37°C. 
p*** < 0.001. Error bars ± standard deviation (S.D). (n=3). 
 
The results obtained from the CV staining assay provided a qualitative 
description of biomass for the mono- and dual-species biofilms. To determine 
the actual quantity of S. aureus and C. albicans present in the mono- and 
dual-species biofilms, a molecular approach was adopted comparing the 
colony-forming equivalents (CFE) of each mono-culture to the co-culture 
(Fig. 3-4).  
Relative standard curves were produced for each organism using the method 
described in Chapter 2: Materials and methods (Graphs can be found in 
Appendix I). The curves displayed great linearity with linear regression 
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coefficients of 0.999 and 0.982 obtained for S. aureus and C. albicans, 
respectively (Appendix I). The CFE for each organism within the mono- and 
co-culture was then calculated in comparison to these standard curves.  
3.2.2.1 Simultaneous growth  
There is a significant 1.91 fold decrease in the CFE of C. albicans when the 
organism was cultured in the presence of S. aureus (Fig. 3-3). Conversely, a 
significant increase of S. aureus CFE was recorded, when S. aureus was 
cultured in the presence of C. albicans (Fig. 3-3). There was a 19.64 fold 
increase in S. aureus in the co-culture compared to the mono-species culture.  
 
Figure 3-3 Bar charts comparing the average colony-forming equivalents (CFE) for C. 
albicans (CA) and S. aureus (SA) in their mono- and co-cultures. Biofilms were grown in 
50% FBS. The biofilms were washed and then sonicated in PBS to remove the biofilm 
from the coverslips. DNA was extracted from the samples using the fungal/bacterial DNA 
extraction method and quantified using qPCR, using species specific primers. Previously 
assembled standard curves were used for DNA quantitation. p** <0.01, p*** <0.001. Error 
bars ± standard deviation (S.D). (n = 3). 
 
 
Chapter 3  121 
3.2.2.2 Sequential growth 
Quantitation was also carried out for the sequential growth of C. albicans and 
S. aureus. When C. albicans cells were added to a mature S. aureus biofilm 
(grown for 24 hours prior to C. albicans inoculation), the quantity of the 
fungus decreased significantly in the co-culture in comparison to its mono-
species counterpart (Fig 3-4 A). There was a 2.94 fold decrease of C. albicans 
in the co-culture compared to the mono-culture after 48 hours of growth (Fig. 
3-4 A). When the quantity of S. aureus in this co-culture was compared to the 
S. aureus mono-cultured biofilm, there was a significant 27.50 fold increase 
in the quantity of the bacteria (Fig.3-4 A).  
The addition of S. aureus cells to a mature C. albicans biofilm resulted in a 
significant decrease  in the number of C. albicans CFE; a 2.06 fold decrease 
compared to the C. albicans mono-culture (Fig. 3-4 B). The quantity of S. 
aureus in the co-culture significantly increased where a 7 fold increase in 
CFE was recorded compared to the S. aureus monoculture (Fig.3-4 B). 
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Figure 3-4 Bar charts comparing the average colony-forming equivalents (CFE) for C. 
albicans (CA) and S. aureus (SA) in their mono- and co-cultures after the addition of (A) 
CA to a mature SA biofilm and (B) SA to a mature CA biofilm. CA (A) and SA (B) were 
added to the mature biofilms after 24 hours of growth and incubated for a further 24 hours. 
Biofilms were grown in 50% FBS. The biofilms were washed and then sonicated in PBS to 
remove the biofilm from the coverslips. DNA was extracted from the samples using the 
fungal/bacterial DNA extraction method and quantified using qPCR, using species specific 
primers. Previously assembled standard curves were used for DNA quantitation. p* <0.05, 
p** <0.01. Error bars ± standard deviation (S.D). (n = 3). 
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3.3.3 Biofilm visualisation 
3.3.3.1 Fluorescence microscopy 
After 24 hours of growth in 50% FBS S. aureus produced very poor, sparsely 
populated biofilms when it was cultured on its own (Fig. 3-5). C. albicans 
formed a densely populated filamentous biofilm in its mono-species culture 
(Fig. 3-6). When the organisms were cultured together C. albicans formed 
biofilms similar to the compact, filamentous observed in its mono-culture 
(Fig. 3-7). Observed around these structures were large clusters of S. aureus 
populations interspersed throughout the biofilm (Fig. 3-7). 
 
Figure 3-5 Fluorescent images of S. aureus with fluorescently stained nucleic acids 
(green) and chitin (blue). Magnification: x40. After 24 hours of growth in 50%FBS the 
biofilms were washed in PBS and fixed in methanol (overnight). The biofilms were stained 
with fluorescent dyes and imaged using a fluorescence microscope. The SA biofilm is 
poorly formed, sparsely populated with bacterial cells Blue: Calcofluor white; green: 
SYTO9. 
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Figure 3-6 Fluorescent images of C. albicans (CA), with fluorescently stained nucleic 
acids (green) and chitin (blue). Magnification: x40. After 24 hours of growth in 50%FBS 
the biofilms were washed in PBS and fixed in methanol (overnight). The biofilms were 
stained with fluorescent dyes and imaged using a fluorescence microscope. CA readily 
forms densely packed filamentous biofilms in FBS. Blue: Calcofluor white; green: 
SYTO9. 
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Figure 3-7 Fluorescent images of S. aureus and C. albicans co-culture, with fluorescently 
stained nucleic acids (green) and chitin (blue). Magnification: x40. After 24 hours of 
growth in 50%FBS the biofilms were washed in PBS and fixed in methanol (overnight). 
The biofilms were stained with fluorescent dyes and imaged using a fluorescence 
microscope. SA has colonised areas on C. albicans with coccoid cells (arrows) in the 
polymicrobial biofilm. Blue: Calcofluor white; green: SYTO9. 
 
3.3.3.2 Scanning electron microscopy (SEM) 
SEM imaging of the S. aureus mono-culture confirmed that S. aureus was 
unable to form strong biofilms in FBS (Fig.3-8). The biofilms produced by 
the bacteria were sparsely populated with very little extracellular matrix 
(ECM) production (Fig. 3-8 B). As expected, C. albicans formed good 
biofilms in FBS which comprised dense networks of filamentous hyphae (Fig. 
3-9). 
The addition of C. albicans to the preformed S. aureus biofilms resulted in a 
biofilm that looked similar to the mono-species C. albicans biofilm (Figs. 3-9 
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& 3-10). The biofilm consisted of the C. albicans hyphal network interspersed 
with very few S. aureus (Fig. 3-10). This image suggested that the fungal 
biofilm could be forming over the top of the bacterial biofilm, with no 
interaction occurring between the two organisms.  
Simultaneous co-culture of S. aureus and C. albicans, and the addition of S. 
aureus to a preformed C. albicans, produce almost identical biofilms. The 
bacteria adhere to the hyphae and ECM of the fungi (Fig. 3-11). The coccoid 
cells of the bacteria clustered around the filamentous structures and were 
coated in ECM (Fig. 3-11). It could not be determined whether the ECM was 
a product of the fungi, bacteria or both organisms from the SEM images. The 
hyphae of the C. albicans appeared wrinkled in comparison to the mono-
species C. albicans hyphae (Fig. 3-9 - 11).   
Chapter 3  127 
 
Figure 3-8 Secondary electron images of S. aureus (SA) at (A) 2000x and (B) 4000x 
magnification. Biofilms were grown for 24 hours before being washed in PBS and fixed 
using aldehydes. The fixed biofilms were imaged using a JEOL JSM-6400 microscope. 
The SA biofilm is sparsely populated with large voids in the structure (A & B).  There is 
little extra cellular matrix production (arrows) indicating poor biofilm development (B). 
Scale bars = 10 µm (A) and 5 µm (B). 
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Figure 3-9 Secondary electron images of C. albicans (CA). Biofilms were grown for 24 
hours before being washed in PBS and fixed using aldehydes. The fixed biofilms were 
imaged using a JEOL JSM-6400 microscope. The biofilm is densely populated with layers 
of interlinking filamentous hyphae. Scale bar = 10 µm. 
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Figure 3-10 Secondary electron images of the co-cultured biofilm. S. aureus was grown in 
50% FBS for 24 hours. C. albicans was added to the mature biofilm and the co-culture 
incubated for a further 24 hours. The mature biofilms were washed in PBS and fixed using 
aldehydes. The fixed biofilms were imaged using a JEOL JSM-6400 microscope. The 
biofilm is mainly composed of C. albicans with very few S. aureus cells (arrows) present.  
Scale bar = 10 µm. 
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Figure 3-11 Secondary electron images of the S. aureus and C. albicans dual-species 
biofilm at (A) 2000x and (B) 4000x magnification. Biofilms were grown for 24 hours 
before being washed in PBS and fixed using aldehydes. The fixed biofilms were imaged 
using a JEOL JSM-6400 microscope. The S. aureus coccoid cells covered in extracellular 
matrix (ECM) (arrows) aggregate around the hyphal structures of the C. albicans cells (A 
& B). The wrinkled hyphae (arrow heads) suggest hyphal cell damage caused by presence 
of S. aureus. Scale bar = 5 µm. 
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3.3.4 Transcriptional analysis 
The previous data described the interaction between S. aureus and C. albicans 
in terms of their physical interaction. To determine whether S. aureus and C. 
albicans interact at the molecular level in the dual-species biofilm, the 
expression levels of two key C. albicans genes were evaluated (Fig. 3-12). 
There was a significant increase in expression of the gene encoding the cell 
surface protein Hwp1 in the co-culture compared to the C. albicans mono-
culture (Fig. 3-12 A). There was a 1.79 fold increase in percentage expression 
of Hwp1 (Fig. 3-12 A). There was an increase in the expression of the 
adhesion gene Als3 (Fig. 3-12 B). Although this increase was not significant, 
there was 2.14 fold change in expression of this gene in the co-culture 
compared to the mono-culture. 
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Figure 3-12 Bar charts comparing the percentage expression of (A) HWP1 (a filamentation 
protein) and (B) ALS3 (an adhesion protein) in mono-cultured C. albicans compared to its 
co-culture with S. aureus. After 24 hours of growth in 50% FBS, the biofilms were washed 
with PBS before RNA extraction was carried out using the TRIzol® method. cDNA was 
synthesised and real-time PCR was used to assess the expression of the two key C. 
albicans genes. The level of expression is shown in comparison to the constitutively 
expressed housekeeping gene, ACT1. Error bars ± standard deviation (S.D). (n=3). 
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3.4 Discussion 
The aim of this study was to characterise the dual-species S. aureus and C. 
albicans biofilm using macroscopic, microscopic and molecular techniques to 
determine the physical and molecular interaction between these two 
nosocomial pathogens. The growth conditions were first optimised and 50% 
FBS chosen for the culture media due similar growth rates observed for both 
the mono- and dual-species cultures. This media was also more clinically 
relevant as the conditions were closer to those that would be present in vivo.  
Crystal violet (CV) staining was used to determine the biomass of each of the 
mono- and the dual-species biofilms. The mono-species C. albicans and the 
dual-species biofilms had a high biomass, whereas the S. aureus mono-
species failed to produce high biomass biofilms in 50% FBS. There was a 
significant increase in biomass observed for the co-culture suggesting that 
there is a synergistic increase in biomass when the bacteria and fungi are 
cultured together. This increase was greater even when the additive biomasses 
of the two mono-cultures were compared to the biomass of the polymicrobial 
biofilm. This result is in agreement with other co-culture studies (Peters, 
Ward, Rane, Lee, & Noverr, 2013).  
This result was confirmed when further analysis was carried out. When 
fluorescence, SEM imaging and quantitation using DNA and qPCR was 
carried out, the biofilms produced by S. aureus were very poor, with large 
voids in the biofilm, few cell numbers and little ECM production; suggesting 
poor adhesion and structural stability. This result is in agreement with other S. 
aureus/C. albicans studies (Harriott & Noverr, 2009, 2010; Jey et al., 2013). 
Harriott et al. (2009) investigated the effect the presence of C. albicans had 
on the ability of S. aureus to form biofilms when grown in serum (Harriott & 
Noverr, 2009). They recorded that in the presence of serum, the surface was 
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sparsely populated and no matrix was observed; indicating a lack of biofilm 
formation. 
When S. aureus and C. albicans were cultured together the bacteria and fungi 
were found interspersed throughout the biofilm. S. aureus appeared to form 
micro-colonies on the surface and they preferentially associated with the 
hyphal forms of C. albicans (Harriott & Noverr, 2009). In the images 
captured in this study S. aureus demonstrated the same preference for 
adherence to the C. albicans hyphae. This trend has been recorded in various 
other studies (Harriott & Noverr, 2009, 2010; Peters, Ovchinnikova, et al., 
2012; Schlecht et al., 2015). Furthermore, Harriott & Noverr concluded that 
the ability of S. aureus to form polymicrobial biofilms with C. albicans 
correlated with the fungi’s ability to form hyphae (Harriott & Noverr, 2010). 
However, this contradicts the findings from a more recent study by Nash et al. 
(2014) (Nash, Peters, Fidel, & Noverr, 2015; Nash et al., 2014). 
Quantitation of the biofilms indicated that the number of S. aureus 
significantly increased in the polymicrobial biofilm compared to the mono-
species biofilm. Conversely, the levels of C. albicans slightly decreased in the 
dual-species biofilm compared to the mono-species culture. An increase in 
bacterial numbers was also recorded by Harriott (Harriott & Noverr, 2009). 
However, Harriott recorded no change in the levels of C. albicans between 
the dual- and mono-species biofilms (Harriott & Noverr, 2009). Harriott 
utilized a CFU counting method for determining numbers of cells in the 
biofilms. The study herein utilized qPCR, which is a much more sensitive and 
accurate technique. This method more accurately detects differences in cell 
numbers using primers specific to each of the micro-organisms, which could 
explain the slightly contradictory findings between these two studies.  
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The difference in the levels of S. aureus recorded between the mono- and co-
cultured biofilms could in part be due to the bacteria’s inability to metabolise 
appropriate nutritional components within the sera or the carbon source being 
unsuitable to support subsequent growth and biofilm formation (Harriott & 
Noverr, 2009; Staib, Geier, & (Germany), 1971). Staib et al. (1971) showed 
that 37 different S. aureus strains could metabolize the proteolytic by-
products of serum albumin produced by C. albicans and hence use it as a 
growth media, whereas undigested serum albumin was unable to support S. 
aureus growth (Staib et al., 1971). However, when Harriott investigated this 
using a Transwell system; in which the two organisms were separated 
physically, but sera components could pass freely, S. albicans was unable to 
form a strong biofilm, suggesting that cross-metabolism was not playing a 
key role in the polymicrobial biofilm (Harriott & Noverr, 2009). Harriott and 
Noverr (2010) investigated this further and found that S. aureus was able to 
form polymicrobial biofilms after being added to a C. albicans biofilm in 
which all the fungi had been killed (Harriott & Noverr, 2010). It was 
concluded that metabolic by-products from C. albicans were not required for 
S. aureus polymicrobial biofilm formation in serum (Harriott & Noverr, 
2010). In the same study, when C. albicans biofilms were killed using 
formalin or heat killing, S. aureus were unable to form polymicrobial 
biofilms, suggesting that hypha-associated formalin- or heat-labile 
components of the C. albicans biofilm could be required for the attachment or 
biofilm formation of S. aureus in serum (Harriott & Noverr, 2010). 
It has previously been shown that serum can interfere with the ability of 
bacteria to attach to abiotic surfaces (Hammond, Dertien, Colmer-Hamood, 
Griswold, & Hamood, 2010). Therefore, the C. albicans could simply be 
providing a physical structure for S. aureus attachment. Hammond et al. 
(2010) demonstrated that serum interfered with the attachment of P. 
aeruginosa to plastic coverslips and hence reduced or blocked biofilm 
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formation by the bacteria (Hammond et al., 2010). Although these results 
make sense with regards to host innate resistance, when Harriott tested this 
theory with S. aureus in serum, the same level of attachment was recorded for 
S. aureus grown in FBS compared to BHI (a medium which promotes S. 
aureus  biofilm formation) (Harriott & Noverr, 2009). Another explanation 
for the increase in bacteria levels could be that S. aureus are using C. albicans 
as a nutrient source, through the scavenging of nutrients from the fungal cell 
wall, the consumption of secreted compounds or through lysis of fungal cells 
(D. A. Hogan & Kolter, 2002). This could also explain the lower level of 
fungal growth and damage to hyphae detected in the polymicrobial biofilm. 
The results from this study are in agreement with the previous Harriott study. 
C. albicans facilitates the growth and promotes biofilm formation of S. aureus 
in serum, a medium that cannot support biofilm formation by S. aureus mono-
microbial cultures and that the bacteria preferentially adhere to the hyphae of 
the fungi (Harriott & Noverr, 2009; Peters, Ovchinnikova, et al., 2012; 
Schlecht et al., 2015; Staib et al., 1971). 
The reduction of the number of C. albicans in the polymicrobial biofilm 
compared to its mono-species biofilm could be the result of competition on a 
basic level between the bacteria and fungi. The limited amount of available 
nutrients could result in the bacteria out-competing the fungi, reducing fungi 
levels compared to the monoculture. If S. aureus and C. albicans were in 
competition for nutrients, the presence of the bacteria on the C. albicans 
surface may allow the bacteria to release bacterially derived antifungal 
compounds directly onto the fungi, which could also deplete fungi numbers 
(D. a Hogan, Wargo, & Beck, 2007).  The C. albicans hyphae appear 
wrinkled in the polymicrobial biofilm compared to the mono-species biofilm. 
This could be suggestive of hyphae damage caused by the presence of S. 
aureus. As with the antagonistic relationship between P. aeruginosa and C. 
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albicans, in which the bacteria release a phenazine toxin which kills the fungi, 
S. aureus may secrete one of its many exotoxins, which could contribute to C. 
albicans cell death resulting in the fewer fungi levels recorded in this study 
(Dinges, Orwin, & Schlievert, 2000; Gibson, Sood, & Hogan, 2009; D. A. 
Hogan & Kolter, 2002; Söderquist et al., 1998). These results contradict the 
results recorded by Peters et al. (2010) who suggested that the relationship 
between S. aureus and C. albicans was entirely synergistic with no lethality to 
either organism (Peters et al., 2010a). However, the organisms were cultured 
in the C. albicans favouring media RPMI, so competition for nutrients may 
not have been as high (Peters et al., 2010a).  
The trend of increased levels of S. aureus growth and decreased levels of C. 
albicans growth recorded for simultaneous culturing was also witnessed 
during sequential biofilm growth, regardless of the order in which the 
organisms were added to the pre-formed biofilms. The pre-formed C. 
albicans biofilm provided a biotic network of hyphae and ECM which 
enhanced S. aureus growth and promoted biofilm formation. When C. 
albicans cells were added to the poorly pre-formed S. aureus biofilm the same 
trends in bacterial and fungal cell growth were recorded. S. aureus is a non-
flagellated, non-motile organism (Kaito & Sekimizu, 2007). The results could 
therefore suggest that the increase in growth of S. aureus within the 
polymicrobial biofilm isn’t solely dependent on a physical interaction 
between the bacteria and the hyphae of the fungi. These results agree with the 
results obtained by Nash et al. (2014), who demonstrated that yeast-hyphal 
morphogenesis wasn’t required for co-infection (Nash et al., 2014).  
From the transcriptional analysis it was found that hyphal wall protein 
(Hwp1) was up-regulated in C. albicans in the polymicrobial biofilm 
compared to the mono-species biofilm. Hwp1 is a key regulator in the 
morphological transition of C. albicans required for hyphal development and 
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also plays a role in biofilm adhesion and development (Nobile, Nett, Andes, 
& Mitchell, 2006; Sharkey, McNemar, Saporito-Irwin, Sypherd, & Fonzi, 
1999). The up-regulation of Hwp1 in the polymicrobial biofilm suggests that 
the presence of S. aureus within the biofilm may act as a trigger for the 
phenotypical transformation of C. albicans into its hyphal form. However, 
Harriott et al. (2010) concluded that although Hwp1 was involved in 
polymicrobial biofilm formation, this protein was not essential to the bacterial 
and fungal interaction, and that it was more likely a mix of Als proteins in 
conjunction with Hwp1 that was required for S. aureus adherence to C. 
albicans (Harriott & Noverr, 2010).  
There was also a trend of increased expression of Als3 in the polymicrobial 
biofilm compared to the mono-species C. albicans biofilm. Als3 has been 
shown to mediate the adherence of S. aureus to C. albicans (Peters, 
Ovchinnikova, et al., 2012). Peters et al. (2012) concluded that Als3 was 
required for strong adherence of S. aureus to the fungi’s hyphae (Peters, 
Ovchinnikova, et al., 2012). The lack of Als3 resulted in decreased adherence 
of S. aureus to the hyphae and an inability of the bacteria to penetrate oral 
epithelium compared to when the bacteria were cultured with the C. albicans 
wild type, not lacking Als3 (Peters, Ovchinnikova, et al., 2012). Therefore, 
Peters concluded that Als3 played a crucial role in the adherence process of C. 
albicans to S. aureus, as the hyphal adhesion acts as a receptor for the bacteria 
on the C. albicans hyphae (Peters, Ovchinnikova, et al., 2012). It is very 
likely that other proteins could mediate inter-species attachment and 
interaction, in particular the MSCRAMM (microbial surface components 
recognizing adhesive matrix molecules) family of S. aureus. Clumping factor 
A (ClfA) a surface-located MSCRAMM shares 3D homology with Als3 
(Edwards, 2012).    
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The results from this study suggest that S. aureus and C. albicans interact on 
a physical level and co-aggregate with one another in their polymicrobial 
environment. The up-regulation of two genes involved in C. albicans 
adherence and biofilm formation, indicate that the bacteria and fungi also 
interact at a molecular level. Although there have been a number of studies 
carried out to characterise the relationship and interaction between S. aureus 
and C. albicans, further analyses is required to fully understand the intricate 
relationship between these two organisms. qPCR was utilized in this study to 
determine the quantity of bacterial and fungal cells within the polymicrobial 
biofilm. Although the data generated enable the numbers to be determined, 
live/dead qPCR would provide a more detailed insight into the state of the 
biofilm. This has recently been carried out by the Ramage group (Gordon 
Ramage, personal communication). Particular attention should be payed to S. 
aureus and C. albicans surface proteins, as well as other genes which have 
been identified as virulence factors. This study examined the polymicrobial 
biofilm after 24 hours of growth, resulting in a study that focussed on a 
mature S. aureus and C. albicans biofilm. It is the suggestion of this author 
that future analysis should be carried out during initial biofilm formation, 
which could uncover more significant bacterial-fungal interactions in relation 
to attachment and subsequent biofilm formation.  
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4.1 Introduction 
Small organic molecules, termed metabolites, undergo biochemical 
modifications during metabolic reactions which are necessary for the correct 
growth, maintenance and function of cells (Dettmer et al., 2007; Haggarty & 
Burgess, 2017). The ability of metabolomics to provide a quantitative rather 
than qualitative description of cellular regulation and control has led to its 
recognition as a powerful tool in the field of cell and systems biology 
(Johnson & Gonzalez, 2012; Teusink, Walsh, Van Dam, & Westerhoff, 
1998). However, due to the number and complexity of metabolites in 
existence, it is accepted that no single analytical technique can cover the 
entire metabolome of even a ‘simple’ biological system, as the platforms 
selected tend to exploit specific chemical characteristics and therefore are 
biased towards certain classes of compounds and ‘blind’ to others (García-
Cañaveras et al., 2016; Haggarty et al., 2015; Haggarty & Burgess, 2017).   
4.1.1 Metabolomics techniques 
LC-MS can be applied to the analysis of the majority of chemical species. 
Innovations in LC technology, instrumentation, and column chemistries have 
led to wider coverage of the metabolome.  
Although there have been recent advancements in single column technologies 
to increase the coverage of the metabolome, including the addition of ion 
pairing agents and the advent of RP pentafluorophenyl (PFPP) phases that 
allow analysis in both reverse- and normal-phase retention (Fekete, Veuthey, 
& Guillarme, 2015; Lv, Palacios, Hartil, & Kurland, 2011; S. Yang, Sadilek, 
& Lidstrom, 2010), it is widely accepted that due to the complexity of 
metabolites, multiple column methods are required for optimum retention and 
separation of both polar and non-polar compounds (Contrepois, Jiang, & 
Snyder, 2015). The coupling of columns can provide a powerful tool in the 
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detection of polar and non-polar metabolites, however, running two different 
chromatographies in parallel increases sample preparation time, as the sample 
buffer has to be appropriate for the solvent system used, and doubles the 
analysis time (Hemström & Irgum, 2006). 
Traditionally, two LC methods have been implemented to improve analyte 
retention. Column switching utilises a 6- or a 10-port valve connected to two 
separate columns and pumps. The sample is loaded onto the valve and 
injected onto the first column and detected at the end of the run. The valve 
then switches to the second position and a second injection from the same 
sample is injected onto the ‘second’ system for separation and detection 
(Figure 4-1). This method has been successfully applied to biochemical, drug 
and food analysis and pesticide monitoring (Bailey & Ayling, 2013; 
Brabcova, Hlavackova, Satinsky, & Solich, 2013; Fernández-Ramos, 
Šatínský, & Solich, 2014; X. Zhang et al., 2015). In the second method, 2-
dimensional liquid chromatography (2D-LC), the entire effluent is run on the 
first column and collected as fractions in aliquots (François, Sandra, & 
Sandra, 2009). The collected fractions are then either analysed in the second 
dimension in their entirety or specific fractions are selected for 2D analysis, 
termed comprehensive and heart-cutting 2D-LC, respectively (François et al., 
2009). The transfer of the effluent can be carried out off-line or online using a 
dedicated switching valve (Figure 4-2). This method is often used in 
proteomics, e.g. using strong cation exchange (SCX) followed by RP, and has 
also been utilised in the analysis of phenolic compounds, carotenoids and bio-
oils (Beelders, Kalili, Joubert, De Beer, & De Villiers, 2012; Cacciola et al., 
2012; Edelmann, 2011; Le Masle et al., 2014). Many different column 
chemistries and lengths can be coupled using these instruments, however, the 
greatest coverage is witnessed when two orthogonal columns are combined 
(Bassanese et al., 2015; Cacciola et al., 2011; Jandera, 2008). These systems 
offer the user the ability to run a sample on two different stationary phases 
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regardless of mobile phase compatibility, with the added advantage of 
independent control over eluent pH and composition, gradient program, flow-
rate and column temperature (Guiochon, Marchetti, Mriziq, & Shalliker, 
2008). However, these methods require complicated system set-ups with 
expensive equipment, along with specialist knowledge and/or training 
meaning that these methods are often not suitable for routine use in many 
laboratories. 
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Figure 4-1 Schematic of the novel column switching method developed by Li et al. (2015) 
that incorporates a six-port switching valve. The system shares a column oven, auto-
sampler and detector. (a) In the 1-6/2-3 position the sample is injected on to the first 
column using the right pump (system 1). (b) When the valve switches to positions 5-6/3-4 
the sample is injected on to the second column using the left pump (system 2) (Haggarty & 
Burgess, 2017; Y. Li et al., 2015). 
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Figure 4-2 Typical configuration for 2D-LC separations. (a) An online set-up. The sample 
is injected onto the first dimension and can then be collected in a sample loop before it is 
introduced to the second column (or dimension) by switching the valve, allowing the other 
loop to be concomitantly filled. (b) Off-line 2D-LC set-up. The sample is analysed in the 
first dimension and is then manually transferred to a second system for second dimension 
analysis (Z. Li, Chen, Guo, & Tang, 2016). The sample can be introduced to the column 
and collected in fractions, with either the analysis path running through the detector or 
running to the collection plate without detection. 
 
The method of serially combining two or more columns together in tandem 
and running both gradients simultaneously, so that one sample injection 
passes through the first column and then the other in one chromatographic 
run, is a simple approach that has been described since the early development 
of LC (Benedict & Risk, 1984; Bonn, 1985; El Rassi & Horváth, 1986; 
Glajch, Gluckman, Charikofsky, Minor, & Kirkland, 1985; Tomellini, Hsu, & 
Hartwick, 1986). Various studies have been carried out previously using a 
variety of different stationary phase combinations; C18 columns from 
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different manufacturers, C18 with cyano, phenyl and amino columns, 
polystyrene-divinylbenzene resins and ion exchange columns, silica-based 
C18 columns and zirconia columns. Columns can be connected using various 
coupling elements including zero dead volume (ZDV) unions, like those used 
with Phase Optimised Liquid Chromatograph® (POPLC®) kits, ZDV finger 
tight couplers screwed directly to the columns, stainless steel or PEEK tubing 
or using a T-piece (K. Bischoff, Szuecs, & Nyiredy, 2010; X. Chen & Li, 
2013; Greco, Grosse, & Letzel, 2013; Haggarty et al., 2015; Hsieh & Chen, 
2005; Louw, Pereira, Lynen, Hanna-Brown, & Sandra, 2008; Ortiz-Bolsico, 
Torres-Lapasió, Ruiz-ángel, & García-álvarez-Coque, 2013). Although there 
have been numerous column chemistry couplings, columns with the most 
orthogonality deliver the best separation for analytes with opposing polarities 
(Bassanese et al., 2015; Camenzuli & Schoenmakers, 2014). The combination 
of HILIC and RP in parallel chromatographic runs increased the number of 
metabolites detected in urine and plasma by 44% and 108%, respectively, 
compared to using RPLC-MS alone (Contrepois et al., 2015). The difficulty 
of serially combining RP and HILIC columns lies in the need for 
diametrically opposite organic concentrations in each mobile phase at the start 
of each chromatographic run. Serially combining an RP column to a HILIC 
column with the addition of a second pump to combat mobile phase 
incompatibility is a less routinely described method, but has been successfully 
applied to the targeted separation of polar and nonpolar pharmaceuticals, 
phenols in wine and quaternary ammonium compounds in brain samples 
(Falasca, Petruzziello, Kretz, Rainer, & Zhang, 2012; Greco et al., 2013; 
Louw et al., 2008). 
The aim of this research was to develop a global (untargeted) metabolomics 
method in which a sample can be injected onto both RP and HILIC columns 
in series for the analysis of polar and non-polar compounds in a single 
injection. This method would allow for the independent optimisation of both 
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columns and would remove the need for separate sample preparations or the 
addition of ion pairing reagents. 
The practicality and the reliability of the method were investigated by the 
analysis of TCA intermediates and bile acid standards. Subsequently, the 
feasibility of the coupled method for non-targeted analysis of large nonpolar 
compounds and small highly polar compounds in a complex sample (beer) 
was evaluated. 
4.2 Materials and methods 
The materials and methods are the same as those described in Chapter 2, with 
the following changes: 
1) The pHILIC column was changed from a 2 mm diameter to a 4 mm to 
improve retention time reproducibility. 
2) The equilibration time for both columns was increased from 10 minutes to 
12.5 minutes to combat retention time drift. 
3) The flow rate of the second gradient pump was increased to 350 µL/min to 
increase the organic content of the mobile phase at the beginning of the 
HILIC separation. 
4.3 Results 
4.3.1 Standards – Organic acids 
The polar organic acids (citrate, isocitrate, cis-aconitate, 2-oxoglutarate, 
succinate, fumarate, malate and oxaloacetate) were retained on the pHILIC 
column between approximately 5 minutes (mins) and 15 mins (Fig. 4-3A). As 
expected, the organic acids were not retained when using the RPLC column 
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alone, with all of them coming off the column in under 1 min (Fig. 4.4B). In 
contrast to the RPLC, when the compounds were analysed using the 
RPLC/HILIC method, all of the organic acids were retained, with retention 
times similar to those observed when using the pHILIC column alone, 
between approximately 5 mins to just over 15 mins (Fig. 4-3C).  
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Figure 4-3 Extracted ion chromatograms (EICs) of selected organic acids ( (a) isocitrate, 
(b) cis-aconitate, (c) 2-oxoglutarate, (d) succinate, (e) fumarate, (f) fumarate and (g) 
pyruvate) using (A): HILIC, (B): RPLC and (C): RPLC/HILIC separation using the same 
dual gradient. Detection: ESI-FTMS, negative mode. The organic acids were retained 
using the single HILIC method (A). None of the organic acids were retained when using 
the single RPLC (B). All of the polar organic acids were retained and separated using the 
RPLC/HILIC method (C). Note: the second component of the double peak observed for the 
mass of fumarate (f) on the HILIC (A) and RPLC/HILIC (C) EICs is a consequence of 
water loss from malate (**). 
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The method was unable to separate the isomers citrate and isocitrate (m/z 
191.0198) (Fig 4-4A & B) therefore citrate was removed from the organic 
acid mix, before further analysis was carried out.  
 
Figure 4-4 EICs of (A): citrate and (B) isocitrate using the combined RPLC/HILIC 
method. Detection: ESI-FTMS, negative mode. The isomers were unable to be separated 
using the combined method. 
 
When the organic acid mix was analysed, a double peak was detected at m/z 
115.00368 (Fig 4-3A & C). The first peak was identified as fumarate by 
matching both the mass and retention time (RT) to the pure standard when it 
was run on its own (Fig 4-3A & C, Fig 4-5A & B). The second peak was 
determined to be a result of water being lost from malate in the organic mix 
(Fig 4-6). 
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Figure 4-5 Extracted ion chromatograms (EICs) of (A): m/z 115.00368 from the organic 
acid mix and (B): malate (m/z 133.01425). The double peak seen when a mass search was 
performed to detect fumarate is the result of fumarate and a water loss from malate. The 
first peak at RT 12.02 has a closer retention time (RT) to the pure standard of fumarate. 
The second peak at m/z 115.00368 has the same retention time (RT) as malate (12.23 min) 
which reconfirmed that it was as a breakdown product of malate. 
 
 
Figure 4-6 Equation showing that water loss from malic acid, results in a compound with 
the same mass as fumaric acid and a water molecule. The resulting compound had the 
same m/z as fumarate (m/z 115.0038) but a slightly different retention time (RT) as the 
compound is a breakdown product of malic acid, which has a different RT than fumaric 
acid. 
 
4.1.2 Standards – Bile acids 
The non-polar bile acids deoxycholic acid, cholic acid, dehydrocholic acid 
and chenodeoxycholic acid were retained on the RPLC column between 
Organic acid mix (A) 
Malate (B) 
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approximately 16 mins and 19.5 mins (Fig. 4-7B). The bile acids were not 
retained very well when using the pHILIC column (Fig. 4-7B). The bile acids 
were retained for approximately 4 mins on the pHILIC column, possibly due 
to a slight polar charge on the acid group in the compounds; however, the bile 
acids were not able to be separated from one another using the pHILIC 
column alone. In contrast to the pHILIC, when the compounds were analysed 
using the RPLC/HILIC method, all of the bile acids were retained between 18 
mins and 22 mins (Fig. 4-7C). The RTs were slightly longer than those 
observed for the RPLC column alone, because the addition of the second 
column lengthened the flow path before introduction of the compounds to the 
mass spectrometer.  
Chenodeoxycholic acid is a synthetic bile acid with a similar structure to 
deoxycholic acid. The RPLC/pHILIC method was unable to separate these 
compounds (Fig 4-7C (a) & (d)).  
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Figure 4-7 Extracted ion chromatograms (EICs) of selected bile acids ((a) deoxycholic 
acid, (b) cholic acid, (c) dehydrocholic acid and (d) chenodeoxycholic acid)  separated 
using (A): HILIC, (B): RPLC and (C): RPLC/HILIC with the same dual gradient. 
Detection: ESI-FTMS, negative mode. The bile acids were not retained using the single 
HILIC method (A). All of the bile acids were retained using the single RPLC method (B). 
All of the non-polar bile acids were retained and separated using the RPLC/HILIC method 
(C). Note: the isomers deoxycholic acid and chenodeoxycholic acid could not be separated 
using the RPLC/HILIC method (C). 
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The average retention time for each of the standards was calculated from nine 
separate LC-MS runs of a standards mix (Appendix II; Table 3). The 
RPLC/HILIC method showed good retention time reproducibility, with RSD 
values for each compound under 2% (Table 4-1). The combined method 
showed RSD values comparable to the pHILIC column on its own and better 
RSD values than those obtained using the single RPLC method (Table 4-1).  
Although the RPLC/HILIC method was able to retain and separate both polar 
and non-polar standards in a mix, it was not capable of separating the isomers 
citrate and isocitrate (m/z 191.01973) and deoxycholic acid and 
chenodeoxycholic acid (m/z 391.28538).  
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Table 4-1 Average retention times (RTs) and relative standard deviations (%RSDs) of the organic and bile acid standards. Each metabolites 
elemental formula (EF) was used to determine its m/z value ([M-H]). m/z values were used to establish RTs. The average RTs were calculated 
from nine separate standard mix injections (Appendix II). From these results the standard deviation (SDs) and relative standard deviations 
(%RSDs) were calculated. (n=9). 
HILIC RPLC RPLC/HILIC 
Metabolite EF [M-H] Average SD %RSD Average SD %RSD Average SD %RSD 
Isocitric acid C6H8O7 191.01973 14.72 0.05 0.36 0.99 0.02 1.59 15.33 0.03 0.20 
cis-Aconitic acid C6H6O6 173.00916 13.14 0.05 0.40 0.93 0.05 5.68 14.27 0.06 0.43 
2-Oxoglutaric acid C5H6O5 145.01425 9.46 0.06 0.64 0.90 0.02 1.73 11.87 0.09 0.78 
Succinic acid C4H6O4 117.01933 9.08 0.07 0.76 0.93 0.02 2.58 11.70 0.09 0.80 
Fumaric acid C4H4O4 115.00368 10.17 0.08 0.79 0.90 0.02 1.73 12.37 0.07 0.58 
Malic acid C4H6O5 133.01425 10.64 0.10 0.98 0.93 0.02 2.58 12.59 0.07 0.57 
Pyruvic acid C3H4O3 87.00877 5.03 0.04 0.80 0.99 0.02 1.57 5.05 0.07 1.48 
Deoxycholic acid C24H40O4 391.28538 3.90 0.05 1.36 19.49 0.25 1.31 22.09 0.10 0.44 
Cholic acid C24H40O5 407.2803 4.04 0.05 1.31 17.62 0.18 1.03 20.20 0.06 0.32 
Dehydrocholic acid C24H34O5 401.23335 3.77 0.03 0.92 16.22 0.23 1.44 18.79 0.09 0.46 
Chenodeoxycholic acid C24H40O4 391.28538 3.90 0.05 1.36 19.43 0.27 1.38 22.09 0.10 0.44 
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4.1.3 Beer sample 
Beer components, suggested from previous beer metabolome studies, were 
searched for using their m/z values (Farag, Porzel, Schmidt, & Wessjohann, 
2012). Eight compounds in total were used; five polar metabolites (putatively 
identified as syringaldehyde (m/z 181.05063), tyrosine (m/z 182.08101), ethyl 
vanillin (m/z 165.05572), succinic acid (m/z 117.01973), and phenylalanine 
(m/z 166.08625)) and three larger, non-polar metabolites (putatively identified 
as ad-/Humulone (m/z 361.20205), iso-/Xanthohumol (m/z 353.13945) and 
cohumulone (m/z 347.18648)). 
The small polar metabolites were retained on the pHILIC column and were 
not retained when using the RPLC column alone (Fig. 4-8A & B, peaks 4-8). 
In contrast to the RPLC, when the polar compounds were analysed using the 
RPLC/HILIC method, all of the selected polar beer metabolites were retained 
and separated (Fig. 4-8C, peaks 4-8). 
The larger non-polar metabolites that were retained on the RPLC column 
were not retained when using the pHILIC column alone (Fig. 4-8B & A). 
Although iso-/xanthohumol appeared to be retained using the pHILIC 
column, the peak shape is incorrect and the peak elutes over 4 minutes, which 
is less than ideal for accurate and efficient chromatography (Fig 4-8A). In 
contrast to the pHILIC, when the compounds were analysed using the 
RPLC/HILIC method, all of the non-polar beer metabolites were retained and 
separated (Fig. 4-8C). 
The RPLC/HILIC combined method demonstrated good RT reproducibility 
with RSD values of less than 1% achieved for all of the putative metabolites 
(Table 4-2). 
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Figure 4-8 Extracted ion chromatograms (EICs) of selected beer metabolites with 
annotations. (1) ad-/Humulone, (2) iso-/ Xanthohumol, (3) cohumulone, (4) 
syringaldehyde, (5) tyrosine (6) ethyl vanillin, (7) succinic acid, (8) phenylalanine. 
Detection: ESI-FTMS. Separation by (A): HILIC, (B): RPLC and (C): RPLC/HILIC. (*) 
isomers with the same m/z, but different RTs as ethyl vanillin. 
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Table 4-2 Average retention times (RT) and RSDs of selected beer metabolites. Each m/z value was used to determine a likely elemental 
formula (EF). EFs were used to putatively identify each beer metabolite. m/z values were used to establish RTs. The average RTs were 
calculated from twenty-three separate injections (Appendix II). From these results the standard deviation (SDs) and relative standard deviations 
(%RSDs) were calculated. (n=23). 
        HILIC RPLC RPLC/HILIC 
Putative 
Metabolite 
KEGG ID EF m/z 
Metabolite ID 
code** 
Average 
RT(mins) 
%RSD 
Average 
RT(mins) 
%RSD 
Average 
RT(mins) 
%RSD 
Ad-/Humulone -/C10695 C21H30O5 361.20205 HRMS1 4.25 6.64 16.69 0.67 19.02 0.04 
Iso-/Xanthohumol -/C16417 C21H22O5 353.13945 HRMS1 18.11 2.04 19.18 0.30 23.66 0.06 
Cohumulone N/A C20H28O5 347.18648 HRMS1 3.98 1.59 16.20 0.30 18.56 0.03 
Syringaldehyde N/A C9H10O4 181.05063 HRMS1 5.51 0.36 1.27 0.00 5.76 0.03 
Tyrosine* C00082 C9H11NO3 182.08101 HRMS1MS2PL 11.04 0.47 1.58 1.16 11.46 0.04 
Ethyl vanillin D01086 C9H10O3 165.05572 HRMS1 4.39 0.00 1.59 1.59 4.57 0.03 
Succinic acid C00042 C4H6O4 117.01973 HRMS1MS2PL 8.78 0.87 1.12 6.84 12.03 0.05 
Phenylalanine* C00079 C9H11NO2 166.08625 HRMS1MS2PL 8.02 0.07 1.78 0.86 19.02 0.04 
*Detected in positive mode, ** Refers to alphanumeric coding scheme from  (Sumner et al., 2014).
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4.4 Discussion 
The aim of this study was to serially combine an RPLC column and a pHILIC 
column for the retention and separation of both polar and nonpolar 
compounds within a single chromatographic run. The columns selected were 
a Hypersil Gold C18 RP column and a SeQuent ZIC-pHILIC column. The 
two columns were connected via a T-piece and two independent UP-HLC 
pumps were utilized, which allowed independent control over the MP 
gradient program for the individual columns. The gradient programs applied 
to each of the phases were typical for RP and HILIC analyses. The RPLC 
gradient starting conditions were high aqueous and low organic, rising to high 
organic and low aqueous and the HILIC gradient started with a high organic 
concentration running to low organic and high aqueous conditions. A sample 
was injected onto the RPLC in high aqueous conditions. The second pump, 
which ran at a higher flow rate of 350 µL/min, compared to 65 µL/min for the 
first pump, diluted the highly aqueous starting MP, with a high ACN MP, 
creating the optimum starting conditions for HILIC analysis as the sample 
was introduced to the pHILIC column. 
Using this setup, non-polar metabolites were retained by the C18/RP 
stationary phase. Polar and ionic metabolites that were not retained on the RP 
column were then captured by the HILIC stationary phase. The gradients were 
then applied simultaneously to separate analytes on both columns.  
This method was adapted from Louw et al. (2008) and Greco et al. (2013) 
who applied the RP/HILIC method to separate polar and nonpolar compounds 
in pharmaceuticals and polar and nonpolar phenols in wine (Greco et al., 
2013; Louw et al., 2008). Louw ran a C18 2 mm ID column at a flow rate of 
200 µL/min and a HILIC 4 mm ID column at a flow rate of 1.4 mL/min. 
Greco suggested that the high flow rates used may affect the sensitivity of MS 
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detection and so used a longer C18 column, with a 3 mm ID, and a shorter 
HILIC column, with a 2 mm ID. They also ran at lower flow rates of 50–100 
and 400 µL/min, respectively. In the experiments described in this paper a 1 
mm ID C18 and a 4 mm ID pHILIC were run at a flow rate of 65 and 350 µL/ 
min, respectively. Unlike Louw and Greco, the samples in this study were 
prepared in high aqueous solutions, the optimum conditions for initial 
injection onto the RP column. Ion pairing reagents were added to the RP 
mobile phases in both the Louw and Greco papers (and to the HILIC mobile 
phase in Louw et al.). In the experiments described herein, ion pairing 
reagents were not introduced into the RP buffers. Ion pairing reagents are 
usually introduced into a RP separation to mask the ionic or polar groups of 
compounds to encourage binding to the RP stationary phase. In this 
experiment this was not desirable as the HILIC column after the RP column 
captured and separated the ionic and polar compounds in the sample. 20 mM 
ammonium bicarbonate was added to the HILIC mobile phase to encourage 
retention of the polar and ionic compounds by increasing the pH to 9. The 
high dilution between the columns, achieved by the difference in flow rates, 
allows each of the methods to be optimised independently to suit sample 
requirements. The ability to inject the sample in low organic solvents onto the 
RPLC column and high organic solvents onto the HILIC column has allowed 
two very different column chemistries to be successfully coupled together.  
The combined method was able to successfully retain and separate a standard 
mixture of polar TCA intermediates and nonpolar bile acids. Slight peak-
tailing was witnessed for some of the TCA intermediates, but this had been 
witnessed before in standard mixes in the laboratory using the routine pHILIC 
method (data not shown). The method was unable to separate isomers of 
citrate and isocitrate and deoxycholic acid and chenodeoxycholic acid. The 
selected polar and non-polar metabolites extracted from beer displayed better 
retention and separation using the RPLC/HILIC method compared to the 
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individual runs. All metabolites exhibited good peak shapes and 
reproducibility.  
Some of the limiting factors of this method include the inability to separate 
the isomers citrate and isocitrate. The ability of an LC system to separate 
isomers is important to ensure accurate metabolite concentrations are detected 
to enable correct conclusions to be drawn from the results. Another limiting 
factor in this study was that the number of metabolites detected using the 
RP/HILIC combined method was not compared to the number of metabolites 
detected when using the RP and HILIC columns individually. This 
comparison would have allowed the capacity of the individual columns to be 
compared to the combined columns. To determine the optimal combined 
chromatography, it would have been beneficial to have compared the 
performance of a variety of different HILIC and RP columns, along with 
different MP compositions and gradient programs (Contrepois et al., 2015).    
When the combined RP/HILIC method is compared to other dual-column 
methods to extend the coverage of the metabolome, through the retention and 
separation of both polar and non-polar metabolites in a single 
chromatographic run, the advantages and disadvantages of this simple system 
can be seen (Table 4-3). Column switching and 2D-LC systems offer greater 
freedom when coupling columns together, as MP incompatibility is not an 
issue, as with the combined method, so two completely different LC methods 
can be used, providing greater experimental freedom. However, they require 
dedicated equipment that is often complex to set-up and expensive, whereas 
the combined method utilizes conventional laboratory equipment. The column 
switching and 2D-LC methods also require a level of expertise, unlike serially 
combining columns, which any analyst with LC experience could cope with. 
Unlike the combined method which requires one injection per sample, column 
switching requires two injections per sample, which may not be possible if the 
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sample volume is very low. As the gradients are run simultaneously, the 
combined method has a higher through-put than 2D-LC, which can have very 
lengthy analysis times.  
A single column method that has been gaining popularity, and has the 
potential to exceed the combined method with regards to polar and nonpolar 
separation is the use of mixed-mode columns (MMCs). MMCs utilize mixes 
of different stationary phases, either by mixing beads with different 
functionalities and packing them into a column (Type I) (Walshe, Kelly, 
Smyth, & Ritchie, 1995), modifying a substrate at its surface with ligands of 
different functionalities (Type II) (R. Bischoff & McLaughlin, 1984), 
embedding ion exchange functionality as part of the hydrophobic ligand, 
‘embedded’ phases (Type III) (Muenter, Stokes, Obie, & Jezorek, 1999) or 
having ion exchange functionality at the free end of the hydrophobic chain, 
‘tipped’ phases (Type IV) (Nogueira, Michael, & Lindner, 2005). There are 
various different columns available including bimodal RPLC/cation (CEX) or 
anion exchange (AEX), HILIC/AEX, HILIC/CEX and trimodal 
RP/AEX/CEX and HILIC/AEX/CEX (K. Zhang & Liu, 2016). Different 
types of MMC are available. Type I and Type II columns are not widely used 
due to performance limitations, but Type III and IV have been 
commercialised for use as general-purpose columns (as alternative to C18) 
and for more specific analyses. As well as silica based MMCs, polymer based 
ones are also available. Mixed-mode separation is achieved by coating a 
macroporous hydrophobic polymer core with an ion exchange latex bead 
layer (Fontanals, Marcé, Borrull, & Cormack, 2010). As with conventional 
LC, MMC research has recently been moving towards the goal of separating 
anionic, cationic and neutral species in one chromatographic run, which has 
led to the development of trimodal stationary phases to provide AEX, CEX 
and RP separations simultaneously. The Scheizo group of columns by Imtakt 
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mix two types of bonded silica particles- one with C18 and CEX and one with 
C18 and AEX and the Obelisc N and Obelisc R by SIELC in which either 
Table 4-3 Comparison of dual- and single-column methods to separate polar and nonpolar 
compounds.  
Method Column Combinations and Applications Comments 
Serially 
combined 
columns 
C18/Silica (HILIC)– Sugars and 
sulphonamides in phramaceuticals (Louw et 
al., 2008) 
BEH C18/Silica (HILIC) - arylamines and 
aminopyridines in pharmaceuticals (Louw et 
al., 2008) 
EC-C18/ZIC-HILIC - Polar and nonpolar 
phenols in wine (Greco et al., 2013) 
C18/ZIC-pHILIC - Bile acid and TCA 
intermediates, polar and nonpolar metabolites 
in beer (Haggarty et al., 2015) 
ZIC-HILIC/RP-amide or RP-amide/ZIC-
HILIC - Polar and nonpolar metabolites in 
mouse serum (Chalcraft & McCarry, 2013) 
Advantages – easy set-up, no 
specialist training required, no 
specialist equipment. 
Limitations- lack of variety and 
expense of column lengths. No 
dedicated software. MPs must be 
compatible. Some set-ups there is 
no independent control over each 
gradient. 
Column 
switching 
C18 x C18 - Carbamate and pyrethroid 
insecticide monitoring in water (Fernández-
Ramos et al., 2014) 
Guard Cartridge RP-18e x C18 - Β-carotene 
in food supplements (Brabcova et al., 2013) 
C8 x phenyl-hexyl /phenyl-hexyl - Folic acid 
and its derivatives in human plasma (Bailey 
& Ayling, 2013) 
C8 X C18 - Quantification of 
monohydroxybutenylmercapturic acid 
(MHBMA), N-acetyl-S-(3, 4- 
dihydroxybutyl) cysteine (DHBMA) and 8-
Hydroxy- 2-deoxyguanosine (8-OHdG) in 
human urine (X. Zhang et al., 2015) 
BEH C18 x HSS T3 - Untargeted analysis of 
metabolites and lipids in human plasma and 
Advantages- ability to combine 
two completely different LC 
separation platforms. 
Incompatible MPs are not an 
issue. 
Limitations – specialist switching 
interface required, expensive 
equipment, specialist training 
required, one sample is injected 
on to one column but does not 
pass through the second column- 
two injections are required  for 
one full analysis. 
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rat livers (Y. Li et al., 2015) 
2DLC HILIC x C18-UHPLC - analysis of a variety 
phenolic compounds (including monomeric 
flavonoids, phenolic acids, coumarins and 
flavan-3-ols) in unfermented and fermented 
rooibos samples (Beelders et al., 2012) 
Cyano column x C18-UHPLC – Separation 
of carotenoids in chilli peppers (Cacciola et 
al., 2012) 
RPLC x HT-RP-UHPLC (variety of silica- 
and non silica-based column combinations 
studied)– separation of standard mix of bio-
oils (Le Masle et al., 2014) 
Advantages- ability to combine 
two completely different LC 
separation platforms. 
Incompatible MPs are not an 
issue. 
Limitations – specialist switching 
interface required, expensive 
equipment, issues with sample 
dilution, specialist training 
required, second dimension 
analysis can be lengthy, creates 
more complexity than a 1D 
system so twice as likely for 
something to go wrong. 
Mixed 
mode 
columns 
RP/AEX/CEX – Separation of a standard mix 
containing one neutral, four acidic and four 
basic compounds (Socia & Foley, 2014) 
RP/AEX/CEX – Separation of RNA 
oligonucleosides, including five isomers 
(Biba et al., 2013) 
 RP/AEX/CEX x HILIC – Separation of 
inorganic/organic anions and cations, active 
pharmaceutical ingredients, and 
carbohydrates (Kazarian et al., 2014) 
Advantages – separation of 
neutral and ionic species within 
one analytical run, no need for 
specialist equipment, interaction 
mechanisms can be controlled by 
MP composition and pH. 
Limitations – complicated method 
development, need for dedicated 
columns, non-linear retention and 
retention time variations. To 
utilize all interaction mechanisms 
more than one MP composition 
has to be run- lengthening 
analysis time.  
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negatively charged groups are bonded onto positively charged groups close to 
a silica surface using a hydrophobic chain or positively charged groups are 
bonded onto negatively charged groups close to a silica surface using a 
hyrophillic chain, respectively. 
These trimodal MMCs have been used in sequential elution liquid 
chromatography (SE-LC), in which different groups of analytes are eluted 
from the column, based on their chemical characteristics (e.g. acids, bases 
and/or neutral compounds) using different modes of mobile phases that are 
selectively strong for that specific group of compounds (Little, Jeansonne, & 
Foley, 1991). SE-LC has been used  for the separation of weak acids from 
weak bases from neutral compounds (Socia & Foley, 2014). A dual gradient 
was employed in the study, the first increasing from acidic to basic (pH 2.0 – 
pH 8.0) and vice versa for 30 mins and then an increasing organic gradient 
over 45 mins (Socia & Foley, 2014). This method not only separated 
ionisable analytes from neutral ones, but also acids from bases. 
MMC were also used to successfully retain and separate RNA olionucleosides 
(Biba et al., 2013). There was no improvement to separation compared to 
conventional methods when using the vendor recommended mobile phase 
composition, but when the MP was changed to a NaCl or NaBr salt gradient 
the column was able to separate oligonucleoside isomers (Biba et al., 2013). 
Recently, a MMC was serially coupled to a HILIC column for the 
simultaneous analysis of inorganic/organic anions and cations, active 
pharmaceutical ingredients and carbohydrates (Kazarian et al., 2014). The 
sample was first injected onto the MMC where an isocratic gradient for ion 
exchange was applied. A dual organic/salt gradient was then applied for 
mixed-mode interactions. At the height of the organic mix mode gradient, the 
flow was switched to the HILIC column and HILIC analysis was carried out 
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on a second injection from the sample (Kazarian et al., 2014). This approach 
successfully resolved up to 23 analytes in one run with reproducible results 
and shows potential for use in comprehensive analysis, although this system 
has yet to be tested on a sample with a complex matrix (Kazarian et al., 2014). 
MMCs could offer a good alternative to serially combined columns, but they 
have a few limitations. Dedicated columns are required for analysis and 
method development is considerably more complicated compared to 
conventional LC method development due to secondary and tertiary 
interactions between the analytes in the solute and stationary phases, which 
can also give rise to non-linear retention behaviours and retention time 
variations (Alvarez-Segura, Ortiz-Bolsico, Torres-Lapasio, & Garcia-Alvarez-
Coque, 2015; Issaq, Gutierrez, Issaq, & Gutierrez, 2017; McLaughlin, 1989; 
Ordoñez, Quintana, Rodil, & Cela, 2012; K. Zhang & Liu, 2016).  Another 
limitation, in comparison to serially combining columns is the need for more 
than one gradient program to take full advantage of the MMCs varied 
stationary phases. 
The results from this study highlight the advantages of using the 
RPLC/HILIC method for the separation and detection of both polar and non-
polar metabolites, within a complex sample, in a single run. This method 
could improve analytical efficiency by halving the time required for analysis 
and removing the need for complicated system set-ups or sample 
preparations. However, more method development is required to determine 
the optimum column combination and MP compositions, the robustness of the 
system and the capacity of the columns. It is also the option of this author that 
the effect of combining an RP and HILIC column on compounds with both 
charged and neutral regions should be investigated to determine how their 
retention will be affected by the two different phases. 
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5.1 Introduction 
As has been discussed previously, targeted metabolomics aims to detect a 
defined group of compounds. Measuring a select group of metabolites can 
provide a powerful insight into key areas of the metabolome which may be 
lost in an untargeted analysis. 
Central carbon metabolism is essential to all living organisms and plays a key 
role in energy and biomolecule production. 
5.1.1 Central carbon metabolism 
Central carbon metabolism which encompasses glycolysis, the pentose 
phosphate pathway (PPP) and the tricarboxylic acid (TCA) cycle is essential 
and ubiquitous to all living cells (Büscher, Czernik, Ewald, Sauer, & 
Zamboni, 2009; Luo et al., 2007).   
These metabolic networks convert incoming nutrients into energy, subunits of 
biopolymers, signalling molecules and in the biotechnological production of 
fine chemicals (e.g. amino acids and vitamins). The metabolites of CCM 
serve as important precursors for the anabolic biosynthetic pathways. A 
summary of glycolysis and the TCA cycle can be found in Figures 5-1 and 5-
2, respectively. Briefly one glucose molecule is converted to two molecules of 
pyruvate, with a net gain of two ATP and two molecules of NADH during 
glycolysis (Fig. 5-1). Each pyruvate molecule is then converted to acetyl-CoA 
before it enters the TCA cycle. Through a number of enzyme mediated 
reactions each pyruvate is converted to oxaloacetate, releasing a total of four 
carbon dioxide (CO2) molecules and forming a total of six molecules of 
NADH, two molecules of FADH2 and two molecules of ATP (Fig. 5-2). The 
electrons from the NADH and FADH2 molecules produced during glycolysis 
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and the TCA cycle are transferred into the electron transport chain which 
drives the synthesis of ATP molecules through oxidative phosphorylation. 
 
Figure 5-1 Schematic of the glycolysis pathway. One glucose molecule is converted into 
two pyruvate molecules through a number of enzyme mediated chemical reactions. 
Glucose is converted into glucose 6-phosphate (G6P) through the transfer of a phosphate 
group from ATP in a reaction catalysed by hexokinase (1). Glucose 6-P is then converted 
into fructose 6-phosphate (F6P) in a reversible reaction catalysed by phosphoglucose 
isomerase. An additional phosphate group is added to fructose 6-P from another ATP 
molecule to produce fructose 1,6-bisphosphate (F1,6-BP) in a reaction that is mediated by 
phosphofructosekinase (2).  F1,6-BP splits into the phosphate-bearing three carbon sugars, 
dihyroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (G3P). DHAP is 
converted to G3P by triosephosphate isomerase to continue through the rest of the 
pathway, therefore this part of the pathway occurs twice. G3P loses two electrons and two 
protons reducing NAD+ to NADH and producing H+, releasing energy for the attachment 
of a phosphate group to G3P producing 1,3-bisphosphoglycerate (1,3-BPG) (3).  A 
phosphate group is transferred from 1,3-BPG to ADP, producing an ATP molecule and in 
the process converting 1,3-BP to 3-phosphoglycerate (3-PG) in a reaction catalysed by 
phosphoglycerate kinase (4). 3-PG is then rearranged to form 2-phosphoglycerate (2-PG). 
2-PG then loses a water molecule, forming the unstable molecule phosphoenolpyruvate 
(PEP). PEP readily donates a phosphate group to ADP producing another molecule of ATP 
in a reaction catalysed by pyruvate kinase, converting PEP to pyruvate (5). Overall 
glycolysis uses two molecules of ATP to produce four molecules of ATP and two 
molecules of NADH.  
Chapter 5  170 
 
Figure 5-2 Schematic of the tricarboxylic acid (TCA) cycle. Citrate produced from the 
combination of acetyl-coenzyme A (acetyl-CoA), produced by the oxidation of pyruvate, 
and oxaloacetate. Citrate is then rearranged in a two-step process to isocitrate in reactions 
catalysed by aconitate hydratase. In an oxidation reaction isocitrate loses a carbon to 
produce carbon dioxide (CO2), reducing NAD+ to NADH forming the five-carbon 
compound 2-oxoglutarate (1). 2-Oxoglutarate is then reduced to a four-carbon compound, 
releasing a molecule of CO2 and reducing NAD+ to NADH (2). Succinyl-CoA is produced 
from the addition of CoA to the four-carbon compound in a reaction mediated by α-
ketoglutarate dehydrogenase. Succinyl-CoA is unstable and the CoA is replaced by a 
phosphate group, which is the transferred to ADP forming ATP (3), leaving succinate. 
Succinate is then oxidized to form fumarate. In this reaction two hydrogen atoms are 
transferred to FAD, producing FADH2 (4). Fumarate is converted to malate through the 
addition of a water molecule to the four-carbon compound. Malate is oxidised to form 
oxaloacetate reducing NAD+ to NADH (5). Two acetyl-CoA molecules are produced for 
every molecule of glucose, so overall the TCA cycle produces four molecules of CO2, six 
molecules of NADH, two molecules of FADH2 and two molecules of ATP. 
 
CCM changes dramatically with the environmental and genetic conditions a 
cell experiences. Due to the fundamental role that these key metabolites and 
pathways play in biology, there’s great interest in obtaining a complete 
understanding of the central metabolic activity of cells as possible for the 
purposes of research, metabolic engineering and biotechnology (Bongaerts, 
Krämer, Müller, Raeven, & Wubbolts, 2001; Chassagnole, Noisommit-Rizzi, 
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Schmid, Mauch, & Reuss, 2002; Fiehn, 2002; Kell, 2004; Kimball & 
Rabinowitz, 2006; Luo et al., 2007; Nielsen & Oliver, 2005; Stitt & Fernie, 
2003; Wendisch, Bott, Kalinowski, Oldiges, & Wiechert, 2006). 
Each of the CCM pathways are essential for energy production, but also play 
key roles in other pathways. For example the TCA cycle follows glycolysis, 
but also for lipid metabolism, amino acid metabolism and signalling in cells 
(He et al., 2004; Keefer & Schuster, 1986). 
The metabolites that participate in CCM include carboxylic acids, 
phosphorylated compounds, including sugar-phosphates (e.g. fructose 6-
phosphate), phospho-carboxylic acids (e.g. PEP) and nucleotides such as ATP 
and NAD. These metabolites are almost entirely anionic species (Soga et al., 
2002). There are various options with regards to the analytical techniques that 
can be adopted for targeted metabolomics. These include NMR, 
chromatography and MS (Lu et al., 2008; Roberts et al., 2012). 
Chromatography based-MS methods are often utilized in targeted 
metabolomics studies as they provide high sensitivity and specificity with 
broad dynamic range (Kimball & Rabinowitz, 2006; Rabinowitz, 2007; 
Rabinowitz & Kimball, 2007; Want, Nordström, Morita, & Siuzdak, 2007). 
5.1.2 Methods to analyse central carbon metabolism (CCM) 
5.1.2.1 GC-MS 
GC-MS is a powerful tool in metabolomics and has been used in both targeted 
and untargeted analysis of small organic molecules (Fiehn, Kopka, Dörmann, 
et al., 2000; Fiehn, Kopka, Trethewey, & Willmitzer, 2000; Martínez & 
Krömer, 2016).  GC-MS has been used successfully in semi-quantitative and 
quantitative studies of volatile compounds (Martínez & Krömer, 2016).  
Although GC-MS has been used in quantitative metabolomics, the 
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compounds analysed have to be volatile to get into the gas phase either 
naturally or through chemical derivatisation (Fiehn, Kopka, Dörmann, et al., 
2000; Fiehn, Kopka, Trethewey, et al., 2000; Weckwerth, Loureiro, Wenzel, 
& Fiehn, 2004; Zamboni, Saghatelian, & Patti, 2015).  
Functional groups such as hydroxyl, amine, amide, phosphate and thiol 
groups are problematic in GC but can be converted to more suitable alkylsilyl 
derivatives through silylation (Blau & Halket, 1993; Knapp, 1979) However 
the direct silylation of sugars results in numerous peaks being detected in the 
GC for each sugar, as the sugar can be found in cyclic and open structures 
(Blau & Halket, 1993; Knapp, 1979). To inhibit the cyclisation of sugars, a 
methoximation step is carried out before silylation, which results in fewer 
peaks for sugars. Methoximation also protects α-ketoacids from 
decarboxylation and fixes enolizable keto groups, which facilitates 
identification of the original structures (Blau & Halket, 1993).  
GC-MS with two-step methoximation and silylation derivatisation has been 
carried out for various compounds involved in CCM (Canelas, Ras, ten 
Pierick, van Gulik, & Heijnen, 2011; Cipollina et al., 2009; Koek, Muilwijk, 
Werf, & Hankemeier, 2006). GC-MS was recently used to analyse 41 
metabolite standards involved in CCM (Jung & Oh, 2015). However, F16B 
and oxaloacetate were not detected due to low derivatization and instability, 
respectively and G3P and eyrthrose 4-phosphate (E4P) were not detected as 
they occurred in low concentrations. When this method was applied to the 
analysis of Kluyveromyces marxianus, a total of 25 CCM metabolites were 
detected and quantified (Jung & Oh, 2015). The results obtained from this 
study were comparable to a recent LC-MS/MS study (Rühl et al., 2012). 
GC-MS is a powerful tool for quantitation studies, however the drawbacks of 
this method include the requirement of derivatisation of non-volatile 
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compounds and the incompatibility of this method for the analysis of large 
and heat labile molecules (Zamboni et al., 2015).   
Although GC-MS provides a robust platform for the detection and 
quantification of small volatile organic molecules, it is generally agreed that 
due to the dynamic range of metabolites, liquid-based chromatographies are 
better suited for the targeted analysis of CCM compounds (Büscher et al., 
2009). 
5.1.2.2 CE-MS 
Capillary electrophoresis (CE) separates compounds based on their intrinsic 
electrophoretic mobility, which is dependent on the size and charge of the 
analyte (Ramautar, Somsen, & de Jong, 2015). This makes CE an extremely 
powerful tool for the analysis of charged analytes, and as CCM compounds 
are almost entirely anionic, CE is well suited for their analysis (Ramautar et 
al., 2015; Soga et al., 2002).  
Traditionally CE was coupled to UV detection, with detection limits above 
those that are required to detect submicromolar metabolite concentration 
levels that are often present in cells (Luo et al., 2007). However, the coupling 
of CE to MS increased the detection limits of this method by up to 100 fold 
(Sato, Soga, Nishioka, & Tomita, 2004). CE-MS has been used in numerous 
studies to separate and detect metabolites involved in CCM.  
Soga et al. (2002) used sheath flow CE-MS operated in ‘negative mode’ with 
a cationic polymer coated capillary to separate a standard mix of 20 
intermediates from glycolysis and the TCA cycle. Citrate, nucleotides and 
CoA compounds were detected as poorly shaped peaks, if detected at all 
(Soga et al., 2002). The method was then successfully applied to the analysis 
of Bacillus subtilis (Soga et al., 2002). This method could separate and detect 
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G3P and DHAP, but was unable to separate the isomers G6P/F6P or 2-/3-PG 
(Soga et al., 2002). To improve the analysis of nucleosides and CoA 
compounds, Sago et al. (2007) developed a pressure-assisted CE-MS (PACE-
MS) method that utilized a normal fused silica-capillary (Soga et al., 2007). 
Silanols masked with phosphates prevented nucleosides from interacting with 
the capillary wall, allowing the nucleosides to be detected (Soga et al., 2007). 
The two CE-MS methods were then merged to create a method for the 
analysis of CCM compounds by sheath flow CE-MS utilizing a platinum ESI 
needle which improved the sensitivity and robustness of the system (Soga et 
al., 2009). This method was used to detect 43 anionic compounds in a 
standard mix and was then applied to the analysis of mouse livers (Soga et al., 
2009). Although the method greatly improved the sensitivity of the CE-MS 
system, the RSD for the majority of the standard mixes and biological 
samples were above 5% (Soga et al., 2009). 
Advancements in CE-MS instrumentation and interfaces has allowed large 
numbers of anions to be separated, without the need for derivatisation, in a 
sensitive and selective manner with fast analysis times (usually <25 min) 
(Soga et al., 2002, 2007, 2009). However, there are a number of drawbacks 
when using CE-MS. In comparison to GC- and LC-MS, the use of CE-MS for 
metabolomics studies is still relatively low and is considered the least suitable 
platform for the detection and quantification of CCM compounds (Büscher et 
al., 2009). The separation power and sensitivity of CE-MS is equal to LC and 
GC, but it lacks the robustness required to analyse biological samples 
(Büscher et al., 2009). Using some CE methods are challenging, e.g. reverse 
polarity methods that are required for carboxylic acid separation (W. C. Yang, 
Regnier, & Adamec, 2008). CE instrumentation also requires greater 
maintenance than both GC and LC and RT variations are greater between 
samples; 3%, compared to 0.5% for GC and LC (Büscher et al., 2009). 
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LC-MS is more time-efficient, requires less maintenance, has greater 
coverage and is more robust than CE-MS methods (Büscher et al., 2009).  
5.1.2.3 LC-MS 
Various LC-MS methods have been employed in CCM studies for the 
detection and quantification of glycolysis, TCA and PPP intermediates. 
Bajad et al. (2006) compared various LC methods for the separation of 163 
metabolites and found that an aminopropyl column run under HILIC 
conditions at pH 9.5  performed the best and was able to separate 141 
compounds out of the 163 CCM standards (Bajad et al., 2006). However, the 
method failed to separate sugar isomers, exhibited poor performance for 
NADH and performed worse than GC-MS for small volatile compounds 
(Bajad et al., 2006). 
To aid in the separation of sugar phosphates (often a challenge in LC-MS due 
to their high polarity and similar structures), ion-pairing agents can be added 
to the RPLC mobile phase (Bennett et al., 2009; Buescher et al., 2010; 
Kimball & Rabinowitz, 2006; Lu et al., 2010, 2014, 2008; Luo et al., 2007; 
Rabinowitz & Kimball, 2007). Luo et al. (2007) compared the suitability of 
different volatile alkylamines as ion-pairing agents for the targeted analysis of 
organic acids, sugar phosphates and nucleotides (Luo et al., 2007). 
Triethylamine (TEA), tripropylamine (TPrA), tributylamine (TBA), 
tripentylamine (TPeA), and trihexylamine (THA), adjusted to pH 6.8 with 
5mM acetic acid were compared in the study (Luo et al., 2007). Alkylamines 
with shorter alkyl chains (TEA and TPrA) were unable to separate isomers. 
TPeA and THA, which contained long alkyl chains, exhibited very long 
retention times and low sensitivity due to broad peaks. TBA was considered 
the most suitable ion-pairing agent for RPLC-MS, although it was unable to 
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separate 2-/3-PG without altering the pH, resulting in a loss of organic acid 
retention and separation (Luo et al., 2007).  
Lu et al. (2008) combined the HILIC method described by Bajad et al. and the 
ion-pair RPLC described by Luo et al.  with negative mode ionization, which 
improved CCM coverage, separation and signal for negatively charged 
analytes (Lu, Bennett, & Rabinowitz, 2009).  
TBA was used as an ion-pairing agent by Buescher et al. (2010) and Ruhl et 
al. (2012) for the analysis of 26 and 20 CCM compounds, respectively 
(Buescher et al., 2010; Rühl et al., 2012). Of the 26 glycolysis, PPP and TCA 
cycle intermediates, 22 were determined to be quantifiable by UHPLC-
MS/MS utilizing a 25 min gradient (Buescher et al., 2010).  The method had 
the ability to separate the isomers citrate/isocitrate, G3P/DHAP and 
R5P/Ru5P, but was unable to separate 2-/3-PG, and was not suitable for the 
quantification of oxaloacetate (Buescher et al., 2010). Although the LC-
MS/MS method developed by Ruhl et al. was applied to the analysis of 20 
CMM, not all of the metabolites could be detected (Rühl et al., 2012). Acetyl-
CoA and oxaloacetate degraded during processing, E4P was below the 
detection limit, G3P and fumarate overlapped in mass and time with unknown 
contaminants and they had difficulty separating the isomers X5P/R5P, 2-/3-
PG and citrate/isocitrate (Rühl et al., 2012).   
Although the use of RPLC-MS with the aid of TBA as an ion-pairing agent 
enhances the separation and detection of different chemical classes involved 
in CCM, such as carboxylic acids, amino acids, sugar phosphates, 
nucleotides, and functionalized aromatics, the use of tributylamine (TBA) 
leads to long-term contamination of LC and MS instrumentation. Switching to 
a different application or polarity will require extensive and tedious cycles of 
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cleaning with hazardous organic solvents, although this may never fully 
eradicate the TBA contamination (Buescher et al., 2010).   
5.1.2.4 Anion Exchange Chromatography (AEX) – MS 
Anion exchange chromatography (AEX) is a branch of liquid chromatography 
that can be used for the analysis anionic compounds, without the need for 
derivatization or ion-pairing agents (Bhattacharya, Fuhrman, Ingram, 
Nickerson, & Conway, 1995; Wunschel et al., 1997). Bhattacharya et al. 
(1995) applied AEX to the analysis of 23 metabolites in a single run, utilizing 
an IonPac AS11 (250 x 4mm) column and a CarboPac PA1 column 
(Bhattacharya et al., 1995). G3P, DHAP, R5P and X5P could not be detected. 
CoA was detected but succinyl-CoA and acetyl-CoA could not be detected 
and the method was unable to resolve succinate/malate, 2-oxoglutarate/G6P, 
2-/3-PG (Bhattacharya et al., 1995). 
Wunchel et al. (1997) used a CarboPac PA1 column with a NaOH/Na acetate 
gradient for the separation of sugars, sugar phosphates and sugar acids 
(Wunschel et al., 1997). 
In the two examples above conductivity was utilized as the mode of detection. 
However as some analytes co-eluted it was impossible to quantify them, even 
if the two analytes had different structures and masses (Bhattacharya et al., 
1995; Wunschel et al., 1997). The coupling of AEX to MS was unfavourable 
as the high ionic strength of the MP required for separation in AEX can cause 
the deposition of non-volatile salts at the ion source inlet of the MS. 
Advancements in ion chromatography instrumentation has led to the advent 
of an internal ion suppressor. The column outlet can be attached to a 
membrane suppressor. The suppressor reduces the salt concentration of the 
eluent by electrochemically exchanging hydroxide ions for protons, so that 
the eluent running through to detector is neutral (Van Dam et al., 2002). The 
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outlet of the detector can then be connected to the inlet of the MS. A make-up 
flow containing organic solvent can be run at a higher flow rate to provide the 
optimum conditions for ESI-MS. 
The AEX-MS method developed by van Dam et al. (2002) has been utilized 
in other studies for the analysis of CCM compounds (Bolten, Kiefer, Letisse, 
Portais, & Wittmann, 2007; Kiefer, Nicolas, Letisse, & Portais, 2007; 
Mashego et al., 2004; Millard, Massou, Wittmann, Portais, & Létisse, 2014; 
Van Winden et al., 2005; Wu et al., 2005). Mashego et al. (2004) and Van 
Winden et al. (2005) used the method described by van Dam for the 
quantification of sugar phosphates in Saccharomyces cerevisiae (Mashego et 
al., 2004; Van Winden et al., 2005). Kiefer et al. (2007) and Bolten et al. 
(2007) used the van Dam method for the analysis of sugar phosphates and 
sugar phosphates and some organic acids in Escherichia coli, respectively 
(Bolten et al., 2007; Kiefer et al., 2007; Van Dam et al., 2002). The adapted 
van Dam method has been used to analyse non-stationary 13C-metabolite flux 
analysis in Chlamydomonas reinhardtii (Martzolff et al., 2012), to determine 
the physiological and molecular timing of the glucose to acetate transition in 
E.coli (Enjalbert, Letisse, & Portais, 2013) and for the 13C metabolic flux 
analysis in E. coli (Millard et al., 2014). 
Although the AEX method developed by van Dam and adapted by Kiefer has 
been used in the successful quantification of CCM compounds in various 
organisms, the emphasis of these studies has been on phosphorylated sugars 
and only a select few organic acids  (Bolten et al., 2007; Kiefer et al., 2007; 
Mashego et al., 2004; Millard et al., 2014; Van Winden et al., 2005; Wu et al., 
2005). 
The aim of this research was to test the suitability of a simple 60 minute AEX 
(IC) -MS targeted method for the analysis of CCM intermediates, including 
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the coenzymes. This method would allow the separation and detection of 
numerous classes of energy metabolites without the need for derivatisation, 
different analytical runs or ion-pairing agents. 
The practicality and reliability of the method were investigated by the 
analysis of glycolysis, TCA and electron chain intermediate standards.  
5.2 Materials and methods 
The materials and methods are the same as those described in Chapter 2, with 
the following changes: 
 (1) The Thermo Scientific Dionex™ ICS-5000 first utilised in this study, was 
substituted for a Thermo Scientific Dionex™ ICS-2100 integrated system, as 
capillary IC was unsuitable for metabolomics analysis. 
5.3 Results 
Firstly, to determine the optimum conditions for metabolite detection 
different MP compositions were investigated to maximise ion abundance in 
the MS. 
5.3.1 Make-up flow composition 
Four make-up flow compositions were investigated for their use with the 
ICMS system: (1) no make-up flow; (2) acetonitrile (ACN); (3) methanol 
with 2 mM acetic acid (MeOH + ace.a) and (4) MeOH only.  
Three energy metabolites were selected to determine the effects of make-up 
flow composition on ionisation and abundance, to aid in the selection of the 
most suitable make-up flow composition for the purposes of this study. 
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When 100 µM of the pyruvate (m/z 87.0088) standard was injected into the 
MS using a by-pass loop with no make-up flow the analyte abundance was 
lower than the abundance of one of the background ions at m/z 94.9804 (Fig. 
5-3A). An organic make-up flow assisted in the ionisation of analytes before 
entry into the MS.  When the make-up flow consisted of an organic solvent 
(ACN, MeOH + ace.a or 100% MeOH) the abundance of pyruvate increased 
by at least a factor of five (Fig. 5.3B-D & Table 5.1). The highest intensity of 
pyruvate was achieved using 100% ACN (~4.2E6), followed by MeOH + 
ace.a (~2E6) and then 100% MeOH (~1.6E6). The spectra became messier 
with the addition of the organic make-up flows (Fig. 5-3B-D), with MeOH + 
ace.a (Fig.5-3C) appearing to have more ionised species compared to ACN 
(Fig. 5-3B) and 100% MeOH (Fig. 5-3C). 
As with pyruvate, when 100 µM glucose (m/z 179.0562) was analysed using 
no make-up flow, the analyte did not reach an intensity greater than the 
intensity recorded for the m/z 94.9804 background ion (Fig.5-4A). When 
ACN was used the intensity of glucose increased, but intensity was lower than 
the m/z 94.9804 background ion (Fig. 5-4B). When MeOH + ace.a and 100% 
MeOH were used the intensity of the glucose ion increased to a level above 
the background ions (Fig.5-4C & D). The intensity of the glucose ion was 
greater when MeOH + ace.a was used instead of 100% MeOH alone; 4E6 
compared to 1.8E6 (Fig. 5-4C & D & Table 5-1). Fewer background ions 
were detected when using 100% MeOH alone, resulting in a cleaner looking 
spectrum (Fig.5-4C & D).  
2-Oxoglutarate (m/z 145.0140) was detected at the highest intensity using 
ACN as the make-up flow (Fig. 5-5A), 3E7 compared to 8.8E6 and 9.7E6 
when using MeOH + ace.a (Fig. 5-5B) and 100% MeOH (Fig. 5-5C), 
respectively. (Note: as the intensities of the previous analytes had not reached 
above the intensities of the background ions when no make-up flow was used, 
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it was left out of the 2-oxoglutarate analysis). 100% MeOH was taken 
forward as the make-flow composition for IC-MS analysis as it produced high 
intensity analyte ions, while resulting in cleaner spectra overall when 
compared to both 100% ACN and MeOH + ace.a. 
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Figure 5-3 Mass spectra of pyruvate (m/z 87.0084) with (A) no make-up flow, (B) 
acetonitrile (ACN), (C) methanol with 2 mM acetic acid (MeOH + ace.a) and (D) 100% 
MeOH only. Detection: ESI-FTMS, negative mode. The analyte ion intensity did not reach 
a level above the background ions when no make-up flow was used (A). The highest 
intensity and cleanest spectrum was obtained using 100% ACN (B). The second highest 
intensity was obtained using MeOH + ace.a (C). The intensity of pyruvate was similar to 
MeOH + ace.a (C) when 100% MeOH used with a cleaner spectrum (D). (*) denotes the 
pyruvate ion. MIC = maximum ion count. 
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Figure 5-4 Mass spectra of glucose (m/z 179.0562) with (A) no make-up flow, (B) 
acetonitrile (ACN), (C) methanol with 2 mM acetic acid (MeOH + ace.a) and (D) 100% 
MeOH only. Detection: ESI-FTMS, negative mode. The analyte ion intensity did not reach 
a level above the background ions when no make-up flow was used (A). The highest 
analyte ion intensity was achieved using MeOH + ace.a (C). The second highest intensity 
was obtained using 100% MeOH (D). The cleanest spectrum was obtained using 100% 
MeOH (D). (*) denotes the glucose ion. MIC = maximum ion count. 
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Figure 5-5 Mass spectra of 2-oxoglutarate (m/z 145.0140) with (A) acetonitrile (ACN), (B) 
methanol with 2 mM acetic acid (MeOH + ace.a) and (C) 100% MeOH only. Detection: 
ESI-FTMS, negative mode. The highest analyte ion intensity was achieved using 100% 
ACN (A). The second highest intensity and cleanest spectrum was obtained using 100% 
MeOH (C). (*) denotes the 2-oxoglutarate ion. MIC = maximum ion count. 
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Table 5-1 Ion intensities of pyruvate (m/z 87.0084), glucose (m/z 179.0562) and 2-
oxoglutarate (m/z 145.0143) using no make-up flow, acentonitrile (ACN), methanol with 2 
mM acetic acid (MeOH + 2 mM a. acid) and 100% methanol (MeOH). The metabolites 
were injected directly into the mass spectrometer and their ion intensities were recorded. 
 
Intensity 
Metabolite No make-up ACN MeOH + 2 mM a.acid MeOH only 
Pyruvate 751245.1 4120633.8 2000482.8 1646202.3 
Glucose 163309.9 1076766 3973986.3 1753060.5 
2-Oxoglutarate - 29776066 8850457 9709970 
 
Once MP composition was optimised, different standard mixes were analysed 
to optimise separation and identification using the IC-MS method. 
5.2.2 Standards 
5.2.2.1 Glycolysis mix 
The individual standards from glycolysis were run through the IC system to 
determine their individual RT times before being analysed in a mix using the 
IC-MS method. A list of the standards, their masses and m/z values can be 
found in Table 5-2. 
All of the glycolysis intermediates could be detected using their intact m/z 
values, with the exception of dihydroxyacetone (DHAP) and glyceraldehyde 
3-phosphate (G3P) (Table 5-2 and Fig. 5-6). The conductivity chromatograms 
of DHAP and G3P had an intense peak at 28.35 and 28.32 min and a smaller 
peak at 9.24 and 9.47 min, respectively (Fig. 5-6). The peaks detected at 9 
min for each sample had an m/z of 89.0244, which suggested that they could 
be the result of DHAP and G3P losing their phosphate group (PO32-) and one 
hydrogen.
 
The presence these peaks at the beginning of the chromatographic 
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run suggests that the phosphate group is breaking off from the compounds in 
solution or as a result of the OH- concentration in the eluent. The more intense 
peaks at 28 min, with an m/z value of 176.9351 could be the result of two 
phosphates joining together to produce diphosphate (H4O7P2). When the [M-
H]- of DHAP was searched for in the MS data, there were numerous peaks 
present (Fig. 5-7A). G3P produced one intense peak for m/z 168.9908 at 
21.51 min when its mass was searched for in the MS data (Fig 5-7B). 
Numerous ion peaks were present throughout the MS data for both DHAP 
and G3P, which could be the result of phosphate losses and bonding, water 
losses and the production of dimers from the monomer standards (Fig. 5-8). 
The presence of numerous peaks for each standard suggest that the 
compounds could be breaking down in the eluent or on column and then 
breaking down further during ionisation (Fig. 5-7 & 5-8).  
The RT of DHAP could not be determined due to the number of peaks 
detected for the m/z of the intact compound (Figs. 5-7A). From the MS data 
the RT of G3P could be 21.51 min (5-7B). Fragment ions with the same m/z 
value as DHAP and G3P were detected in the G6P and F6P standards. The 
G6P fragment ion had a very similar RT to G3P, 21.70 min compared to 
21.50 min. Unfortunately, the two peaks could not be resolved from one 
another using the IC-MS method.  
As the intact ion peaks for DHAP and G3P could not be used various reporter 
ions were considered (Figure 5-8), however none of these were deemed 
suitable as they were present in almost all of the glycolysis intermediates at 
the same RTs. 
Due to the effect that the presence of the DHAP and G3P standards had on the 
IC spectrum of the glycolysis mix, and the inability to find unique RTs or 
reporter ions, these standards were omitted from further standard mixes. 
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Table 5-2 A list of the glycolysis standards elemental formulae (EF), molecular weights 
(MW) and m/z values ([M-H]). The table lists whether the metabolite was detected (+) or 
not detected (-) using the IC-MS method and, if it was detected, whether the metabolite 
mass chromatogram contained multiple peaks (+) or a single peak (-).  
Glycolysis      
Metabolite EF MW [M-H] 
Detected/N
ot detected 
Multiple 
peaks 
Glucose C6H12O6 180.0634 179.0562 + - 
Glucose-6-phosphate C6H13O9P 260.0297 259.0225 + - 
Fructose-6-phosphate C6H13O9P 260.0297 259.0225 + - 
Fructose-1,6-biphophate C6H14O12P2 339.9961 338.9889 + - 
Dihydroxyacetone 
phosphate 
C3H7O6P 169.9980 168.9908 + + 
Glyceraldehyde-3-
phosphate 
C3H7O6P 169.9980 168.9908 + + 
3-Phosphoglyceric acid C3H7O7P 185.9929 184.9857 + - 
2-Phosphoglyceric acid C3H7O7P 185.9929 184.9857 + - 
Phosphoenolpyruvic acid C3H5O6P 167.9824 166.9752 + + 
Pyruvic acid C3H4O3 88.0160 87.0088 + + 
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Figure 5-6 The conductivity chromatograms of (A) dihydroxyacetone (DHAP) and (B) 
glyceraldehyde 3-phosphate (G3P). Detection: conductivity. Both conductivity 
chromatograms show a peak at approximately 9.20 min and a more intense peak at 
approximately 28.5 min (A & B) The presence of more than one peak suggests that the 
compounds may be breaking down on column or in the eluent. 
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Figure 5-7 Extracted ion chromatograms (EICs) of m/z 168.9908 from the (A) 
dihydroxyacetone (DHAP) and (B) glyceraldehyde 3-phosphate (G3P) standards. 
Detection: ESI-FTMS, negative mode. Multiple peaks present when the m/z of the DHAP 
monomer was searched for in the individual standards run (A). When the m/z of G3P was 
searched for one intense peak was present at 21.51 min, with two less intense peaks at 
21.69 min and 28.50 min (B). Due to the presence of multiple peaks for the same m/z 
value, the RT of DHAP could not be determined using the intact ion (A). 20.51 min 
appeared to be the most likely RT for G3P (A). 
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Figure 5-8 Mass spectrums (MS) of (A) dihydroxyacetone (DHAP) and (B) 
glyceraldehyde 3-phosphate (G3P) with possible elemental compositions. Detection: ESI-
FTMS, negative mode. Mass tolerance : 4 ppm. Some of the ions detected for the DHAP 
standard included phosphate (m/z 96.9693), phosphate with a water loss (m/z 78.9586), 
pyrophosphate (m/z 176.9358), pyrophosphate hydrate (m/z 194.9463) and pyrophosphate 
with a water loss (m/z 158.9252) (A). Some of the possible ions detected for G3P included 
the dimer of G3P (m/z 338.9889), the G3P monomer (m/z 168.9907), the G3P monomer 
with a water loss (m/z 150.9799), phosphate (m/z 96.9599) and phosphate with a water loss 
(m/z 78.9588). Although there were many ions present, none of these were unique to the 
DHAP and G3P standards and could be detected in other glycolysis standards (data not 
shown). 
 
The IC method was able to separate the sugar-phosphate isomers G6P and 
F6P (m/z 259.0225) (Fig. 5-12(b)). However, they were unable to be 
completely resolved from one another. The isomers 2- and 3-
phosphoglycerate (m/z 184.9857) were unable to be resolved to a sufficient 
level to be detected as individual ions by the mass spectrometer (Figs. 5-9 & 
5-12(d)). Phosphoenolpyruvate (PEP) (m/z 166.9752) and pyruvate (m/z 
87.0088) were detected as multiple peaks in the glycolysis mix (Fig. 5-12(e) 
& (f)). From the individual standards runs it was determined that the correct 
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RT for  PEP was approximately 35.10 min (Fig 5-10) and the correct RT for 
pyruvate was approximately 10.94 min (Fig 5-11). The second peak detected 
for PEP was most likely a breakdown product of 2-/3-PG (Fig. 1-12). The 
peaks detected at RT 29.81 min and 35.20 min for m/z 87.0088 were most 
likely breakdown products of 2-/3-PG and PEP, respectively (Fig. 5-12). 
Using the RT data from the individual standards runs all of the glycolysis 
metabolites were separated using the IC and their m/z values detected using 
the ESI-FTMS (Fig. 5-13), with the omission of DHAP and G3P, whose RTs 
could not be determined from the IC-MS data, and the exception of 2-/3-PG, 
which could be detected in the MS as one peak, but not separated by the IC. 
 
Figure 5-9 The (A) IC conductivity chromatogram and (B) EIC from MS of 2- and 3-
phosphoglycerate. Detection: ESI-FTMS, negative mode. These isomers were unable to be 
sufficiently separated using the IC method (A) and so were detected as one peak in the MS 
(B). 
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Figure 5-10 The extracted ion chromatogram (EIC) of phosphoenolpyruvate (m/z 
166.9752), showing the actual RT for PEP is closer to 35 minutes rather the peak seen at 
29 minutes in the glycolysis mix (Fig.5.12 (e)). Detection: ESI-FTMS, negative mode. 
 
 
 
Figure 5-11 The extracted ion chromatogram (EIC) of the pyruvate standard (m/z 
87.0088). Detection: ESI-FTMS, negative mode. Two peaks suggest that the standard may 
be contaminated. The most intense peak at a RT of 10.94 was pyruvate.  
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Figure 5-12 The extracted ion chromatograms (EICs) of the glycolysis metabolites. 
Detection: ESI-FTMS, negative mode. (a) glucose (m/z 179.0562), (b) (1) glucose 6-
phosphate & (2) fructose 6-phosphate (m/z 259.0225), (c) fructose 1,6-bisphosphate, (d) 2-
/3-phosphoglycerate (m/z 184.9857), (e) (3) phosphoenolpyruvate  (m/z 166.9752) and (f) 
(4) pyruvate (m/z 87.0088). Note: dihydroxyacetone and glyceraldehyde 3-phosphate were 
omitted from the glycolysis mix. 
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Figure 5-13 The (A) ion conductivity (IC) chromatogram (B) mass spectrum and (C) an 
extracted ion chromatogram (EIC) of glucose (m/z 179.0562) of the glycolysis mix. 
Detection: ESI-FTMS, negative mode. (1) fragment ion with a m/z 89.0244 (2) unknown 
(not detected in MS); (3) glucose 6-phosphate; (4) fructose 6-phosphate; (5) mix of 
phosphate, diphosphate and pyrophosphate; (6) 2-/3-phosphoglycerate; (7) 
phosphoenolpyruvate; (8) fructose 1,6-bisphosphate. Mass spectrum showing the relative 
abundance of the ions present in the glycolysis mix (B). All of the peaks correspond to the 
metabolites detected in the IC (A).  The presence of glucose (m/z 179.05611) at a retention 
time (RT) of 3.11 mins, although not prominent in either the IC conductivity or MS, can be 
confirmed when its m/z value is searched for (m/z 179.0562) using an extracted ion 
chromatogram (EIC) from the MS data (C). 
 
5.2.2.2 The Citric Acid (TCA) cycle 
The individual standards from the TCA cycle were run through the IC system 
to determine their individual RTs before being analysed in a mix using the IC-
MS method. A list of the standards, their masses and m/z values can be found 
in Table 5-3. 
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All of the TCA intermediates could be detected using their intact m/z values 
(Table 5-3 and Fig. 5-20), with the exception of the coenzymes, which will be 
discussed later. 
The isomers citrate and isocitrate (m/z 191.0198), that were unable to be 
separated using the combined LC RPLC/pHILIC method (Fig. 5-14) were 
able to be baseline resolved from one another using the IC-MS method (Fig.5-
15).  
Two peaks were present in the IC and MS when the cis-aconitate (m/z 
173.0092) standard was run (34.79 min and 39.02 min) consisting of a high 
abundance of a fragment ion with m/z 129.0190, a smaller abundance of the 
intact standard (m/z 173.0089) and another fragment ion with an m/z value of 
85.0292 (Fig. 5-16). The fragment ion with m/z 129.0190 could be the result 
of the parent ion losing a CO2 (Fig. 5-16 C). A loss of another CO2 from the 
m/z 129.019 fragment could result in the m/z 85.0292 fragment ion (Fig. 5-16 
C). 35.09 min was taken as the correct RT of cis-aconitate as there was a 
higher abundance of the 173.0092 ion compared to 39.24 min. To determine 
which of the two peaks was cis-aconitate, fragmentation of each of the peaks 
could be carried out and the fragmentation patterns matched to a known 
fragmentation spectrum of cis-aconitate.  
Succinate (m/z 117.0194), fumarate (m/z 115.0038) and malate (m/z 
133.0143) could not be separated using IC alone (Fig. 5-17 A), but were able 
to be distinguished from one another using the IC-MS method (Fig. 5-17 B). 
Succinate and malate were unable to be resolved from each other on the IC 
(Fig. 5-17 A), but could be detected in the MS separately using their m/z 
values (Fig 5-17 (B) (b) & (d)). Fumarate was separated from succinate and 
malate in the IC (Fig. 5-17 A), and the breakdown product from malate with 
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the same mass as fumarate (m/z 115.0038) could be determined in the MS due 
to the difference in RT from fumarate (Fig. 5-17 B (b) & (c)). 
Oxaloacetate (m/z 130.9987) was detected as several peaks in the IC and MS 
(Fig. 5-18). The EIC of the oxaloacetate standard showed multiple peaks for 
m/z 130.9987 (Fig. 5-18 B). The presence of multiple peaks in the IC and the 
MS could be the result of the standard breaking up in the eluent or on column. 
One RT could not be determined for oxaloacetate due to the presence of three 
intense peaks when m/z 130.9987 was extracted from the mass spectrum data 
and the inability to identify any fragments unique to the standard. The most 
intense peak for m/z 130.9987 was detected at 36.17 min, which could be 
used as the RT of oxaloacetate. 
Using the RT data from the individual standards runs all of the TCA 
metabolites were separated using the IC-MS method (Fig. 5-19), with the 
exception of oxaloacetate and the co-enzymes.  
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Table 5-3 A list of the TCA cycle intermediates elemental formulae (EF), molecular 
weights (MW) and m/z values ([M-H]). The table lists whether the metabolite was detected 
(+) or not detected (-) using the IC-MS method and, if it was detected, whether the 
metabolites mass chromatogram contained multiple peaks (+) or a single peak (-). 
TCA cycle 
 
    
Metabolite Formula MW [M-H] 
Detected/N
ot detected 
Multiple 
peaks 
Citric acid C6H8O7 192.0270 191.0198 + - 
Isocitric acid C6H8O7 192.0270 191.0198 + - 
cis-Aconitic acid C6H6O6 174.0164 173.0092 + + 
2-Oxoglutaric acid C5H6O5 146.0215 145.0143 + - 
Succinyl-CoA C25H40N7O19P3S 867.1313 866.1241 + + 
Succinic acid C4H6O4 118.0266 117.0194 + - 
Fumaric acid C4H4O4 116.0110 115.0038 + - 
Malic acid C4H6O5 134.0215 133.0143 + - 
Oxaloacetic acid C4H4O5 132.0059 130.9987 + + 
Acetyl-CoA C23H38N7O17P3S 809.1258 808.1186 + + 
CoA C21H36N7O16P3S 767.1152 766.108 + + 
 
 
 
 
 
Chapter 5  198 
 
Figure 5-14 The extracted ion chromatograms (EICs) of (A) citrate and (B) isocitrate 
obtained using the combined RPLC/pHILIC LCMS method. Detection: ESI-FTMS, 
negative mode. The isomers could not be separated for quantification using this method. 
 
 
  
 
Figure 5-15 The extracted ion chromatogram (EIC) of a citrate and isocitrate mix using the 
IC-MS method. Detection: ESI-FTMS, negative mode. Using the RTs from the IC data the 
peak at RT 31.85 min was identified as citrate and the peak at RT 33.49 min was identified 
as isocitrate. 
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Figure 5-16 The (A) extracted ion chromatogram (EIC) (m/z 173.0092) and (B) mass 
spectrum (MS) of the cis-aconitate standard. Detection: ESI-FTMS, negative mode. When 
the m/z of cis-aconitate was searched for, two peaks were detected (A). The intact mass of 
cis-aconitate was not the most abundant ion, instead a fragment with m/z 129.0190, 
possibly resulting from a CO2 loss from the standard, was the most abundant (B). Other 
fragment ions included m/z 111.0085 (possibly due to a water loss from m/z 129.0190) and 
m/z 85.0292 (possibly resulting from a CO2 loss from the m/z 129.0190 fragment) (B). 
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Figure 5-17 Comparison of the (A) IC chromatogram of (1) malate & succinate and (2) 
fumarate and (B) the extracted ion chromatograms (EICs) of (a) the full MS of a malate, 
succinate and fumarate mix (b) malate (m/z 133.0143), (c) fumarate (m/z 115.0038) and (d) 
succinate (m/z 117.0194). Detection: conductivity (A) and ESI-FTMS, negative mode (B).  
In the IC, malate and succinate co-elute at around 19 min (A; peak (1)). The mass 
spectrometer was used to distinguish between these two metabolites as they have different 
masses (B (b)&(d)). Conversely, the IC was used separate fumarate (4) and the breakdown 
product of malate (3), which has the same mass as fumarate (B). This enabled the correct 
RTs to be determined and malate, fumarate and succinate to be identified using IC-MS. 
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Figure 5-18 The (A) conductivity chromatogram and (B) extracted ion chromatogram 
(EIC) of the oxaloacetate (m/z 130.0143) standard. Detection: conductivity (A) and ESI-
FTMS, negative mode (B). Multiple peaks were detected for oxaloacetate in the IC (A) and 
the MS (B), suggesting that the standard was contaminated or breaking up in the eluent or 
on column in the IC. 
 
 
Figure 5-19 The extracted ion chromatograms (EICs) of the individual intermediates in the 
TCA mix. Detection: ESI-FTMS, negative mode. (a) (1) citrate and (2) isocitrate (m/z 
191.0198), (b) (3 and 4) cis-aconitate (m/z 173.0092), (c) 2-oxoglutarate (m/z 145.0143), 
(d) succinate (m/z 117.0194), (e) (5) fumarate (m/z 115.0038), (f) malate  (m/z 133.0143). 
Note: * is a breakdown product of malate (e). 
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5.2.2.3 The Co-enzymes 
When coenzyme A (CoA), acetyl-CoA and succinyl-CoA standards were 
analysed using the IC-MS method each of the compounds produced two 
intense peaks at RTs of 52.7 and 57.4 min (Fig. 5-20).  
The [M-H]- of the singly charged intact masses of acetyl-CoA (m/z 808.1186) 
and succinyl-CoA (m/z 866.1241) could not be used to determine these 
compounds RTs. The doubly charged m/z values could not be used either, m/z 
403.5556 and m/z 432.5583, respectively. In all three co-enzyme MS, the 
intense peak at 52.7 min corresponded to a small abundance of singly charged 
CoA (m/z 766.1080) and a high abundance of doubly charged CoA (m/z 
382.5503). The peaks at 57.4 min corresponded to a small abundance of ions 
with the m/z 765.1015 and m/z 509.7315 and a high abundance of doubly 
charged m/z 765.1015; m/z 382.0481. 
To determine whether the compounds were breaking up in the eluent or 
during ionisation into the MS, the mass spectra from direct infusion of the co-
enzymes into the MS were compared to the mass spectra obtained when the 
co-enzymes were run on a 100mM OH- isocratic gradient (Figs. 5-21 – 5-23). 
Doubly charged acetyl-CoA (m/z 403.5556) was the most abundant ion when 
the standard was injected directly into the MS (Fig. 5-21 A). When acetyl-
CoA was run through the column using 100 mM OH- the most abundant ion 
detected was the doubly charged CoA (m/z 382.5503), with no doubly 
charged acetyl-CoA (Fig. 5-21 B). From the results it appeared that acetyl-
CoA was being broken down in the eluent or on the column before 
introduction into the MS (Fig. 5-21). Regardless of the method of introduction 
to the MS, the most abundant ion detected in the succinyl-CoA standard was 
doubly charged CoA with a small amount of succinate (Fig. 5-22). When the 
succinyl-CoA standard was run using the OH- gradient, succinate eluted 
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before the CoA fragment (Fig. 5-22 B). These results suggest that the 
compound is breaking up in solution. CoA was detected in its doubly charged 
form regardless of the method used. 
The RT of CoA could be determined using its doubly charged m/z value. 
However the IC-MS method was not suitable for the separation and detection 
of the co-enzymes as the RTs of acetyl-CoA and succinyl-CoA could not be 
determined and the compounds readily broke down to CoA in the eluent, with 
identical RTs and the lack of any unique fragments.  
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Figure 5-20 EICs of the base peak of (A) acetyl-CoA, (B) succinyl-CoA and (C) CoA. 
Detection: ESI-FTMS, negative mode. Concentration: 100 µM. Each of the standards 
produced an almost identical peak pattern when run on the IC-MS gradient. Succinyl-CoA 
and acetyl-CoA displayed the same peak intensities at each of the RTs, with a more intense 
peak eluting at 52.7 min (A & B). CoA had the same peak pattern, but with a more intense 
peak eluting at 57.4 min (C). The succinyl-CoA spectrum had a small peak at 19.04 min 
(marked with *) which had m/z of 117.0194, relating to the succinate group from the 
compound.  
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Figure 5-21 Mass spectrum of (A) the direct injection of acetyl-CoA into the mass 
spectrometer and (B) acetyl-CoA injected on to the column with a 100 mM isocratic 
gradient. Detection: ESI-FTMS, negative mode. Concentration: 100 µM. Double charged 
acetyl-CoA (m/z 403.5562) was the most abundant peak when acetyl-CoA was directly 
injected onto the mass spectrometer (A). Double charged CoA (m/z 382.5509) was the 
most abundant ion detected when acetyl-CoA was injected onto the column (B) suggesting 
that acetyl-CoA is being broken down in the eluent or on the column before introduction to 
the MS.  
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Figure 5-22 Mass spectrum of (A) the direct injection of succinyl-CoA into the mass 
spectrometer and (B) succinyl-CoA injected on to the column with a 100 mM isocratic 
gradient. Detection: ESI-FTMS, negative mode. Concentration: 100 µM. Double charged 
CoA (m/z 382.5511) was the most abundant peak when succinyl-CoA was directly injected 
onto the mass spectrometer (A) and also when it was injected onto the column (B). 
Succinate (m/z 117.0188) eluted first when the standard was injected onto the column (RT 
2.70), followed by CoA at RT 3.37 (B). Succinate was also present when the standard was 
directly injected into the MS (*m/z 117.0188). This suggests that the standard was 
degraded or that the compound was breaking up in solution. 
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Figure 5-23 Mass spectrum of (A) the direct injection of CoA into the mass spectrometer 
and (B) CoA injected on to the column with a 100 mM isocratic gradient. Detection: ESI-
FTMS, negative mode. Concentration: 100 µM. Double charged CoA (m/z 382.5511) was 
the most abundant peak when CoA was directly injected into the mass spectrometer (A) 
and when the standard was injected onto the column (B).  
 
5.2.2.4 Coenzymes and nucleoside phosphates  
The individual standards were run through the IC system to determine their 
individual RTs before being analysed in a mix using the IC-MS method. A 
list of the standards, their masses and m/z values can be found in Table 5-4. 
ADP and FAD could be detected using their intact m/z values.  ATP, when 
analysed using the IC-MS, produced an intense peak at 51.81 min, composed 
of a low intense peak, which corresponded to the intact ion (m/z 505.9886) 
and a very intense peak that corresponded to ATP minus a phosphate group, 
i.e. ADP (m/z 426.0222). ADP eluted at approximately 42.16 min, so the peak 
of the same mass eluting at 51.81 min did not interfere with the identification 
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of ADP (Fig. 5-24). As the m/z 426.0222 peak was more intense than the m/z 
505.9886, this mass was used for the identification of ATP. 
Although FAD could be detected by its intact m/z value, the most abundant 
peak at the RT was doubly charged FAD (Fig. 5-25). 
The IC-MS method was not suitable for the detection of NAD+ or NADP+. 
 
 
Figure 5-24 The extracted ion chromatograms (EICs) of m/z 426.0222 from the (A) 
adenosine triphosphate (ATP) and (B) adenosine diphosphate (ADP) standards. Detection: 
ESI-FTMS, negative mode. Although the peak was present in both standards, the peak at 
RT 51.81 min was a fragment of ATP (A) and the peak at RT 42.16 min was the ADP 
standard (B).  
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Table 5-4 A list of the coenzymes and nucleoside phosphates intermediates elemental 
formulae (EF), molecular weights (MW) and m/z values ([M-H]). 
Coenzymes and nucleoside phosphates   
Metabolite Formula MW [M-H] 
NADP+ C21H28N7O17P3 743.0755 742.0683 
NAD+ C21H29N7O14P2 664.1170 663.1098 
FAD C27H33N9O15P2 785.1571 784.1499 
ADP C10H15N5O10P2 427.0294 426.0222 
ATP C10H16N5O13P3 506.9958 505.9886 
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Figure 5-25 The (A) extracted ion chromatogram (EIC) of the molecular ion of flavin 
adenine dinucleotide (FAD) m/z 784.1499 and (B) the mass spectrum (MS) at the RT of 
the FAD standard (53.36 min). Detection: ESI-FTMS, negative mode. The most intense 
peak at 53.36 min is the doubly charged compound (m/z 391.5724) (B). 
 
Using the data from the standard mixes a total mix of all of the energy 
metabolites analysed in this study were able to be separated and detected 
using the developed IC-MS method, with the exception of DHAP, G3P, 
oxaloacetate, acetyl-CoA, succinyl-CoA, NAD+ and NADP+ (Fig. 5-26). 
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Figure 5-26 IC conductivity chromatogram of the total mix of the energy metabolism 
standards using IC-MS. (1) Fragment ion with a m/z 89.0244; (2) pyruvate; (3) malate and 
succinate (same RT but different mass); (4) 2-oxoglutarate and glucose 6-phosphate 
(similar RT, different mass); (5) fructose 6-phosphate; (6) fumarate; (7) mix of phosphate, 
diphosphate and pyrophosphate; (8) 2-/3-phosphoglycerate; (9) citrate; (10) isocitrate; (11) 
phosphoenolpyruvate and cis-aconitate (similar RT, different mass); (12) cis-aconitate; 
(13) ADP; (14) fructose 1,6-bisphosphate; (15) ATP; (16) FAD.  
 
To determine the robustness of the system, the RT reproducibility and the 
limits of detection of the IC-MS system were calculated. 
5.2.2.5 Reproducibility 
The IC-MS method showed good retention time reproducibility, with RSD 
values for all of the detectable compounds under 1%, with the exception of 
fructose 1,6-bisphosphate whose RSD value was 1.03% (Table 5-5). 
 
 
 
 
 
Chapter 5  212 
Table 5-5 The average retention times (RTs), standard deviations (SD) and relative 
standard deviations (%RSDs) of each detectable energy metabolism standard. (n=3). 
Retention Time (mins) 
Metabolite 1 2 3 
Average 
RT (mins) SD %RSD 
Glucose 3.15 3.17 3.11 3.14 0.03 0.97 
Glucose-6-phosphate 21.66 21.71 21.75 21.71 0.04 0.21 
Fructose-6-phosphate 22.25 22.22 22.36 22.28 0.07 0.33 
Fructose-16-biphosphate 46.24 45.44 46.28 45.99 0.47 1.03 
3-phosphglycerate 29.72 29.43 29.78 29.64 0.19 0.63 
2-phosphoglycerate 29.72 29.61 29.78 29.70 0.09 0.29 
Phosphoenolpyruvate 35.06 34.91 35.20 35.06 0.14 0.41 
Pyruvate 10.83 10.93 10.94 10.90 0.06 0.56 
Citrate 31.84 31.86 31.85 31.85 0.01 0.03 
Isocitrate 33.47 33.49 33.48 33.48 0.01 0.03 
cis-Aconitate 35.09 35.12 35.07 35.09 0.03 0.07 
2-Oxoglutarate 21.78 21.79 21.79 21.79 0.01 0.03 
Succinate 19.05 19.07 19.04 19.05 0.02 0.08 
Fumarate 22.87 22.87 22.86 22.87 0.01 0.03 
Malate 19.15 19.15 19.13 19.14 0.01 0.06 
FAD 53.46 53.45 53.36 53.42 0.05 0.10 
ADP 42.38 42.40 42.14 42.31 0.14 0.34 
ATP 51.81 51.84 51.79 51.81 0.03 0.05 
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5.2.2.6 Limits of Detection 
Using the IC-MS method, the detectable sugar-phosphates and organic acids 
could be detected at concentrations of lower than 2 pmol, with the exception 
of PEP, which could be detected to a concentration of 10 pmol (Table 5-6).  
F16B, ADP and ATP could be detected to concentrations of lower than 0.2 
pmol (Table 5-7). 
The detection response was linear for glucose, G6P, F6P, citrate, isocitrate, 
cis-aconiate, 2-oxoglutarate, succinate, fumarate and malate over a range of 2 
– 200pmol (Table 5-6 and Fig. 5-27). The detection response was linear for 
2/3-phosphoglycerate from 2 – 1000 pmol (Table 5-6) and 
phosphoenolpyruvate from 10 – 1000 pmol (Table 5.6), with all linear 
regression coefficients ≤ 0.99 (Table 5-6). The range of linearity for F16B, 
ADP and ATP was 0.2 – 100 pmol (Table 5-7 and Fig. 5-28), with linear 
regression coefficients ≤0.98 (Table 5-7). 
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Figure 5-27 Graph illustrating the peak areas detected for a selection of energy 
metabolites. The graph shows the peak areas detected for glucose, 2/3-phosphoglycerate, 
citrate, phosphoenolpyruvate, 2-oxoglutarate, succinate, fumarate and malate ranging from 
2 – 200 pmol. A list of the R2 values can be found in Table 5-6. 
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Figure 5-28 Graph illustrating the peak areas detected for fructose 1,6-bisphosphate, ADP 
and ATP ranging from 200 fmol – 100 pmol. A list of the R2 values can be found in Table 
5-7. 
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Table 5-6 A list of the elemental formulae (EF), peak areas and linear regression coefficients (R2) for the energy metabolites at 2 pmol - 1nmol. 
 
 
Quantity (pmol) 
  
Metabolite EF 1000 200 100 66.7 40 20 10 2 
R2  
(2-200 
pM) 
R2  
(2-1000 
pM) 
  Intensity   
Glucose C6H12O6 2.61E+06 1.09E+06 5.79E+05 4.33E+05 2.45E+05 1.36E+05 7.20E+04 1.85E+04 0.9962 0.9520 
Glucose 6-P C6H13O9P 2.40E+07 1.25E+07 7.56E+06 5.09E+06 3.13E+06 1.56E+06 8.63E+05 1.67E+05 0.9881 0.8868 
Fructose 6-P C6H13O9P 2.25E+07 1.10E+07 6.37E+06 4.49E+06 2.60E+06 1.25E+06 7.16E+05 1.41E+05 0.9908 0.9104 
2/3-PG C3H7O7P 3.15E+06 8.73E+05 4.30E+05 2.95E+05 1.69E+05 6.94E+04 3.50E+04 6.82E+03 0.9996 0.9935 
PEP C3H5O6P 3.45E+05 9.29E+04 4.26E+04 3.25E+04 1.49E+04 7.81E+03 2.93E+03 - 0.9967 0.9946 
Citrate C6H8O7 1.50E+07 7.34E+06 3.89E+06 2.81E+06 1.59E+06 7.21E+05 3.94E+05 7.64E+04 0.9970 0.9130 
Isocitrate C6H8O7 1.44E+07 7.19E+06 3.87E+06 2.74E+06 1.56E+06 6.96E+05 3.86E+05 2.13E+04 0.9964 0.9062 
cis-Acon C6H6O6 4.88E+06 2.14E+06 1.15E+06 8.06E+05 4.78E+05 2.08E+05 1.18E+05 7.35E+04 0.9973 0.9412 
2-Oxo C5H6O5 7.64E+05 3.79E+05 2.14E+05 1.43E+05 8.78E+04 4.32E+04 2.47E+04 4.76E+03 0.9956 0.9080 
Succinate C4H6O4 6.64E+06 3.27E+06 1.78E+06 1.28E+06 7.71E+05 3.11E+05 1.65E+05 3.32E+04 0.9945 0.9093 
Fumarate C4H4O4 2.31E+06 1.07E+06 5.44E+05 3.60E+05 1.97E+05 9.47E+04 5.40E+04 1.04E+04 0.9994 0.9302 
Malate C4H6O5 5.80E+06 2.86E+06 1.43E+06 9.74E+05 5.62E+05 2.38E+05 1.30E+05 2.33E+04 0.9996 0.9133 
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Table 5-7 A list of the elemental formulae (EF), peak areas and linear regression coefficients (R2) for the energy metabolites at 200 fmol – 100 
pmol. 
  
Quantity (pmol) 
 
Metabolite EF 100 20 10 6.7 4 2 1 0.2 R2 Value 
  Intensity  
Fructose 1,6-biphosphate C6H14O12P2 3616549 955527 526981 332416 211887 96852 44952 10911 0.9952 
ADP C10H15N5O10P2 11429135 3002949 1661896 1147555 705999 330488 184087 35715 0.9955 
ATP C10H16N5O13P3 978058 313324 172271 121838 63300 28840 15635 3427 0.9832 
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5.3 Discussion 
The aim of this study was to develop a targeted IC-MS method for the 
separation and detection of various energy metabolism standards within a 
sample in a single chromatographic run. The column selected was a Thermo 
Dionex™ IonPac™ AS11-HC-4µm (2 x 250 mm). The metabolites were 
detected on the Dionex™ ICS-2100 Integrated IC System using a 
conductivity detector. The ICS-2100 system was coupled to an Orbitrap 
Fusion™ Tribrid™ Mass Spectrometer (Thermo Scientific) via an external 
pump running at a flow rate of 70 µL/min. The make-up flow consisted of 
100% MeOH. The gradient applied was an increasing OH- concentration from 
1 mM to 100 mM over 60 min, at a flow rate of 230 µL/min. There was a 7 
min step at the beginning of each chromatographic run to allow the 
conductivity detector to equilibrate before the next run, resulting in a total run 
time of 67 min. 
This method was adapted from methods first described by Bhattacharya et al. 
(1995) and Groussac et al. (2000). Bhattacharya utilized an IonPac AS11 
column (250 x 4mm) in a 40 min run, at an alkaline pH, with UV and 
conductivity detection for the analysis of 33 metabolites, however many 
metabolites were not retained, resolved and/or detected (acetate, pyruvate, 
G3P, DHAP, R5P, X5P, succinate/malate, 2-oxoglutarate/G6P, 2-/3-PG and 
CoA derivatives) (Bhattacharya et al., 1995). To improve and simplify this 
method, Groussac employed the AS11 column with a 0.5 – 35 mM NaOH 
gradient over 30 min with a flow rate of 2 mL/min and conductivity detection 
for the analysis of a selection of organic acids (Groussac, Ortiz, & Francois, 
2000). A CarboPac PA1 (4 x 250 mm) column with a NaOH/Na-acetate 
gradient running from 0 – 500 mM over 75 min, holding for 10 min and then 
returning to the initial starting conditions until 95 min at a flow rate of 1 
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mL/min with pulsed amperometry detection (PAD) was used for the analysis 
of sugar-phosphates (Groussac et al., 2000).  
Van Dam et al. (2002) coupled the AEX to an MS to aid in the detection of 
co-eluting compounds that could not be distinguished from one another using 
conductivity detection or PAD (Van Dam et al., 2002). The flow rates 
employed for the AEX analysis by Bhattacharya, Groussac and van Dam were 
too high for MS pairing, so to counteract this van Dam used a flow splitter to 
lower the flow rate to ~ 100 µL/min (Van Dam et al., 2002). These methods 
have been adapted by various other groups for the analysis of various organic 
acids and phosphorylated compounds in bacteria and fungi (Bolten et al., 
2007; Kiefer et al., 2007; Martzolff et al., 2012; Millard et al., 2014; Van 
Dam et al., 2002), almost all using the method that Kiefer et al. (2007) 
adapted from van Dam (Kiefer et al., 2007).  
Kiefer ran an AS11 (4 x 250 mm) column at a flow rate of 350 µL/min. The 
mobile phase consisted of Eluent A: 0.1: MeOH and Eluent B: 20% MeOH. 
Eluent B was increased from 0% to 8% over 25 min, held for 40 min, 
decreased to 0% and held for 5 min. The KOH concentration was increased in 
a step gradient from 0.5 mM to 40 mM over 65 min, decreased to 0.5 mM and 
held for 5 min, to give a total analysis time of 70 min. In the experiments 
described herein a 4mm AS11 column was run at a lower flow rate of 230 
µL/min. Unlike Kiefer, the mobile phase in this study consisted of an 
increasing OH- concentration without the addition of a second MeOH 
containing eluent. MeOH can be used to enhance the separation of the organic 
acids succinate, malate, fumarate and 2-oxoglutarate (Groussac et al., 2000), 
but as the MS can distinguish between these compounds using their masses, 
the addition of the organic solvent was considered unnecessary. It is unclear 
whether van Dam and Kiefer ran make-up flows in their analyses. In the 
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experiments described in this study, a make-up flow consisting of 100% 
MeOH was selected to enhance metabolite ionisation into the MS inlet.  
Many of the studies utilizing various adaptations of the AEX method are 
aimed at a specific group or selection of CCM compounds (Bolten et al., 
2007; Kiefer et al., 2007; Martzolff et al., 2012; Millard et al., 2014; Van 
Dam et al., 2002).  In this study glycolysis, TCA and ETC intermediates were 
separated using the IC-MS method. 
The IC-MS method was able to successfully retain and separate a standard 
mixture of glycolysis intermediates with the exception of DHAP and G3P. 
The DHAP and G3P standards produced numerous fragment ions when 
analysed using IC-MS. DHAP and G3P have been unable to be detected in 
previous studies (Bhattacharya et al., 1995; Groussac et al., 2000). This could 
be the result of chemical decomposition of the compounds due to hydrolysis 
of the phosphodiester bond by OH- ions (Bhattacharya et al., 1995). Unique 
fragment ions that could be used for the identification of these compounds 
could not be determined from the MS data, so DHAP and G3P were unable to 
be identified within the mix using this method.  
All of the TCA intermediates were detected and succinate, fumarate and 
malate were distinguished from each other with the use of high-resolution 
accurate mass MS. For reasons that are not understood cis-aconitate and 
oxaloacetate were detected as numerous peaks. The peaks were composed of 
fragment ions and a small abundance of the intact standards. It is unclear 
whether this decomposition was a product of the eluent conditions or whether 
weak collision induced dissociation (CID) was taking place in the ionisation 
source or interface (Luo et al., 2007). The difficulty in the detection of 
oxaloacetate has been encountered in other studies, using different analytical 
platforms (Buescher et al., 2010; Jung & Oh, 2015; Rühl et al., 2012). 
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The IC-MS method demonstrated good separation for the isomers 
citrate/isocitrate and G6P/F6P, however was unable to separate 2-/3-PG. The 
inability to separate 2-/3-PG is a common occurrence throughout energy 
metabolism analysis (Bajad et al., 2006; Soga et al., 2002). Soga et al. (2002) 
developed a CE-MS method for the analysis of energy metabolites, however 
were unable to separate 2-/3-PG (Soga et al., 2002, 2009). Bajad et al. (2006) 
developed an LC-MS/MS method, however never tested its performance for 
the separation of 2-/3-PG or G6P/F6P (Bajad et al., 2006). The method was 
unable to separate other sugar phosphate isomers (including F6P/other sugar 
isomers that were not G6P) (Bajad et al., 2006). GC-MS is particularly useful 
in the separation of sugar-phosphates, using known fragmentation patterns for 
the identification and quantitation of structural isomers, and has also been 
utilized to separate 2-/3-PG (Jung & Oh, 2015). 
Of the coenzymes, FAD, ADP and ATP could be detected. CoA, succinyl-
CoA and acetyl-CoA could not be distinguished from each other using the IC-
MS method. Succinyl- and acetyl-CoA broke down in the eluent during the 
chromatography procedure to produce one peak that corresponded to CoA. 
This is in agreement with other IC studies (Bhattacharya et al., 1995; 
Groussac et al., 2000; Rühl et al., 2012). Bajad et al. (2006) developed a 
HILIC LC-MS/MS method that enabled the detection and differentiation of 
CoA, succinyl-CoA and acetyl-CoA (Bajad et al., 2006). 
The method showed good RT reproducibility with most of the metabolites 
having RSD values of <1%. The reproducibility of this method is comparable 
to those of LC- and GC-MS and greater than the reproducibility of CE-MS 
(Büscher et al., 2009; Soga et al., 2009). 
A selection of sugars, sugar phosphates and organic acids could easily be 
detected down to concentrations lower than 2 pmol. Phosphoenolpyruvate 
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could be detected to a concentration of 10 pmol. Fructose 1,6-bisphosphate, 
ADP and ATP could all be detected to concentrations of lower than 0.2 pmol. 
F16B, ADP and ATP displayed linearity over a range of 0.2 – 100 pmol and 
PEP had a range of linearity over 10 – 1000 pmol. All of the remaining 
standards displayed good linearity over a range of 2 – 200pmol. The lower 
limits of detection are better than the detection limits achieved by 
Bhattacharya and are comparable to the LoDs recorded by van Dam for sugar-
phosphates (however further dilutions would need to be analysed to determine 
the lowest amount that can be detected) (Bhattacharya et al., 1995; Van Dam 
et al., 2002). The lower detection limits achieved in this study were greater 
than those achieved using LC/TOF-MS (200 pmol) and were comparable to 
GC/TOF-MS (2.5 pmol), with some compounds comparable to the LoDs 
achieved using CE/TOF-MS (0.2 pmol) (Büscher et al., 2009). 
Overall the IC-MS method performed well. Almost all of the CCM 
intermediates were detectable within a 60 min analysis, without the need for 
ion-pairing agents or derivatisation. The limitations of the method surround 
the high OH- concentration in the eluent, which causes hydrolysis of the 
phosphodiester bonds of a number of compounds. The IC-MS method is 
suitable for the analysis of organic acids, some sugar-phosphates, ADP, ATP, 
FAD and CoA. It may not be suitable for the analysis of DHAP, G3P or CoA 
derivatives without the consideration of lowering the concentration of the OH- 
ions in the eluent. However, the presence of OH- may cause hydrolysis even at 
very low concentrations. The effect the lower concentration of OH- would 
have on the retention of the sugar-phosphates and nucleosides would need to 
be determined as these compounds require higher concentrations to elute from 
the column. 2-/3-PG were unable to be separated. The addition of MeOH 
could possibly aid in their separation, although this would need to be 
investigated.  
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When this method is compared to other chromatography-MS methods the 
advantages and limitations of this system can be seen. GC-MS offers better 
separation of sugar-phosphates and volatile compounds; however lengthy 
derivatisation steps are sometimes required for non-volatile compounds and 
GC is unsuitable for the analysis of large, labile compounds. Samples are 
prepared and injected onto the IC column, without the need for derivatisation. 
LC-MS offers a wide coverage with a wide dynamic range. However, the 
need for non-volatile organic ion-pairing agents, e.g. TBA, can lead to 
contamination of MS instrumentation and LC may not be suitable for the 
detection of low abundance metabolites. Ion-pairing agents are not required in 
IC-MS and the sensitive instrumentation has a LoD of ≤ 2 pmol for most 
CCM compounds. CE-MS has been gaining popularity in recent years and is 
well suited for the analysis of polar compounds and metabolites that are in 
low abundance. However, the CE-MS system lacks the robustness required to 
analyse biological samples and the instrumentation requires a lot of 
maintenance. CE-MS reproducibility can also be poor, with large retention 
time drifts between samples and batches. IC instrumentation requires very 
little maintenance and has demonstrated highly reproducible results.  
Sample derivatisation before LC-MS analysis offers an alternative to TBA 
ion-pairing RPLC and has the potential to perform better than IC-MS for the 
analysis of CCM compounds (D. Kloos et al., 2012; Tan, Lu, Dong, Zhao, & 
Kuo, 2014). Kloos et al (2012) carried out derivatisation of TCA 
intermediates using N-methyl-2-phenylethanamine and carried out LC-MS 
analysis in positive mode (D. Kloos et al., 2012).  The intermediates were 
separated with an analysis time of 10 mins and the method was successfully 
applied to the targeted analysis of 13C labelled heart tissue. However, only a 
select number of TCA intermediates were chosen, not the full complement 
(D. Kloos et al., 2012).  A more in-depth LC-MS/MS analysis was carried out 
for the separation and quantification of all of the TCA intermediates by Tan et 
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al (2014) (Tan et al., 2014). Derivatisation was carried out using O-
benzylhydroxylamine (O-BHA) with the samples run on a C18 column and 
analysed in positive mode (Tan et al., 2014). A run time of 8 min was 
implemented for most analytes, although this had to be increased to 17 min, 
with the use of a different C18 column, for the separation of 
methylmalonate/succinate and maleate/fumarate (Tan et al., 2014). This 
method showed improved sensitivity, broader coverage with a faster analysis 
time when compared to the commonly used HILIC and RP/ion-pairing LC-
MS/MS methods without derivatisation (Tan et al., 2014). Although this 
method has not been applied to wider CCM studies, Tan et al (2014) suggest 
that the method can be adapted for other common organic acids and biological 
matrices (Tan et al., 2014). 
The results from this study highlight the advantages of using the IC-MS 
method for the separation and detection of CCM intermediates within a single 
chromatographic run. This method could detect and separate the majority of 
the CCM compounds selected in this study and has the capability to be set up 
as a simple routine method in a laboratory. However, more investigation is 
required to determine the fate of DHAP and G3P in the eluent and also at the 
ionisation source. More method development should be carried out utilizing 
different columns and chromatographic conditions, to determine whether the 
analytical platform is suitable for the detection of CoA derivatives and the 
separation of 2-/3-phosoglycerate.  The IC-MS method should also be applied 
to the analysis of the pentose phosphate pathway intermediates. This would 
allow the method to be tested for wider coverage of CCM.  It is the opinion of 
this author that the IC-MS method developed in this study would be a good 
method to adopt for ease of use, sample preparation and instrument 
robustness. However, CCM coverage of the method is limited and more 
development is required to investigate the applicability of the method for the 
detection of all central carbon intermediates. At the moment, GC-MS would 
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be a preferable method for greater CCM coverage and it will be interesting to 
see if LC-MS/MS with derivatisation has the potential to surpass GC-MS in 
relation to CCM coverage. 
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6.1 Introduction 
The aim of this study was to apply the IC- and LC-MS methods developed 
during this research (Chapter 4 & 5) to the analysis of mono- and dual-species 
S. aureus and C. albicans biofilms. It was hypothesised that analysis of the 
biofilms using IC-MS would highlight differences in central carbon 
metabolism (CCM) between the mono-species S. aureus, C. albicans and dual 
species biofilms.  It was hoped that any differences in CCM would enable the 
behaviour of the microorganisms in their dual-species biofilm to be 
elucidated. 
Similarly, it was hypothesised that the application of the LC-MS method to 
the analysis of the mono- and dual-species biofilms would uncover significant 
differences in a number of metabolic pathways. Unlike the IC-MS method, it 
was hoped that the untargeted method would generate a number of different 
hypotheses and aid in directing possible future analyses to investigate the 
intricate relationship between S. aureus and C. albicans in their dual-species 
biofilm. 
6.2 Materials and methods 
The materials and methods are the same as those described in Chapter 2, with 
the following changes: 
(1) Issues with the RPLC/pHILIC instrumentation and the metabolomics data 
quality led to the standard pHILIC method being utilised in place of the 
RPLC/pHILIC combined method. 
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6.3 Results 
The mono- and dual-species biofilms were analysed using the developed IC-
MS and LC-MS methods, previously described in Chapters 3 & 4. Method 
evaluation was carried out prior to data interpretation to determine system 
performance and applicability to the biofilm samples. After method 
evaluation, the intracellular data was analysed to determine its biological 
significance. Due to the sheer volume of data generated from the untargeted 
LC-MS analysis, data interpretation was limited to three significantly 
changing pathways.  
6.3.1 Targeted analysis – IC-MS method 
6.3.1.1 Method evaluation 
Energy intermediates were identified in the intracellular and extracellular 
biofilm samples using their known RT and m/z values (Table 6-1). 
A Thermo™ Xcalibur™ processing method was created for automated peak 
detection and integration. The presence or absence of analyte peaks not 
detected using this processing method were confirmed manually using Quan 
Browser in the Thermo™ Xcalibur™ software suite. To be considered present 
in a sample, the metabolite peak had to have a minimum intensity of 5.0E3. 
Overall, peak area was utilized in relative abundance comparisons in place of 
highest intensities, as intensities assume peak symmetry and not all of the 
peaks were symmetrical. The peaks produced during IC-MS analysis were 
jagged. Although this was expected noise due to the nature of ESI, during 
processing, peak smoothing was employed as it allowed for the presence of 
artefacts and enabled more accurate peak area comparisons to be carried out. 
However, a symptom of peak smoothing is peak broadening. This 
phenomenon has to be taken into account when analysing analytes in this 
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way. For an analyte to be considered present within a sample group, it had to 
be detected in at least 60% of the individual samples within that group. A 
summary of the presence or absence of each energy metabolite within each of 
the samples is listed in Table 6-1. 
Glucose was detected in all of the sample groups (Table 6-1). From 
glycolysis, none of the phosphorylated compounds were detected in the 
media, with the exception of 2-/3-phosphoglycerate, which was detected in 
two individual S. aureus samples, although overall it was considered absent 
from the sample group. All of the glycolysis intermediates were detected in 
all of the intracellular sample groups (Table 6-1). Pyruvate was detected in all 
sample groups except from the fresh media and C. albicans spent media 
samples (Table 6-1). Of the TCA intermediates, citrate, 2-oxoglutarate, 
succinate and malate were detected in all of the sample groups. Isocitrate was 
detected in all but one of the sample groups: - the S. aureus intracellular 
group. cis-Aconitate was detected in the all of the spent media samples, but 
not in the fresh media or any of the intracellular sample groups (Table 6-1). 
Fumarate was only present in both C. albicans sample groups and the fresh 
media. 
When applied to analysis of a complex sample, the IC-MS method displayed 
good retention time reproducibility with all of the selected compounds 
achieving RSD values under 1%, with the exception of glucose, which had an 
RSD value of 4.29% (Table 6-2) A list of the individual RTs used to calculate 
the average RTs, SDs and RSDs can be found in Appendix III.  
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Table 6-1 A list of detected (+) and undetected (-) energy intermediates in C. albicans 
(CA), S. aureus (SA), dual-species (CASA) biofilms and fresh media (FM) using the 
targeted IC-MS method. The number of + corresponds to the number of samples each 
metabolite was detected in. A negative sign (-) indicates that the metabolite was not 
detected in any of the replicates within a sample group. The metabolite had to be detected 
in at least 3/5 samples (+++) to be considered present within a sample group. 
 
Detected/not detected in media 
Detected/not detected in 
cells 
Metabolite CA SA CASA FM CA SA CASA 
Glucose +++++ +++++ +++ +++++ +++++ +++++ ++++ 
Glucose-6-phosphate - - - - +++++ ++++ ++++ 
Fructose-6-phosphate - - - - +++++ +++ ++++ 
Fructose-16-biphosphate - - - - ++++ +++ ++++ 
2-/3-phosphglycerate - ++ - - +++++ ++++ +++++ 
Phosphoenolpyruvate - - - - +++++ +++ ++++ 
Pyruvate - ++++ +++ - +++ +++ +++ 
Citrate +++++ +++++ +++++ +++++ +++++ +++++ +++++ 
Isocitrate +++++ +++++ +++++ ++++ +++++ + ++++ 
cis-Aconitate +++++ +++++ ++++ ++ ++ - + 
2-Oxoglutarate +++++ +++++ ++++ ++++ +++++ +++ +++ 
Succinate +++++ +++++ +++++ +++++ +++++ +++++ +++++ 
Fumarate +++++ + - +++ +++++ - ++ 
Malate +++++ +++++ +++++ +++++ +++++ ++++ +++++ 
FAD - - - - - - - 
ADP - + ++ + +++++ +++++ +++++ 
ATP - +++ +++ +++ +++++ +++++ +++++ 
Double charged FAD - - - - - - - 
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Table 6-2 The elemental formulae (EF), m/z values ([M-H]), expected retention times (RTs), 
average RTs, standard deviations (SDs) and relative standard deviations (RSDs) of the energy 
metabolism intermediates detected in the biofilm samples. (n=9). 
Metabolite EF [M-H] 
Expected 
RT 
Average 
RT 
SD %RSD 
Glucose C6H12O6 179.0562 3.14 3.27 0.14 4.29 
Glucose-6-phosphate C6H13O9P 259.0225 21.74 21.54 0.03 0.12 
Fructose-6-phosphate C6H13O9P 259.0225 22.10 22.01 0.02 0.08 
Fructose-16-biphosphate C6H14O12P2 338.9889 45.85 45.91 0.02 0.03 
2-/3-phosphglycerate C3H7O7P 184.9857 29.61 29.33 0.07 0.23 
Phosphoenolpyruvate C3H5O6P 166.9752 35.06 34.73 0.08 0.24 
Pyruvate C3H4O3 87.0088 10.80 10.86 0.07 0.67 
Citrate C6H8O7 191.0198 31.78 31.55 0.02 0.06 
Isocitrate C6H8O7 191.0198 33.43 33.11 0.03 0.10 
cis-Aconitate C6H6O6 173.0092 35.02 34.83 0.13 0.38 
2-Oxoglutarate C5H6O5 145.0143 21.76 21.59 0.02 0.08 
Succinate C4H6O4 117.0194 19.06 18.88 0.04 0.19 
Fumarate C4H4O4 115.0038 22.86 22.64 0.02 0.08 
Malate C4H6O5 133.0143 19.14 18.94 0.03 0.15 
ADP C10H15N5O10P2 426.0222 42.31 41.97 0.02 0.06 
ATP C10H16N5O13P3 505.9886 51.81 51.67 0.02 0.03 
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Although the RT reproducibility of the instrument was robust in relation to 
the analysis of complex biological samples, the complexity of the samples 
and presence of multiple structural isomers had a negative effect on peak 
resolution (Fig. 6-1). Most of the analytes were detected as one peak, however 
multiple peaks were present when the m/z of glucose, G6P and F6P were 
searched for in the IC-MS data (Fig. 6-1). The presence of multiple peaks 
could be a consequence of the open and closed ring forms of these 
compounds. It could also be a consequence of structural isomers with 
chemical properties similar to glucose and the hexose-phosphates. Glucose 
belongs to a group of monosaccharides, which contain 6 carbon atoms with 
the chemical formula C6H12O6, known as hexoses. Hexoses can be classed as 
aldohexoses or ketohexoses depending on whether there is an aldehyde at 
position one or a ketone at position two (Fig. 6-2). The aldohexoses have four 
chiral centres for a total of 16 possible aldohexose stereoisomers and the 
ketohexoses have three chiral centres and therefore eight possible 
stereoisomers. The naturally occurring aldohexoses and ketohexoses all share 
the same chemical structures and masses. As well as this, the hexoses can 
have a D or L configuration depending on the orientation of the hydroxyl 
group at position five (Fig. 6-3). These 6-carbon sugars can form cyclic 
hemiacetals. The formation of cyclic hexoses causes the symmetric carbon at 
position one to become asymmetric. This means that acyclic (or open ring) 
hexoses yield two cyclic isomers (anomers) denoted by ‘α-‘and ‘β-‘ (Fig.6-4). 
The acyclic and cyclic forms are present in nature in equilibrium, the ring can 
spontaneously open and close, allowing rotation around the C1 bond, yielding 
either the α- or β-configuration through a reaction process termed 
mutarotation. It is likely that the complex samples contain a mix of the hexose 
stereoisomers and anomers, which results in multiple peaks obtained in the IC 
(Fig. 6-1). 
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Unfortunately the analyte peaks were not baseline resolved, making 
quantitation inaccurate. Manual peak integration aided in identifying the 
analyte peaks, however the lack of resolution interfered with quantitation. To 
combat the effects of anomers derivatisation, such as those employed before 
GC analysis, could be investigated to determine their suitability to stop the 
interconversion of the acyclic and cyclic forms of the hexoses, as well as 
other monosaccharides within the samples. 
 
Figure 6-1 Extracted ion chromatograms (EICs) of (A) glucose (m/z 179.0562) and (B) 
G6P and F6P (m/z 259.0225). 24 hour biofilms were washed in PBS and metabolites 
extracted using chloroform:methanol:water (1:3:1 v:v:v). Intracellular metabolites were 
extracted using a 4°C bead beating method. Extracellular metabolites were extracted with a 
ratio of 1:40 supernatant:extraction buffer at 4°C. Detection: ESI-FTMS, negative mode. 
Mass tolerance: 4 ppm. Two peaks were detected at m/z 179.0562 (A). The peak at RT 
3.12 was glucose. The peak at RT 2.76 was an isomer of glucose. Multiple peaks present 
when m/z 259.0225 was searched for in the sample run (B). Peaks at RT 21.53 and 22.02 
pertain to G6P and F6P, respectively. Due to an inability to baseline resolve multiple peaks 
with the same mass, quantitation was not accurate. 
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Figure 6-2 Schematic diagrams of the stereoisomers of (A) glucose and (B) sorbose in D- 
and L- configurations.  
 
 
Figure 6-3 Schematic diagram of the ring configuration of α- and β-D-glucose. 
 
Another phenomenon observed was peak tailing (Fig. 6-4). Peak tailing 
occurs when there is excessive dead volume in the system or solute 
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adsorption takes place on column. Peak tailing interferes with quantitation by 
affecting peak symmetry. Again, manual peak integration was utilized to try 
and minimise the effect of tailing on the relative quantitation of the analytes.  
Metabolite comparisons were carried out for the intracellular and extracellular 
biofilm samples with the acknowledgement that further optimisation of this 
IC-MS method would be desirable. 
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Figure 6-4 EICs of (A) citrate and isocitrate (m/z 191.0198) and (B) succinate (m/z 
117.0194). 24 hour biofilms were washed in PBS and metabolites extracted using 
chloroform:methanol:water (1:3:1 v:v:v). Intracellular metabolites were extracted using a 
4°C bead beating method. Extracellular metabolites were extracted with a ratio of 1:40 
supernatant:extraction buffer at 4°C. Detection: ESI-FTMS, negative mode. Mass 
tolerance: 4 ppm. Peak tailing was observed in numerous chromatograms. This 
phenomenon is undesirable as it interferes with quantitation accuracy and resolution of 
analyte peaks. 
 
6.3.1.2 Data analysis 
When the intracellular data was analysed, some of the energy metabolites 
were not detected in the S. aureus mono-species samples (Table 6-1 & Fig. 6-
5). The absence of these metabolites could be a result of the low cell number 
and biomass obtained when the bacteria were grown in FBS. It could be 
argued that the absence of isocitrate, cis-aconitate and fumarate were due to 
metabolite abundances being lower than the detection limits of the instrument. 
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Many of the metabolites were detected at a lower abundance in the S. aureus 
mono-species compared to the dual species biofilm, with the exception of 
pyruvate, succinate and ADP (Fig. 6.5). When the C. albicans mono-species 
was compared to the dual-species biofilm metabolite abundances were similar 
(Fig. 6-5). 
A heat map was created for the comparison of the spent media metabolites 
(Table 6-3). The metabolites were first compared to abundances detected in 
the fresh media before being compared to each other.   
A positive value indicated that the analyte was found in a higher abundance in 
the sample spent media compared to the fresh media. A positive value could 
suggest that the analyte was being secreted by the cells or was being produced 
due to the breakdown of a larger compound. A negative value was indicative 
of higher analyte abundance in the fresh media compared to the spent media. 
This could suggest that the analyte was being taken up by the cells or that the 
metabolite was being broken down in the media.  
Similar abundances of glucose, citrate, iso-citrate, cis-aconitate and succinate 
were detected in all three sample groups (Table 6-3). Glucose, citrate, iso-
citrate and succinate abundances were similar to those detected in the fresh 
media. cis-Aconitate was found at a higher abundance in all of the sample 
groups compared to the fresh media. 2-Oxoglutarate was detected at similar 
abundances in C. albicans and the fresh media, whereas higher abundances of 
this metabolite were detected in S. aureus and the dual-species spent media 
compared to fresh media. Pyruvate was found in a higher abundance in the S. 
aureus spent media compared to the C. albicans and dual-species spent media 
(Table 6-3). Fumarate was found in lower abundances in the S. aureus and 
dual-species spent media compared to the fresh media. Similar abundances of 
fumarate were detected in the C. albicans spent media and fresh media. 
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Malate was found in similar abundances in the fresh media and the fungal 
spent media. The S. aureus mono-species and the dual-species biofilms had 
similar abundances of malate to each other, but lower abundances of malate 
compared to the fresh media. ADP was found at a lower abundance in all 
three sample groups when compared to fresh media. Far less ADP was 
detected in the C. albicans mono-species media compared to both the S. 
aureus and the dual-species spent media (Table 6-3). 
 
 Figure 6-5 Bar chart comparing the average peak areas calculated for each of the 
intracellular energy metabolites detected in C. albicans (CA), S. aureus (SA) and the dual-
species biofilm (SC). 24 hour biofilms were washed in PBS and intracellular metabolites 
extracted using chloroform:methanol:water (1:3:1 v:v:v) in conjunction with a 4°C bead 
beating method. Detection: ESI-FTMS, negative mode. Mass tolerance: 4 ppm. Error bars 
± standard deviation (SD). (n=5). 
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Table 6-3 Heat map comparison of the energy metabolites detected in the spent media of 
the C. albicans (CAM), S. aureus (SAM) and the dual species (SCM) biofilms. Data was 
normailsed between each sample group using total useable signal. For each metabolite, 
average peak areas from each sample group were compared to fresh media (MO). LogFC = 
log2 (Sample peak area/fresh media). Positive values indicate that the spent media 
contained more of the metabolite than the fresh media and a negative value indicates that 
the spent media contained less of the metabolite than the fresh media. (n=5). 
Metabolite LogFC CAM/MO LogFC SAM/MO LogFC SCM/MO Metabolite ID code* 
Glucose -0.41 -0.54 -0.87 R:HRMS:'  
Pyruvate -0.51 1.90 0.34 R:HRMS:'  
Citrate 0.06 0.06 0.20 R:HRMS:'  
Iso-citrate 0.60 0.38 0.57 R:HRMS:'  
cis-Aconitate 1.02 1.53 1.04 R:HRMS:'  
2-Oxoglutarate 0.55 1.32 1.56 R:HRMS:'  
Succinate 0.10 0.56 0.56 R:HRMS:'  
Fumarate 0.55 -1.24 -3.11 R:HRMS:'  
Malate 0.29 -1.14 -1.95 R:HRMS:'  
ADP -8.26 -3.80 -2.01 R:HRMS:'  
* Refers to alphanumeric coding scheme from  (Sumner et al., 2014). 
 
6.3.2 Untargeted analysis – RPLC/HILIC method 
6.3.2.1 Method evaluation 
To ensure the optimum LC-MS method was employed for the analysis of the 
S. aureus and C. albicans mono- and dual-species biofilms, the combined 
RPLC/pHILIC method was compared to the standard pHILIC method 
routinely used within the metabolomics laboratory. Less than half of the 
number of metabolites were detected using the RPLC/pHILIC method 
compared to the pHILIC method (Table 6-4). The peak shapes obtained using 
the RPLC/pHILIC method were poorer than those obtained using the pHILIC 
method (Fig. 6-6). When the ToxID™ reports were consulted, a lot of peak 
splitting was observed (Fig. 6-7). Peak splitting is a symptom of poor 
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chromatography and can arise from different problems. As a significant 
number of peaks were splitting, it appeared that the problem occurred before 
separation. The most common reasons for peak splitting are a blocked frit or a 
void at the head of the column.  
Table 6-4 Comparison of the RPLC/pHILIC combined and the routine pHILIC methods. 
Comparisons took into consideration the number of intracellular, and extracellular 
(secretome) metabolites detected, identified and the number of KEGG pathways the 
annotated and identified metabolites mapped onto.  
 
Intracellular metabolome Secretome 
 
RPLC/pHILIC pHILIC RPLC/pHILIC pHILIC 
Metabolites Detected 1151 3368 1465 3661 
Metabolites Identified 39 67 49 68 
KEGG Metabolite Pathways 175 186 180 208 
 
 
Figure 6-6 An example of the peak shapes obtained using (A) the RPLC/pHILIC 
combined method and (B) the standard pHILIC method. The standard pHILIC method 
resulted in peaks that resembled the normal-Gaussian-shaped peak (B). The peak shape 
obtained using the combined RPLC/pHILIC columns resulted in broader peaks that 
deviated from this ‘ideal’ chromatography peak. Detection: ESI-FTMS, negative mode. 
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Figure 6-7 An example of peak splitting observed using the RPLC/pHILIC combined 
method. 
 
These three observations, coupled with the difficulties encountered 
maintaining the backpressure of the system within the maximum limits of the 
HPLC pumps led to the standard pHILIC method being utilized for the 
analysis of the bacterial and fungal biofilms. The pHILIC method is an 
established method, which has been optimised and perfected over a number of 
years. It was therefore concluded that more information could be gained using 
this method compared to the RPLC/pHILIC method. It should be emphasised 
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here that the RPLC/pHILIC method displays a great deal of potential for the 
separation and detection of polar and nonpolar analytes, however this method 
requires a great deal of development to determine the best column 
combinations, mobile phase compositions and the effect linking two column 
chemistries has on analyte separations in complex samples. 
6.3.2.2 Purine metabolism 
Fifteen metabolites were detected from the purine metabolism pathway. Six 
of these were identified and seven were annotated (or putatively identified). 5-
amino-4-imidazole carboxylate was detected at similar levels in blank LC-MS 
runs compared to those detected in sample runs and therefore was omitted 
from purine metabolism analysis. 
Overall, the relative abundance of purine metabolites were higher in the co-
culture biofilm compared to the S. aureus mono-species biofilm (Table 6-5), 
with exception of L-glutamine, adenosine monophosphate (AMP) and 
xanthosine (Table 6-5 & Fig. 6-8). The abundances of L-glutamine, AMP and 
xanthosine were higher in the S. aureus biofilm than both the mono-species 
C. albicans and the dual-species biofilms (Table 6-5 & Fig. 6-8). AMP, 
3’AMP and deoxyguanosine monophosphate (dGMP) are structural isomers 
of each other. Although AMP was identified using a standard it was unknown 
whether 3’AMP and dGMP were separated from AMP. A slightly higher 
abundance of xanthosine was detected in the S. aureus mono-species biofilm, 
but this was not considered a significant difference (Table 6.5 & Fig. 6.8 C). 
Significantly higher abundances of hypoxanthine, adenosine, 
deoxyguanosine, xanthine, uric acid and (R/S)(-/+)-allantoin were detected in 
the co-culture compared to the S. aureus mono-species biofilm (Table 6-5 & 
Fig. 6-8). Higher abundances of adenine and sulphate were detected in the 
dual-species biofilm compared to the bacterial mono-species biofilm, 
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although the differences were not significant at a p-value of 0.05 (Table 6-5). 
These results suggested that purine metabolism was up-regulated in the dual-
species biofilm compared to the S. aureus mono-species biofilm. 
When the abundances of the detectable purine metabolites in C. albicans were 
compared to the co-culture, many of the metabolites had similar relative 
abundances (Table 6-5). Similar abundances of L-glutamine, adenine, uric 
acid, sulphate and (R/S)(-/+)-allantoin were detected in the dual-species and 
C. albicans biofilms (Table 6-5). A significantly higher abundance of 
hypoxanthine was detected in the C. albicans mono-species biofilm compared 
to both the S. aureus mono-species and the dual-species biofilms (Table 6-5). 
Higher abundances of adenosine, deoxyguanosine, AMP, 3’AMP, dGMP and 
xanthine were detected in C. albicans compared to the co-culture, although 
these differences were not considered significant. A slightly higher abundance 
of xanthosine was detected in the co-culture compared to the C. albicans 
mono-culture, although this difference was not considered significant (Table 
6-5). With the exception of xanthosine, L-glutamine and adenine, overall 
lower abundances of purine metabolites were detected in the dual-species 
biofilm compared to C. albicans biofilm (Table 6-5). Although many of the 
differences recorded were not significant, they did suggest a trend of 
decreased purine metabolism in the co-culture compared to the C. albicans 
mono-species biofilms.  
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Table 6-5 Heat map comparison of the intracellular metabolite abundances detected in the 
C. albicans (CAC), S. aureus (SAC) and the dual species (SCC) biofilms. The elemental 
formulae (EF), metabolite identification and log-fold changes (logFC) of the identified and 
annotated metabolites from the purine metabolism pathway are listed. LogFC = log2 (dual-
species/mono-species). (n = 5). 
Metabolite EF LogFC SCC/CAC LogFC SCC/SAC Metabolite ID code* 
L-Glutamine C5H10N2O3 0.27 -1.06 R:HRMS:'  
Adenine C5H5N5 0.52 0.91 R:HRMS:'  
Hypoxanthine C5H4N4O -1.74 1.82 R:HRMS:'  
Adenosine C10H13N5O4 -0.93 1.9 R:HRMS:'  
AMP C10H14N5O7P -0.74 -1.18 R:HRMS:'  
Xanthine C5H4N4O2 -0.61 2.11 R:HRMS:'  
Deoxyguanosine C10H13N5O4 -0.93 1.9 HRMS1 
3'-AMP C10H14N5O7P -0.74 -1.18 HRMS1 
dGMP C10H14N5O7P -0.74 -1.18 HRMS1 
Urate C5H4N4O3 -0.28 1.75 HRMS1 
Sulphate H2SO4 -0.1 0.7 HRMS1 
(R/S)-Allantoin C4H6N4O3 -0.43 1.31 HRMS1 
Xanthosine C10H12N4O6 0.94 -0.56 HRMS1 
* Refers to alphanumeric coding scheme from  (Sumner et al., 2014). 
 
Figure 6-8 Bar charts comparing the relative abundance of intracellular (A) L-glutamine 
and (B) adenosine monophosphate (AMP) detected in the mono-species C. albicans 
(CAC), S. aureus (SAC) and their co-culture (SCC). The biofilms were cultured in 50% 
FBS for 24 hours. Mature biofilms were washed twice in PBS. Metabolites were extracted 
according to the established protocol in ice-cold chloroform:methanol:water (1:3:1, v:v:v). 
Higher levels of L-glutamine and AMP were detected in the mono-species S. aureus 
compared C. albicans and the co-culture. Similar levels of L-glutamine were detected in C. 
albicans and the co-culture (A). More AMP was detected in the C. albicans compared to 
the co-culture (B). Analysis: HPLC-ESI-FTMS. Polarity mode: pos/neg switching. Mass 
tolerance: 4 ppm. Error bars ± standard deviation (SD). (n=5). 
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6.3.2.3 Pyrimidine metabolism 
Twenty-two metabolites from pyrimidine metabolism were detected in the 
intracellular biofilm samples. Of these, eight metabolites were identified from 
in-house standards and the remaining fourteen were annotated from their 
masses. 
Uridine diphosphate (UDP)-glucose, deoxyuridine and ureidopropoinic acid 
were detected in the co-culture and C. albicans mono-species biofilms, but 
not in S. aureus mono-species biofilms (Fig. 6-9 A-C). S. aureus lacks the 
enzyme to incorporate UDP-glucose into the cell so the absence of this 
compound in the intracellular metabolome of the bacteria was expected. 
Uridine, thymidine, uracil and pseudouridine were all detected at significantly 
higher levels in the co-culture compared to S. aureus (Fig. 6-9 D-F). 3-
Hydroxypropanoate was detected at a higher abundance in the dual-species 
biofilm compared to the S. aureus biofilm; however, this difference was not 
significant. L-Glutamine, orotate and 3-ureidoisobutyrate were detected at 
significantly higher abundances in the S. aureus biofilm compared to the 
dual-species biofilm (Fig. 6-10). The remaining metabolites were detected at 
similar abundances in both cultures. The trend was towards higher 
abundances in the co-culture, with the exception of cytosine, 5-
methylcytosine and 5-methylbarbiturate (Table 6-6). The levels of detectable 
metabolites from pyrimidine metabolism suggested that pyrimidine 
metabolism was up-regulated in the dual-species biofilm compared to the 
mono-species S. aureus biofilm (Table 6-6). 
Methylmalonate, deoxyuridine, thymidine, uridine and pseudouridine were all 
detected at higher intensities in the mono-species fungal biofilm compared to 
the dual-species biofilm (Table 6-6). Although not considered significant, 
UDP-glucose, β-alanine, ureidopropoinic acid and 3-Hydroxypropanoate 
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were detected at higher intensities in the C. albicans biofilm compared to the 
co-culture (Table 6-6). 3-Amino-isobutanoic acid and 3-oxoproanoate, which 
were detected at similar levels in the S. aureus mono-species and the dual-
species biofilms, were detected at significantly lower levels in the mono-
species C. albicans biofilm (Table 6-6). The remaining metabolites were 
detected at similar levels in the dual-species and C. albicans mono-species 
biofilms (Table 6-6). Although some of the metabolites were detected at 
similar abundances the significantly lower levels of deoxyuridine, uridine and 
thymidine detected in the co-culture compared to the mono-species C. 
albicans could suggest that pyrimidine synthesis is down-regulated in the 
dual-species biofilm compared to when C. albicans is cultured in a mono-
species biofilm.  
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Table 6-6 Heat map comparison of the intracellular metabolite abundances detected in the 
C. albicans (CAC), S. aureus (SAC) and the dual species (SCC) biofilms. The elemental 
formulae (EF), metabolite identification and log-fold changes (logFC) of the identified and 
annotated metabolites from the pyrimidine metabolism pathway are listed. LogFC = log2 
(dual-species/mono-species). (n = 5). 
Metabolite EF 
LogFC 
SCC/CAC 
LogFC 
SCC/SAC 
Metabolite 
ID code* 
L-Glutamine  C5H10N2O3 0.27 -1.06 R:HRMS:'  
UDP-glucose C15H24N2O17P2 -0.68 15.52 R:HRMS:'  
Methylmalonate C4H6O4 -0.97 0.13 R:HRMS:'  
beta-Alanine C3H7NO2 -0.74 0.39 R:HRMS:'  
Deoxyuridine C9H12N2O5 -2.81 14.64 R:HRMS:'  
Thymidine C10H14N2O5 -2.82 9.13 R:HRMS:'  
Uridine C9H12N2O6 -2.22 12.26 R:HRMS:'  
Orotate C5H4N2O4 0.3 -0.96 R:HRMS:'  
3-Ureidoisobuyrate C5H10N2O3 0.27 -1.06 HRMS1 
3-Aminooisbutyric acid C4H9NO2 1.16 0.39 HRMS1 
Ureidopropoinic acid C4H8N2O3 -0.75 16.16 HRMS1 
3-Hydroxypropanoate C3H6O3 -0.87 0.81 HRMS1 
Dihydrouracil C4H6N2O2 -0.09 0.05 HRMS1 
Cytosine C4H5N3O -0.13 -0.22 HRMS1 
5-Methylcytosine C5H7N3O 0.04 -0.08 HRMS1 
Pseudouridine C9H12N2O6 -1.75 7.25 HRMS1 
3-Oxopropanoate C3H4O3 1.44 0.37 HRMS1 
Uracil C4H4N2O2 -0.03 0.99 HRMS1 
Barbiturate C4H4N2O3 0.02 0.2 HRMS1 
Malonate C3H4O4 -0.05 0.01 HRMS1 
5,6-Dihydrothymine C5H8N2O2 0.66 0.19 HRMS1 
5-Methylbarbiturate C5H6N2O3 -0.04 -0.21 HRMS1 
* Refers to alphanumeric coding scheme from  (Sumner et al., 2014). 
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Figure 6-9 Bar charts comparing the relative abundance of intracellular (A) uridine 
diphosphate (UDP)-glucose; (B) deoxyuridine; (C) ureidopropoinic acid; (D) uridine; (E) 
thymidine and (F) pseudouridine  detected in the mono-species C. albicans (CAC), S. 
aureus (SAC) and their co-culture (SCC). The biofilms were cultured in 50% FBS for 24 
hours. Mature biofilms were washed twice in PBS. Metabolites were extracted according 
to the established protocol in ice-cold chloroform:methanol:water (1:3:1, v:v:v). UDP-
glucose, deoxyuridine and ureidopropoinic acid were not detected in the mono-species S. 
aureus, but were detected in the co-culture and C. albicans (A-C). Slightly higher levels of 
UDP-glucose and ureidopropoinic acid were detected in the C. albicans compared to the 
co-culture (A & C). Significantly higher levels of deoxyuridine were detected in C. 
albicans compared to the dual-species biofilm (B). Lower levels of uridine, thymidine and 
pseudouridine were detected in S. aureus compared to C. albicans and the co-culture (D-
E). Higher levels of uridine, thymidine and pseudouridine were detected in C. albicans and 
the co-culture (D-E). Analysis: HPLC-ESI-FTMS. Polarity mode: pos/neg switching. Mass 
tolerance: 4 ppm. Error bars ± standard deviation (SD). (n=5). (Note: * indicates putative 
identification).  
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Figure 6-10 Bar charts comparing the relative abundance of intracellular (A) L-glutamine 
and (B) orotate detected in the mono-species C. albicans (CAC), S. aureus (SAC) and their 
co-culture (SCC). Significantly higher levels of L-glutamine and orotate were detected in 
the mono-species S. aureus compared C. albicans and the co-culture (A & B). Similar 
levels of L-glutamine and orotate were detected in C. albicans and the co-culture (A & B). 
Analysis: HPLC-ESI-FTMS. Polarity mode: pos/neg switching. Mass tolerance: 4 ppm. 
Error bars ± standard deviation (SD). (n=5). 
 
6.3.2.4 Cysteine and methionine metabolism 
Fifteen metabolites from cysteine and methionine metabolism were detected 
using LC-MS (Table 6-7). Of these, six were identified to known standards 
and eleven were annotated using mass alone.  
5’Methylthioadenosine, glutathione, s-adenosyl-L-homocysteine, L-
methionine and S-adenosyl-L-methionine were not detected in S. aureus, but 
were detected in C. albicans and the co-culture (Fig. 6-11). L-Aspartate, O-
succinyl-L-homoserine and L-homoserine were detected at higher abundances 
in the S. aureus monoculture compared to both the C. albicans monoculture 
and the co-culture (Fig. 6-12). Similar levels of O-acetylserine, pyruvic acid 
and L-alanine were detected in S. aureus and the co-culture (Table 6-7). 
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Higher abundances of L-alanine, glutathione, S-adenosyl-L-homocysteine and 
L-methionine were detected in the C. albicans monoculture compared to the 
co-culture (Fig. 6-11 B-D). Similar levels of 5’methyladenosine, S-adenosyl-
L-methionine, L-apartate, sulphate and O-acetylserine were detected in the 
co-culture and C. albicans (Table 6-7 and Fig. 6-11 A & E). O-succinyl-L-
homoserine was detected at a higher abundance in the co-culture compared to 
C. albicans (Table 6-7 & Fig. 6-1215 C). The difference was recorded as a 
logFC of 12.03, but in the bar chart comparing the abundance of O-succinyl-
L-homoserine found in each of the mono-species and dual-species biofilms 
the levels appeared similar (Table 6-7 & Fig. 6-13 A). However, when the 
individual mono-species C. albicans samples were examined, the metabolite 
was only detected in one of them (Fig. 6-13 B). Therefore, although the 
abundances in bar chart look similar between the co-culture and C. albicans, 
the results from the individual C. albicans samples agree with the logFC 
listed in the table (Table 6-7 & Fig. 6-13). 
L-cystathionine was present at a lower abundance in the co-culture compared 
to both of the mono-species biofilms (Table 6-7 & Fig. 6-14A). O-acetyl-L-
homoserine and 3-sulfino-L-alanine were detected at higher abundances in the 
co-culture compared to both the S. aureus and C. albicans mono-species 
cultures (Table 6-7 & Fig. 6-14 B & C). 
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Table 6-7 Heat map comparison of the intracellular metabolite abundances detected in the 
C. albicans (CAC), S. aureus (SAC) and the dual species (SCC) biofilms. The elemental 
formulae (EF), metabolite identification and log-fold changes (logFC) of the identified and 
annotated metabolites from the cysteine and methionine metabolism pathway are listed. 
LogFC = log2 (dual-species/mono-species). (n = 5). 
Metabolite EF Mass 
logFC 
SCC/CAC 
logFC 
SCC/SAC 
Metabolite 
ID code* 
5'Methylthioadenosine C11H15N5O3S 
 
0.24 23.27 R:HRMS:'  
S-Adenosyl-L-homocysteine C14H20N6O5S 
 
-1.84 16.99 R:HRMS:'  
L-Methionine C5H11NO2S 
 
-0.92 18.43 R:HRMS:'  
L-Aspartate C4H7NO4 
 
-0.38 -1.24 R:HRMS:'  
L-Alanine C3H7NO2 
 
-0.74 0.39 R:HRMS:'  
L-Cystathionine C7H14N2O4S 
 
-9.57 -9.69 R:HRMS:'  
O-Acetyl-L-serine C5H9NO4 
 
0.53 -0.51 HRMS1 
Glutathione C10H17N3O6S 
 
-1.66 17.75 HRMS1 
S-Adenosyl-L-methionine C15H22N6O5S 
 
0.03 18.47 HRMS1 
O-Acetyl-L-homoserine C6H11NO4 
 
0.85 0.82 HRMS1 
Pyruvate C3H4O3 
 
1.44 0.37 HRMS1 
Sulphate H2SO4 
 
-0.1 0.7 HRMS1 
O-Succinyl-L-homoserine C8H13NO6 
 
12.03 -3.34 HRMS1 
L-Homoserine C4H9NO3 
 
0.38 -0.87 HRMS1 
3-Sulfino-L-alanine C3H7NO4S 
 
0.79 0.63 HRMS1 
* Refers to alphanumeric coding scheme from (Sumner et al., 2014). 
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Figure 6-11 Bar charts comparing the relative abundance of intracellular (A) 
5’methylthioadenosine; (B) glutathione; (C) S-adenosyl-L-homocysteine; (D) L-
methionine and (E) S-adenosyl-L-methionine  detected in the mono-species C. albicans 
(CAC), S. aureus (SAC) and their co-culture (SCC). The biofilms were cultured in 50% 
FBS for 24 hours. Mature biofilms were washed twice in PBS. Metabolites were extracted 
according to the established protocol in ice-cold chloroform:methanol:water (1:3:1, v:v:v). 
None of the metabolites were detected in the S. aureus mono-species biofilm. Similar 
abundances of 5’methyladenosine and S-adenosyl-L-methionine were detected in the co-
culture and the C. albicans mono-species biofilm (A & E). Higher abundances of 
glutathione, S-adenosyl-L-homoserine and L-methionine were detected in C. albicans 
compared to the co-culture (B, C & D). Analysis: HPLC-ESI-FTMS. Polarity mode: 
pos/neg switching. Mass tolerance: 4 ppm. Error bars ± standard deviation (SD). (n=5).  
(Note: * indicates putative identification).  
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Figure 6-12 Bar charts comparing the relative abundance of intracellular (A) L-aspartate; 
(B) L-homoserine and (C) O-succinyl-L-homoserine detected in the mono-species C. 
albicans (CAC), S. aureus (SAC) and their co-culture (SCC). The biofilms were cultured 
in 50% FBS for 24 hours. Mature biofilms were washed twice in PBS. Metabolites were 
extracted according to the established protocol in ice-cold chloroform:methanol:water 
(1:3:1, v:v:v). Higher abundances of the metabolites were detected in the S. aureus mono-
species biofilm compared to both the C. albicans mono-species biofilm and the dual-
species biofilm. Similar abundances of L-aspatate were detected in the co-culture and C. 
albicans biofilms (A). Higher abundances of L-homoserine and O-succinyl-L-homoserine 
were detected in the co-culture compared to the C. albicans biofilm (B & C). Analysis: 
HPLC-ESI-FTMS. Polarity mode: pos/neg switching.  Mass tolerance: 4 ppm. Error bars ± 
standard deviation (SD). (n=5). (Note: * indicates putative identification).  
 
 
Figure 6-13 Bar charts comparing the relative abundance of O-succinyl-L-homoserine 
detected in (A) the mono-species C. albicans (CAC), S. aureus (SAC) and their co-culture 
(SCC) and (B) the individual C. albicans samples. The relative abundance of O-succinyl-
L-homoserine look similar in the co-culture compared to the C. albicans mono-species (A). 
However, this metabolite was only present in one of the individual C. albicans samples 
(B). Analysis: HPLC-ESI-FTMS. Polarity mode: pos/neg switching. Mass tolerance: 4 
ppm. Error bars ± standard deviation (SD). (n=5). 
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Figure 6-14 Bar charts comparing the relative abundance of intracellular (A) L-
cytsthionine; (B) O-acetyl-L-homoserine and (C) 3-sulfino-L-alanine detected in the 
mono-species C. albicans (CAC), S. aureus (SAC) and their co-culture (SCC). The 
biofilms were cultured in 50% FBS for 24 hours. Mature biofilms were washed twice in 
PBS. Metabolites were extracted according to the established protocol in ice-cold 
chloroform:methanol:water (1:3:1, v:v:v). L-cytsthionine was detected at a significantly 
lower abundance in the co-culture compared to both mono-species biofilms (A). Relatively 
higher abundances of O-acetyl-L-homoserine and 3-sulfino-L-alanine were detected in the 
dual-species biofilm compared to the mono-species biofilms (B & C). Analysis: HPLC-
ESI-FTMS. Polarity mode: pos/neg switching. Mass tolerance: 4 ppm. Error bars ± 
standard deviation (SD). (n=5). (Note: * indicates putative identification). 
 
6.4 Discussion 
The aim of this research was to apply the previously developed targeted IC-
MS and untargeted RPLC/pHILIC methods to the analysis of S. aureus and C. 
albicans mono- and dual-species biofilms. It was hoped that the 
metabolomics data generated from these analyses would enable the 
relationship between S. aureus and C. albicans within the dual-species 
biofilm to be explored in further detail. Greater understanding of this 
relationship could highlight potential drug targets for the treatment of S. 
aureus/C. albicans cross-infections.  
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6.4.1 IC-MS 
The IC-MS method was applied to the analysis of S. aureus and C. albicans 
mono- and dual-species biofilms. Although the samples were analysed 
successfully using the IC-MS method, and the method displayed good RT 
reproducibility, the presence of structural isomers and peak tailing made 
quantitation difficult. As well as this, many metabolites were not detected in 
the cellular S. aureus mono-species.  This made any intracellular comparisons 
tricky, as the absence of these metabolites could be because the analyte 
intensities were lower than the detection limits of the instrument. The low 
analyte intensities could be a result of the very low biomasses obtained when 
S. aureus was cultured in serum in isolation. It has been shown previously 
that sera does not facilitate S. aureus growth or biofilm formation (Harriott & 
Noverr, 2009; Peters, Ovchinnikova, et al., 2012; Schlecht et al., 2015; Staib 
et al., 1971). This problem was encountered previously in this study, during 
biofilm characterisation (Chapter 3). RNA analysis was carried out on a 
selection of important S. aureus biofilm genes (ClfB, FnbA, Sas6 and SasF). 
Although extractions were carried out numerous times and attempts were 
made for extraction optimisation, the quantity of RNA collected from the S. 
aureus samples were too low to synthesise cDNA. Therefore, if intracellular 
metabolites exist at low abundances, low biomass and/or cell number would 
make analyte detection difficult.  
With the omission of the S. aureus mono-species, overall the intracellular 
metabolite abundances were similar between C. albicans and the dual-species 
biofilm. However, for unknown reasons fructose 1,6-bisphosphate and 
fumarate were not detected in the dual-species culture.  
The biofilms were cultured for 24 hours before metabolite extractions were 
carried out. Yeater et al. (2007) carried out gene expression analysis during C. 
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albicans biofilm formation and identified the upregulation of different cellular 
processes at different developmental stages (Yeater et al., 2007). Glycolysis, 
pyruvate metabolism and energy production were upregulated during biofilm 
formation at 6 and 12 hours, but not at 48 hours. At the mature biofilm stage, 
genes relating to energy conservation were upregulated. These observations 
could corroborate the data generated from this research. After 24 hours of 
growth the microorganisms within the mature biofilms could reach an 
equilibrium with regards to energy metabolism. This could explain why few 
differences were recorded between the sample groups. Carrying out a targeted 
analysis during the early stages of biofilm formation may provide better 
insight into the behaviour of S. aureus and C. albicans within their mono- and 
dual-species biofilms.  
Further to this, metabolic flux analysis (MFA), that is the in vivo reaction 
rates of enzymes, could provide a better insight into the metabolic activity of 
S. aureus and C. albicans within their mono- and dual-species biofilms 
(Sauer, 2006). Fluxes are time-dependant motions of metabolites through a 
metabolic network (Sauer, 2006). Fluxes are mapped through computer 
model-based interpretation of measurable quantities (Sauer, 2006). 
Commonly 13C-labelled substrates are used, e.g. 13C6-glucose. 13C MFA is 
based on carbon labelling experiments (Marx, De Graaf, Wiechert, Eggeling, 
& Sahm, 1996). The 13C-labelled substrate is fed to a population of cells and 
the labelled carbon atoms are distributed over a metabolic network, which can 
then be measured by NMR or MS (Marx et al., 1996). Labelling patterns are 
detected within metabolic intermediates which directly relate to the 
distribution of fluxes (Marx et al., 1996; Sauer, 2004, 2006; Wiechert, 2001). 
Network distribution of fluxes are then reconstituted from measured 13C data 
and can show the rate at which metabolites are anabolically or catabolically 
distributed within a network. Using MFA, differences in rate of metabolic 
activity and the fate of intermediates within CCM could be determined for S. 
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aureus and C. albicans in their mono- and dual-species biofilms. Tracking 
fluxes would enable temporal changes in the behaviour of the bacteria and 
fungi to be observed. 
However, the IC-MS method would have to be improved to ensure baseline 
separation of glucose and sugar phosphate isomers before any further analysis 
could be carried out. Method optimisation options include altering the mobile 
phase gradient, testing different columns and investigating the suitability of 
the addition of organic solvents to aid in peak separation.  
Next, untargeted RPLC/pHILIC-MS analysis was carried out on the extracted 
biofilm samples. 
6.4.2 LC-MS 
The RPLC/pHILIC combined method was applied to the analysis of S. aureus 
and C. albicans mono- and dual-species biofilms. Although the samples were 
analysed successfully using the combined method, when the results were 
compared to those obtained using a pHILIC method far fewer metabolites 
were detected. 3368 intracellular and 3661 extracellular metabolites were 
detected when the pHILIC method was used compared to 1151 intracellular 
and 1465 extracellular when the RPLC/HILIC combined method was utilized. 
More metabolites were identified using the pHILIC method compared to the 
RPLC/pHILIC method. 67 intracellular metabolites were identified using the 
pHILIC method compared to 39 for the combined method, and 68 
extracellular metabolites compared to 49, respectively. The significant 
decrease in the number of metabolites detected, coupled with the poorer peak-
shapes witnessed, led to mono-column pHILIC method being utilized in place 
of the RPLC/pHILIC dual-column method.   
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6.4.2.1 Biochemical interpretation 
The intracellular analysis of the mono- and dual-species biofilms indicated 
that 51 identified metabolites and 241 annotated metabolites were 
significantly changing between the S. aureus mono-species biofilm and the 
dual-species biofilm. 26 identified metabolites and 183 annotated metabolites 
were significantly changing between the C. albicans mono-species biofilm 
and the dual-species biofilm. Relative abundances of individual metabolites in 
isolation are unable to provide a clear picture of the metabolic state of a 
sample, therefore to enable accurate interpretation of the data, metabolic 
pathways were visualised in place of individual metabolites. 
Due to the key roles that purine and pyrimidine metabolism play in RNA, 
protein and DNA synthesis, as well as energy production, these two pathways 
were analysed first.  
6.4.2.1.1 Comparison of purine metabolism in S. aureus and the 
dual-species biofilm 
The relative abundances of the detected metabolites involved in purine 
metabolism were higher in the co-culture compared to the S. aureus biofilm, 
with the exception of L-glutamine, adenosine monophosphate (AMP), 
deoxyguanosine monophosphate (dGMP) and xanthosine (Fig. 6-15). 
Glutamine plays an important role in the production of purines and 
pyrimidines. It donates nitrogen atoms that form the N-9 and N-3 of the 
purine ring and participates in the amination of xanthine monophosphate 
(XMP) to form guanosine monophosphate (GMP). The higher levels of 
glutamine, coupled with the lower levels of other purine metabolites within 
the pathway could suggest lower levels of purine synthesis. However, the 
presence of higher abundances of AMP, dGMP and xanthosine in the S. 
aureus mono-species compared to the co-culture conflict with this conclusion.  
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The higher levels of AMP detected in S. aureus could suggest up-regulation 
of either ATP or dATP synthesis in the bacterial monoculture compared to the 
co-culture. AMP is an intermediate in the conversion of inosine 
monophosphate (IMP) to adenosine triphosphate (ATP) through the purine 
nucleotide cycle (Fig. 6-16). In the presence of guanosine triphosphate (GTP), 
IMP reacts with aspartate to form adenylosuccinate, which is then cleaved to 
form AMP and fumarate. AMP can be phosphorylated to ADP which can 
used to produce adenosine triphosphate (ATP). ATP can be used for energy 
by the cell as well as being utilized in RNA synthesis. ADP can also be 
reduced to deoxyadenosine diphosphate (dADP) in a reaction mediated by 
ribonucleotide reductase. dADP is then phosphorylated to form 
deoxyadenosine triphosphate (dATP) which can be used for the synthesis of 
DNA. The higher abundance of AMP could suggest that the bacteria are 
altering their metabolism to favour energy production.  
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Figure 6-15 Schematic diagram depicting identified and annotated metabolites within the 
purine metabolism pathway in relation to known S. aureus enzymes. Colour code: grey = 
undetected, red = higher abundance detected in S. aureus mono-species, blue = higher 
abundance detected in dual-species biofilm, black = found in equal abundance in both S. 
aureus and dual-species biofilms. Inosine monophosphate (IMP) is produced from a 
reaction pathway that begins with 5’phospho-alpha-D-ribose-1-diphosphate. L-Glutamine 
is utilized in the next reaction to produce ribosylamine 5-phosphate. After a number of 
reactions IMP is produced. Adenosine monophosphate (AMP) can be synthesised from 
IMP through the conversion of IMP to adenylosuccinate. AMP can then be converted to 
adenine, either directly or through conversion to adenosine, which in turn is converted to 
adenine. Adenine can then be utilized for DNA synthesis. AMP can also be converted to 
ADP and ATP, which are utilized in energy production, as well as DNA and RNA 
synthesis. IMP can also be converted to xanthosine monophosphate (XMP), which in turn 
is converted to guanosine monophosphate (GMP). GMP can undergo various reactions for 
its conversion to metabolites that can be incorporated into DNA synthesis, RNA synthesis, 
riboflavin metabolism and folate biosynthesis. GMP can also be converted to guanine. 
Guanine can then be reduced to form deoxyguanosine. Deoxyguanosine is phosphorylated 
to produce deoxy-GMP (dGMP), which can then be utilized in DNA synthesis.  Higher 
abundances of andenosine monophospate (AMP), xanthosine and deoxyguanosine 
monophosphate (dGMP) were detected in the S. aureus mono-species biofilm compared to 
the dual-species biofilm. Higher abundances of deoxyguanosine, xanthine, hypoxanthine 
and adenosine were detected in the co-culture compared to S. aureus. There was a similar 
abundance of adenine detected in both the S. aureus mono-species and dual-species 
biofilms.  
 
Biosynthesis of  polymers is one of the most energy demanding processes in 
bacteria (Mongodin, Climo, Rosato, Gill, & Archer, 2003). In vancomycin 
resistant bacteria metabolic alterations directed metabolism towards increased 
production of AMP compared to their vancomycin susceptible counterparts 
(Mongodin et al., 2003). The up-regulation of AMP production was explained 
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through the increase in cell-wall volume of the resistant bacteria. Precursor 
metabolites used in substrate-level phosphorylation in the generation of ATP 
were likely utilized in polymer biosynthesis for cell wall construction. An 
increase in AMP would allow ATP production through AMP 
phosphorylation, there-by alleviating the need to utilize other metabolites, 
which could be used in polymer biosynthesis, in ATP generation (Mongodin 
et al., 2003). The S. aureus present in the mono-species biofilm could be 
directing their metabolism towards AMP production for ATP generation in a 
bid to save precursor metabolites for different processes. 
 
Figure 6-16 Adenosine triphosphate (ATP) and deoxyadenosine triphosphate (dATP) 
synthesis from inosine monophosphate (IMP). In the presence of guanosine triphosphate 
(GTP) and aspartate, IMP is converted to adenylosuccinate in an irreversible reaction 
mediated by adenylosuccinate synthetase. Adenylosuccinate is cleaved to produce 
adenosine monophosphate (AMP) and fumarate through the action of adenylosuccinate 
lyase. Adenosine diphosphate is synthesised by through the transfer of a phosphate group 
from ATP to AMP by AMP kinase. ADP can then be converted into ATP, through the 
addition of a phosphate group, or it can be converted to deoxyadenosine diphosphate 
(dADP) by ribonucleotide kinase. dADP can then be converted to dATP, by the addition of 
a phosphate group. ATP and dATP can be utilised in the synthesis of RNA and DNA, 
respectively.  
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Another explanation for higher AMP abundance could be that the bacteria 
have entered a starvation state due to nutrient depletion in the media 
(Khakimova, Ahlgren, Harrison, English, & Nguyen, 2013; Potrykus, 
Murphy, Philippe, & Cashel, 2011). The stringent response in bacteria 
involves alarmones e.g. guanosine tetra- or penta-phosphate ((p)ppGpp), 
which are activated in response to a shortage of amino acids. Alarmones 
regulate gene expression at the transcription level. (p)ppGpp inhibits RNA 
synthesis and therefore causes a decrease in translation, which enables 
bacteria to conserve the levels of the remaining amino acid pools. The 
stringent response also causes up-regulation in amino acid biosynthesis 
pathways and other genes involved in the stress response. The higher levels of 
AMP detected in the bacterial mono-species could be due to the stringent 
response in S. aureus halting RNA synthesis, as AMP plays a key role in the 
synthesis of metabolites for utilization in RNA synthesis (Fig. 6-16). 
Unfortunately, none of the other metabolites involved in this part of the 
metabolic pathway were detected, so it is unclear whether the bacteria shifted 
towards AMP production in the mono-species compared to the dual-species 
biofilm or whether the increased abundance of AMP was as a result of the 
stringent response due to environmental stress.  
It could be argued that the results from the comparison of purine metabolism 
in the bacterial mono-species and the dual-species biofilms points to the latter 
of these two conflicting conclusions. The poor biofilm formation and lower 
numbers of bacteria detected in the mono-species S. aureus biofilm compared 
to the dual-species biofilm during biofilm characterisation support the opinion 
that the increased abundance of AMP detected in the S. aureus mono-species 
is a result of the stringent response of the bacteria to the culturing conditions. 
Defective purine biosynthesis caused decreased biofilm formation and 
virulence in persistent infections such as endocarditis (Ge et al., 2008). In S. 
aureus purine biosynthesis has been associated with survival in stressed 
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conditions, such as vancomycin and daptomycin treatment and it has been 
speculated that purine biosynthesis plays a crucial role in S. aureus biofilm 
formation (Keer, Smeulders, & Williams, 2001; D. Mack et al., 2004; 
Mongodin et al., 2003). Purine biosynthesis plays a crucial role in S. aureus 
persisters in response to rifampicin treatment and genes involved in purine 
biosynthesis have also been shown to be important for antibiotic and stress 
tolerance in S. aureus (Yee, Cui, Shi, Feng, & Zhang, 2015).  
As well as this, the down-regulation of other purine metabolism intermediates 
could suggest lower levels of DNA synthesis and ATP production. This 
explanation is in agreement with the presence of fewer number of S. aureus in 
the mono-species compared to the co-culture recorded during biofilm 
characterisation, as DNA is required for replication. 
The lower levels of adenine and hypoxanthine detected in S .aureus compared 
to the co-culture and the mono-species C. albicans (Fig. 6-15) are suggestive 
of S. aureus utilising purine ‘salvage pathways’ (Fig. 6-17). AMP and IMP 
can be synthesised from the transfer of phosphoribosyl pyrophosphate (PRPP) 
to adenine and hypoxanthine by adenine phosphoribosyl transferase (PTR) 
and hypoxanthine-guanine PTR, respectively (Fig. 6-17). The higher levels of 
AMP detected in the S. aureus mono-species (Fig. 6-15) could be a result of 
the bacteria utilizing adenine to synthesis AMP. Recycling free purine bases 
from degraded nucleic acids and nucleotides through salvage pathways 
requires less ATP than energy-intensive de novo pathways and could be 
employed by the bacteria as an ATP saving method of purine biosynthesis. 
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Figure 6-17 Salvage pathways for purines. Adenosine monophosphate (AMP) and inosine 
monophosphate (IMP) can be salvaged from adenine and hypoxanthine through the 
transfer of phosphoribosyl pyrophosphate (PRPP) using specific phosphoribosyl 
transferases (PTRs). 
 
6.4.2.1.2 Comparison of purine metabolism in C. albicans and the 
dual-species biofilm 
In contrast to the results obtained for S. aureus, when C. albicans was 
compared to the co-culture almost all of the purine metabolism intermediates 
were detected at lower abundances in the dual-species biofilm, with the 
exception of adenine and xanthine (Fig. 6-18). Overall, this suggests down-
regulation in purine metabolism when C. albicans is cultured with S. aureus 
compared to when the fungi is cultured in isolation. This result was 
unexpected due the important role purine metabolism plays in the virulence of 
various microorganisms (Ge et al., 2008; Keer et al., 2001; J. K. Kim et al., 
2014; Mongodin et al., 2003; Yee et al., 2015). Although purine metabolism 
may enhance biofilm formation in S. aureus, it may not be identical in C. 
albicans.  In a recent study, low (LBF) and high (HBF) biofilm forming C. 
albicans phenotypes were compared to determine the differences in gene 
expression between the two phenotypes (Rajendran et al., 2016). It was 
determined that purine metabolism was up-regulated in LBF compared to 
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HBF (Rajendran et al., 2016). In another study, down-regulation of purine 
metabolism was found to be involved in the morphological change in C. 
albicans from yeast cells to its hyphal form (T. li Han, Cannon, & Villas-
Bôas, 2012). Therefore, down regulation of purine metabolism in the dual-
species biofilm compared to the C. albicans mono-species biofilm may 
indicate higher biofilm formation. These results would be in agreement with 
the significant increase in biomass noted in the dual-species biofilm compared 
to both mono-species biofilms when the samples were characterised using CV 
staining methods. 
 
Figure 6-18 Schematic diagram of the purine metabolism pathway in relation to known C. 
albicans enzymes. Colour code: grey = undetected, red = higher abundance detected in the 
dual species bioiflm, blue = higher abundance detected in C. albicans, black = found in 
equal abundance in both C. albicans and dual-species biofilms. The reaction pathways for 
purine metabolism in C. albicans are similar to those seen in S. aureus with some 
differences. C. albicans possess enzymes for the direct conversion of inosine 
monophosphate (IMP) to adenosine monophosphate (AMP), IMP to inosine, inosine to 
adenosine, xanthosine monophosphate (XMP) to xanthosine, guanosine monophosphate 
(GMP) to guanosine and hypoxanthine to guanine. All of the detected metabolites within 
the purine metabolism pathway were down-regulated in the dual-species biofilm compared 
to the C. albicans mono-species biofilm, with the exception of adenine and xanthine, 
which were detected at similar abundances in both the dual- and mono-species biofilms.  
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Only 15 metabolites were detected out of a possible 92, resulting in 17.39% 
coverage of this pathway. More metabolites in this pathway would have to be 
detected for precise conclusions to be drawn. To determine whether the 
increased abundance of AMP in the S. aureus biofilm is a result of stringent 
response to harsh environmental conditions, efforts should be made to detect 
purine intermediates involved in AMPs conversion to ADP, dADP and ATP. 
The detection of IMP, XMP, GMP along with guanosine could help elucidate 
whether salvage pathways are being utilised in the mono-species bacterial 
biofilm. The detection of intermediates involved in initial purine biosynthesis 
would enable conclusion to be drawn as to whether purine metabolism is 
being up- or down-regulated in each of the three samples.  
Next pyrimidine metabolism pathways were analysed. 
6.4.2.1.3 Comparison of pyrimidine metabolism in S. aureus and 
the dual-species biofilm 
Overall, detectable pyrimidine metabolites were found in a lower abundance 
in the mono-species S. aureus biofilm when compared to abundances detected 
in the co-culture. However, from the metabolites that were detected a 
difference was observed in the abundance of metabolites involved in de novo 
pyrimidine biosynthesis. These metabolites were detected at a higher 
abundance in the S. aureus biofilm than the dual-species biofilm (Fig. 6-19). 
UDP-glucose is utilized in the synthesis of uracil monophosphate (UMP) in 
pyrimidine biosynthesis. According to KEGG pathways both S. aureus and C. 
albicans lack the enzyme to synthesize UMP from UDP-glucose. The lack of 
UDP-glucose detected in the intracellular metabolome of the bacteria is in 
agreement with this.   
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Figure 6-19 Schematic diagram depicting identified and annotated metabolites within the 
pyrimidine metabolism pathway in relation to known S. aureus enzymes. Colour code: 
grey = undetected, red = higher abundance detected in S. aureus mono-species, blue = 
higher abundance detected in dual-species biofilm, black = found in equal abundance in 
both S. aureus and dual-species biofilms. Orotate and L-glutamine were detected at a 
higher abundance in the S. aureus mono-species. Cytosine was detected at a similar level 
in the bacterial mono-species and the dual-species biofilm. UDP-glucose, uridine, uracil, 
deoxyuridine and thymidine were detected at a higher abundance in the co-culture 
compared to the bacterial mono-species. 
 
The higher levels of L-glutamine and orotate detected in the S. aureus mono-
species compared to both the C. albicans mono-species and the dual-species 
biofilms could be indicative of up-regulation of the de novo pyrimidine 
biosynthesis pathway in the bacterial mono-species (Figs. 6-19 & 6-20). Up-
regulation of de novo biosynthesis could be a result of growing the bacteria in 
50% FBS. Purine and pyrimidine biosynthesis are critical for bacterial growth 
in blood (Samant et al., 2008). The inactivation of nucleotide biosynthesis 
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genes in E. coli, Salmonella enterica & Bacillus anthracis prevented bacterial 
growth in human serum, and Mei et al. (1997) demonstrated the importance 
of nucleotide biosynthesis for the survival and replication of S. aureus in 
blood (Mei, Nourbakhsh, Ford, & Holden, 1997). The pyrimidine de novo 
biosynthetic pathway has a higher energy cost than salvage pathways, so up-
regulation of this pathway over less costly salvage pathways could suggest 
that S. aureus is unable to utilize salvage pathways when grown in sera. The 
need for S. aureus to synthesise pyrimidines de novo could result in lower 
energy production and fewer available metabolite precursors for the synthesis 
of components required for biofilm formation, which could result in the poor 
biofilms observed when S. aureus is grown in 50% FBS (Harriott & Noverr, 
2009; Peters, Ovchinnikova, et al., 2012; Schlecht et al., 2015; Staib et al., 
1971). Another possible reason for higher abundances of the de novo pathway 
metabolites in S. aureus could be that the accumulation of energetically costly 
metabolites is a result of S. aureus starvation (Link, Fuhrer, Gerosa, Zamboni, 
& Sauer, 2015). Using real-time metabolome profiling, Link et al. (2015) 
demonstrated that E. coli maintained AMP abundance during starvation. The 
higher abundance of de novo intermediates, lack of salvage pathway 
intermediates and poor biofilm formation could be the manifestation of the 
lack of metabolisable nutrients in the growth media. 
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Figure 6-20 Schematic diagram of pyrimidine biosynthetic de novo pathway in S. aureus. 
Colour code: grey = undetected, red = higher abundance detected in S. aureus mono-
species, blue = higher abundance detected in dual-species biofilm, black = found in equal 
abundance in both S. aureus and dual-species biofilms. Higher abundances of L-glutamine 
and orotate were detected in the S. aureus mono-species compared to the dual-species 
biofilm.  
 
6.4.2.1.4 Comparison of pyrimidine metabolism in C. albicans and 
the dual-species biofilm 
When C. albicans was compared to the dual-species biofilm, similar 
abundances of L-glutamine and orotate were detected. This suggests similar 
levels of pyrimidine de novo biosynthesis. Higher abundances of the 
metabolites involved in pyrimidine salvage pathways were detected in the C. 
albicans compared to the dual-species biofilm. Nucleotide biosynthesis is 
required for antifungal resistance (Banerjee, Burkard, & Panepinto, 2014). 
The inactivation of de novo pyrimidine biosynthesis affects the ability of the 
yeast Cryptococcus neoformans to grow at 37°C (de Gontijo et al., 2014). 
Upregulation of salvage pathways requires less energy than de novo 
biosynthesis, which would enable the fungi to drive metabolism towards other 
pathways. These observations substantiate the results obtained from the 
biofilm characterisation.  The results suggest that C. albicans is able to 
maintain pyrimidine metabolite pools in sera compared to S. aureus. The 
increased numbers of S. aureus detected in the dual-species biofilm could be 
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due, in part, to the increased availability of UMP precursors, either those 
required for de novo biosynthesis or free bases utilised in salvage pathways, 
provided through cross-feeding from C. albicans.  
22 metabolites in this pathway were detected out of a possible 66, which 
resulted in 36.36% coverage. More metabolites would have to be detected for 
any conclusions to be drawn.  
As there appeared to be some significant changes occurring in these 
pathways, cysteine and methionine metabolism were also analysed. 
6.4.2.1.5 Comparison of methionine metabolism in S. aureus and 
the dual-species biofilm 
Although the majority of the metabolites detected within cysteine and 
methionine metabolism were at a higher abundance in the dual-species 
biofilm compared to the S. aureus mono-species biofilm, the majority of those 
involved in methionine biosynthesis were found in a higher abundance in the 
bacterial mono-species biofilm, with the exception of L-methionine, S-
adenosyl-L-methionine (SAM) and O-acetyl-homoserine (Fig. 6-21). Many 
microorganisms produce methionine through de novo biosynthesis. To 
generate methionine staphylococci employ the trans-sulfuration pathway (Fig. 
6-21) (Rodionov, Vitreschak, Mironov, & Gelfand, 2004).  
L-methionine and SAM were absent from the bacterial mono-species samples 
(Fig. 6-21). The increased abundance of methionine biosynthesis 
intermediates and the absence of methionine and SAM from this pathway 
could suggest that culturing S. aureus in sera results in the inhibition of the 
end-point of this pathway (Fig. 6-21).  
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Figure 6-21 Schematic diagram depicting identified and annotated metabolites within the 
(A) methionine and S-adenosyl-L-methionine (SAM) biosynthetic pathway and (B) the 
alternative reactions for the O-acylation of homoserine in relation to known S. aureus 
enzymes. Colour code: grey = undetected, red = higher abundance detected in S. aureus 
mono-species, blue = higher abundance detected in dual-species biofilm. Aspartate, 
homoserine, O-succinyl-L-homoserine and cystathionine were detected at a higher 
abundance in the bacterial mono-species biofilm (A). Methionine and SAM were not 
detected in the S. aureus mono-species biofilm, but were present in the dual-species 
biofilm (A). S. aureus Newman strain possesses the metA gene encoding both homoserine 
O-succinyltransferase and homoserine O-acetyltransferase (B). 
 
Methionine and its chemical derivatives have important functions in the cell 
(Schoenfelder et al., 2013). For example (formyl-)methionine is the universal 
N-terminal amino acid of nearly all proteins and plays a crucial role in the 
initiation of protein biosynthesis. SAM serves as a methyl donor in a number 
of metabolic and biosynthetic processes, which include methylation, SAM 
radical-mediated vitamin synthesis, and propylamine group transfer in 
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polyamine synthesis (Parveen & Cornell, 2011). Intracellular SAM is utilized 
in the methylation of nucleic acids and proteins in both eukaryotes and 
prokaryotes, a product of which is S-adenosyl-L-homocysteine (SAH) 
(Parveen & Cornell, 2011). Following methylation, the products are 
detoxified and recycled to homocysteine, which in is turn is reused for 
methionine/SAM synthesis (Schoenfelder et al., 2013). SAM is also utilised 
in the synthesis of polyamines and acylhomoserine lactones, although 
acylhomoserine lactones are only produced by Gram negative bacteria 
(Parveen & Cornell, 2011; Schoenfelder et al., 2013). 5’methylthioadenosine 
(MTA), produced during polyamine synthesis is again metabolized to 
methionine through the methionine salvage pathway (Parveen & Cornell, 
2011; Schoenfelder et al., 2013). S-adenosyl-L-homocysteine and 
5’methylthioadenosine were not detected in the S. aureus mono-species. 
Staphylococci lack both the methionine salvage and polyamine synthesis 
pathways (Schoenfelder et al., 2013). The absence of the polyamine synthesis 
pathway can explain the lack of MTA detected in the S. aureus mono-species. 
The absence of SAH could suggest an inability of the bacteria to synthesise 
macromolecules, which in turn could be a symptom of the inactivation of 
methionine and SAM biosynthesis.  The inability of S. aureus to synthesis 
macromolecules due to deficiencies in methionine biosynthesis is in 
agreement with the failure of mono-cultured S. aureus to form strong biofilms 
in serum. 
Methionine abundance may not be a limiting factor under normal growth 
conditions (Schoenfelder et al., 2013). However, when methionine supply is 
limited, e.g. during host colonization, or exposure to antimicrobials, de novo 
methionine biosynthesis becomes crucial (Chaffin, Taylor, Skerrett, & 
Rubens, 2012; Pietiäinen et al., 2009; Schoenfelder et al., 2013). Furthermore, 
a recent study highlighted the critical role that methionine biosynthesis plays 
in S. aureus colonization (Krismer et al., 2014). S. aureus depended heavily 
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on de novo synthesis of methionine during growth in a synthetic nasal media 
(SNM3) and its biosynthesis was up-regulated in this media compared to 
when it was cultured in basic media (Krismer et al., 2014). Mutants defective 
in methionine biosynthesis exhibited reduced colonisation capabilities in 
cotton rat models when compared to a parental Newman’s strain (Krismer et 
al., 2014). Recently the methionine biosynthesis pathway has been 
highlighted as a potential staphylococcal ‘Achilles Heel’ (Ochsner et al., 
2005; Schoenfelder et al., 2013). 
Interestingly, the methyl group donator methyl-tetrahydrofolate (Me-THF) 
and resulting THF are crucial for pyrimidine synthesis, specifically this co-
factor is utilized in the conversion of uridine monophosphate to thymidine 
monophosphate (Fig. 6-22). Due to its role in DNA, RNA and amino acid 
biosynthesis, the bacterial THF synthesis pathway is already a target for 
various antibacterial drugs, e.g. sulfonamides (such as sulfamethoxazole) and 
diaminopyrimidines (such as trimethoprim).  The results from this study could 
suggest that the inactivation of one of the pathways (most likely pyrimidine 
synthesis) is having an inhibitory knock-on effect for the other. However, 
further research would be required to investigate this.  
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Figure 6-22 A simple diagram highlighting the relationship between the (A) methionine, 
(B) tetrahydrofolate and (C) pyrimidine synthesis pathways. (1) S-adenosylmethionine 
synthetase; (2) methionine synthase; (3) dihydrofolate reductase; (4) serine 
hydroxymethyltransferase; (5) methylenetetrahydrofolate reductase and (6) thymidylate 
synthase (adapted from Crider 2012). 
 
6.4.2.1.6 Comparison of methionine metabolism in C. albicans 
and the dual-species biofilm 
The absence of O-succinyl-L-homoserine from the fungal mono-species 
biofilm was expected as C. albicans lacks the metA gene encoding O-
succinyltransferase, so only has the ability to acylate homoserine to O-acetyl-
L-homoserine (http://www.candidagenome.org) (Fig. 6-23). In fungi, L-
homoserine is O-acetylated through the action of L-homserine transacetylase. 
The sulphur atom is then introduced in one of two ways- either through the 
action of O-acetylhomoserine(thiol)-lyase to give homocysteine, or through 
the conversion of O-acetyl-homoserine and cysteine to L-cystathionine, which 
is then converted to L-homocystiene. This two-step reaction is mediated by 
cystathionine γ-synthase and cystathionine β-lyase, respectively. The final 
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step is the S-methylation of L-homocysteine to form methionine in a reaction 
that is catalysed by methionine synthase (Fig. 6-23). Methionine can then be 
converted to SAM and utilized in methylation reactions. SAH can be 
converted back to L-homocysteine in the S-adenosyl-L-methionine cycle, in a 
reaction catalysed by S-adenosyl-L-homocyteine hydrolase (Fig. 6-23). 
Methionine biosynthesis is essential for the survival of pathogenic fungi in a 
human host during infection (Jastrzębowska & Gabriel, 2015). Deletion of 
different genes within the methionine biosynthetic pathway cause an inability 
of fungi to produce methionine (Jastrzębowska & Gabriel, 2015). Met6 
inhibition causes accumulation of the toxic intermediate L-homocysteine, 
which interferes with ergosterol biosynthesis, an important cell membrane 
component (Hatanaka, Ariga, Nagai, & Katsuki, 1974; McCammon & Parks, 
1981; Parks & Casey, 1995). Inactivation of Met2 resulted in attenuated 
virulence of Cryptococcus neoformans in a mouse model, inhibited sexual 
development and reduced virulence in Fusarium graminearum (Y. K. Han, 
Lee, Han, Yun, & Lee, 2004; Nazi et al., 2007). Inhibition of Str2 in the 
fungal plant pathogens F. graminearum and Magnaporthe grislea resulted in 
a significant reduction of virulence (Balhadere, Foster, & Talbot, 1999; Fu, 
Wu, Jiang, Wang, & Ma, 2013). F. graminearum also exhibited 
hypersensitivity to specific fungicides (Fu et al., 2013).  
When the C. albicans mono-species was compared to the dual-species biofilm 
the higher abundances of SAH and MTA could be suggestive of fungal 
regulation of methionine/SAM metabolism through the utilisation of salvage 
and recycling pathways (Parveen & Cornell, 2011). 
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 Figure 6-23 Schematic diagram depicting identified and annotated metabolites within the 
(A) methionine and S-adenosyl-L-methionine (SAM) biosynthetic pathway. Colour code: 
grey = undetected, red = higher abundance detected in C. albicans mono-species, blue = 
higher abundance detected in dual-species biofilm. Aspartate, homoserine and Sam were 
detected at similar abundances in the fungal mono- and dual species biofilms. Methionine, 
cystathionine and S-adenosyl-L-homocysteine were detected at a higher abundance in the 
C. albicans mono-species. O-acetyl-homoserine was detected at a higher abundance in the 
dual-species biofilm.  
 
A common observation was the significantly lower abundance of L-
cystathionine in the dual-species biofilm compared to both the fungal and 
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bacterial mono-species biofilms. As well as its role as an intermediate in the 
biosynthesis of methionine (Figs 6-21 & 6-23), it is also an intermediate in 
the conversion of methionine to cysteine, through the reverse transsulfuration 
pathway (Fig. 6-24) (Guédon & Martin-Verstraete, 1997).  
6.4.2.1.7 Cysteine and the reverse transsulfuration pathway 
Cysteine plays a crucial role in cellular physiology, and its biosynthesis is the 
primary pathway for sulphur incorporation into the cell (Guédon & Martin-
Verstraete, 1997). As well as being a precursor for methionine, cysteine is 
also a precursor for thiamine, biotin, lipoic acid, CoA and co-enzyme M 
(CoM). It is involved in the biogenesis of [Fe-S] clusters, is found at the 
catalytic site of several enzymes and forms disulphide bonds in proteins, 
which aid in folding and assembly. As well as this, cysteine-derived proteins 
such as glutathione and thioredoxine help protect cells against oxidative 
stress. 
There are two major cysteine biosynthetic pathways in microorganisms; - the 
thiolation pathway and the reverse transsulfuration pathway (Guédon & 
Martin-Verstraete, 1997). The thiolation pathway directly incorporates 
sulphide or thiosulfate into O-acetly-serine, whereas in the transsulfuration 
pathway L-homocysteine is converted to cysteine with cystathionine as an 
intermediate.  
Many microorganisms employ this pathway, including B. subtilis, Klebsiella 
aerogenes, P. aeruginosa, M. tuberculosis and S. cerevisiae, which enable 
them to utilise methionine as a sole sulphur source (Seiflein & Lawrence, 
2001; Sekowska & Danchin, 1999; Thomas & Surdin-Kerjan, 1997; Vermeij 
& Kertesz, 1999; Wheeler et al., 2005). Methionine is converted to SAM, 
which in turn is converted to SAH during methylation reactions. SAH is then 
degraded to L-homocysteine either by SAH hydrolase or by SAH 
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nucleosidase and an S-ribosyl-homocysteine in a two-part reaction (Guédon 
& Martin-Verstraete, 1997). L-homocysteine is then converted to cysteine 
through the reverse transsulfuration pathway. Cystathionine β-synthase 
catalyses the condensation reaction of L-homocysteine and serine to 
cystathionine, which in turn is converted to ammonia, α-ketobutyrate and 
cysteine via another condensation reaction, this time catalysed by 
cystathionine γ-lyase (Guédon & Martin-Verstraete, 1997).  
Glutathione is a cysteine containing tripeptide (γ-glu-cys-gly) which can be 
used as a sulphur source in many organisms. Glutathione can be taken up by 
the cell and broken down to cysteine, glycine and glutamate in sequential 
reactions catalysed by γ-glutamyltranspeptidase, aminopeptidases A, B, and N 
and dipeptide D (Suzuki, Hashimoto, & Kumagai, 1993; Suzuki, Kamatani, 
Kim, & Kumagai, 2001). 
With the exception of cystathionine, none of the detectable metabolites within 
the reverse transsulfuration pathway were present in the S. aureus mono-
species. This could suggest that the bacterial pools of these metabolites were 
depleted after 24 hours of growth in the media. It could also suggest that S. 
aureus lack the genes encoding the enzymes required for this pathway. 
Glutathione was also absent from the bacterial mono-species, again this could 
either suggest that the bacteria lack the enzymes for glutathione uptake and 
metabolism.  
In stark contrast to these findings, all of the metabolites involved in the 
reverse transsulfuration pathway were detected in the C. albicans mono-
species (Fig. 6-24). Glutathione was also detected in the fungal mono-species 
biofilm. Although all of these metabolites were detected in the dual-species 
biofilm, they were detected at lower abundances, suggesting that these 
pathways are down-regulated when C. albicans is cultured with S. aureus. It 
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could be argued that suppression of this pathway is indicative of antagonistic 
behaviour towards one (or both) of these microorganisms. Cystathionine γ-
synthase inactivation could account for the lower abundance of cystathionine 
detected in the dual-species biofilm. 
 
Figure 6-24 Schematic diagram of the reverse transsulfuration pathway for the conversion 
of methionine to cysteine. Colour code: grey = undetected, red = higher abundance 
detected in dual-species biofilm, blue = higher abundance detected in C. albicans, black = 
similar abundance detected in both C. albicans and dual-species biofilms. 
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6.4.3 Conclusions 
Overall, results from the LC-MS analysis were able to detect numerous 
differences between the S. aureus and C. albicans mono- and dual-species 
biofilms. The differences detected within individual pathways are suggestive 
of a difference in behaviour when the microorganisms are cultured with one 
another. The absence of a large portion of essential metabolites within purine, 
pyrimidine, cysteine and methionine pathways is indicative of the bacteria 
struggling to proliferate and form strong biofilms in sera. In agreement with 
the results obtained during biofilm characterisation, C. albicans facilitates S. 
aureus growth in sera. The LC-MS analysis has highlighted some of the 
pathways that could be examined in further detail to determine their role and 
importance in the formation of a healthy dual-species biofilm. 
All of the pathways were down-regulated in the dual-species biofilm 
compared to the C. albicans mono-species biofilm. This could indicate that 
the presence of S. aureus within the biofilm is having an adverse effect on the 
C. albicans. This conclusion would corroborate some of the observations 
made during biofilm characterisation. Lower C. albicans cell numbers and the 
presence of ‘crinkled’ hyphae support the notion that S. aureus may behave 
antagonistically towards the fungi. This observation is in partial agreement 
with a study carried out by Peters et al. (2010), which documented the 
upregulation of proteins related to stress response in both S. aureus and C. 
albicans when the microorganisms were cultured with each other compared to 
when they were cultured in isolation (Peters et al., 2010b). However, further 
analysis would have to be carried out to confirm this hypothesis. 
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Microorganisms within their microenvironment do not exist in isolation, but 
rather within complex polymicrobial biofilm communities (Brogden et al., 
2005). Within these communities’ bacteria, fungi, parasites and/or viruses 
interact both directly and indirectly with one other. Cross-feeding, signalling 
and physical interactions influence behaviour, growth, virulence and survival 
of the organisms within these biofilms (De Sordi & Mühlschlegel, 2009; 
Anton Y Peleg et al., 2010). In recent years, increasing attention has been 
paid to the influence of polymicrobial interactions on antimicrobial resistance, 
virulence and disease outcomes, however relatively little is known about the 
subtle changes caused to the metabolic pathways. 
S. aureus and C. albicans are human commensals that are found on the skin 
and in other areas around the body, including the GI and reproductive tracts  
(Achkar & Fries, 2010; Ganguly & Mitchell, 2011; Kennedy & Volz, 1985; 
Kumamoto, 2002, 2011; Wertheim et al., 2005). Often these microorganisms 
exist on/in the host without causing any harm. However, this prokaryote and 
eukaryote can exhibit pathogenicity towards healthy and 
immunocompromised individuals, causing a plethora of infections and disease 
that can often be very severe and/or life-threatening (Calderone & Fonzi, 
2001; Rex et al., 2004; Wisplinghoff et al., 2004). In addition, S. aureus and 
C. albicans form polymicrobial biofilms that increase antimicrobial resistance 
and pathogenicity (Eunice Carlson, 1983; Eunice Carlson & Johnson, 1985a, 
1985b; Dahlén et al., 2009; Ekwempu et al., 1981; Harriott & Noverr, 2009, 
2010; S. a. Klotz et al., 2007; Siegman-Igra et al., 1988; A. J. Smith et al., 
2003; Valenza et al., 2008).  
Although S. aureus and C. albicans polymicrobial biofilms are of clinical 
importance, their interactions within their micro-environment are not well 
understood. Therefore, the overall aim of this research was to develop and 
apply novel metabolomics methods to the analysis of a dual species S. 
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aureus/C. albicans biofilm to provide further insight into the interaction 
between this bacteria and fungi.  
We first carried out microscopic and molecular characterisation of the dual-
species biofilm. 
7.1 S. aureus and C. albicans biofilm characterisation 
A variety of macroscopic, microscopic and molecular techniques were utilised 
to investigate the interaction between S. aureus and C. albicans.  Culture 
conditions were optimised.  
The results obtained were mainly in agreement with other studies that have 
been carried out; C. albicans facilitates the growth of S. aureus in serum (a 
medium that doesn’t support S. aureus biofilm development) and S. aureus 
preferentially adhere to the hyphal elements of the C. albicans (Harriott & 
Noverr, 2009, 2010; Jey et al., 2013; Peters et al., 2013). In addition, a 
significant increase in the number of S. aureus was recorded as well as a 
decrease in the number of C. albicans. Furthermore, an increase in the 
expression of two proteins involved in biofilm formation in C. albicans was 
observed. An interesting observation was the presence of ‘crinkled’ hyphae 
which could suggest that the relationship between the bacteria and fungi is not 
mutually synergistic as has previously been suggested, although Peters et al. 
(2010) did observe an increase in the expression of proteins related to stress 
response in both micro-organisms (Peters et al., 2010a).  
Biofilm characterisation enabled optimisation of culture conditions, aided in 
biofilm visualisation and the determination of the spatial distribution within 
the biofilm, and offered an insight into the behaviour of S. aureus and C. 
albicans.  
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The limitations of this analysis included an inability to carry out successful 
RNA extraction of S. aureus MSCRAMM genes, the cell counts carried out 
using qPCR did not take into account whether the cells were viable or not and 
only the mature biofilm was analysed. 
For the biofilm characterisation a more in-depth analysis should be carried 
out. Live/dead staining would enable the state of the microorganisms within 
the dual species biofilm to be determined. S. aureus RNA extractions were 
unsuccessful; therefore an optimised method to study gene expression in S. 
aureus would be beneficial. The biofilms that were analysed had been 
allowed to mature for 24 hours. Sequential microscopic and molecular studies 
characterising early, intermediate and late stage biofilms could lead to a 
deeper understanding of how the nature of the relationship between S. aureus 
and C. albicans progresses from initial attachment. Genes involved in biofilm 
formation were targeted during this study. It could be of benefit to investigate 
the regulation of other known virulence genes, and perhaps genes related to 
stress response in both organisms or toxin production in S. aureus.  
7.2 Serially combined Reverse phase (RP)/Hydrophilic Interaction 
      Liquid Chromatography (HILIC) method development 
A combined RPLC/HILIC method was then developed to allow the separation 
and detection of polar and nonpolar metabolites in one analytical run. 
Overall the method worked well and the chromatographic system was able to 
separate polar and nonpolar standards and compounds within a complex 
sample. The RPLC/HILIC system presented reproducible results with low 
RSDs. 
However, the system was unable to separate the isomers citrate and isocitrate 
in the standard mix and there were some difficulties regarding the back 
pressure of the system. This could have been due to a blockage in the tubing 
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or on the C18 column. Other limitations surrounded optimisation of the 
method. Due to time constraints, instrument down-time and the cost of 
running the MS, the effects of MP composition on the selectivity, retention, 
efficiency and resolution of analytes were never investigated. The flow rates 
were optimised so that the correct dilution between the columns could be 
achieved, but alternative flow rates (that would still result in the correct 
dilution factor but that could possibly lead to improved resolution) were not 
considered.  
7.3 Ion chromatography - mass spectrometry (IC-MS) method  
      development for central carbon metabolism (CCM) analysis 
A targeted IC-MS was also developed for the analysis of intermediates 
involved in CCM. 
Good separation of almost all of the glycolysis intermediates (with the 
exception of DHAP/G3P and 2-/3-PG) and TCA intermediates (with the 
exception of oxaloacetate) was achieved. The system exhibited great RT 
reproducibility and wide ranging LoD. 
The IC system employed was unsuitable for the analysis of the co-enzymes, 
NADH or NADPH. The high OH- concentration in the eluent could be 
responsible for the breakdown of the co-enzymes on column; however this 
high hydroxide concentration is required for the elution of ADP and ATP. 
Altering the pH or column may hold the key to utilizing IC-MS to analyse 
these compounds, but unfortunately the instrument was removed from the 
laboratory before any alternative chromatographic conditions could be 
investigated. 
Overall the IC results had significant impact on Thermo Scientific’s 
marketing of capillary flow ICMS for metabolomics.  
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Although IC-MS was able to separate numerous CCM intermediates, due to 
the complexity of the samples’ peak resolution was poor. Method 
development to improve peak separation could be carried out. The IC 
instrument utilised in this study had an integrated eluent generator. This was 
beneficial in relation to instrument maintenance and system set-up. However, 
it meant that only the hydroxide concentration of the eluent could be varied. 
Using a system which offers greater control over the MP composition could 
enable separation optimisation through manipulation of the MP components 
and additives.  
Another option could be to use a more established targeted method that 
encompasses the pentose phosphate pathway as well as the other pathways 
targeted in this study. Although GC-MS involves a lot more sample 
preparation, it could provide wider coverage as well as better quantitation. 
Derivatisation before LC-MS analysis could also offer a powerful method for 
CCM analysis.  
Analysing the biofilms from initial attachment over a time-course could 
provide a better understanding of central carbon metabolism in these 
microorganisms. Flux analysis could be carried out to follow the movement 
of metabolites through metabolic networks. Feeding S. aureus and C. albicans 
heavy labelled glucose would enable differences in the fate of glucose within 
each of the microorganisms to be determined. However, as both 
microorganisms metabolise glucose studying the dual species culture in this 
way may prove problematic as it will be impossible to distinguish which 
organism has utilised the glucose in which way.  
Another possibility to improve this targeted analysis could be through the 
optimisation of a metabolite extraction method that targets energy metabolites 
such as organic acids and sugar-phosphates. 
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7.4 Metabolomics analysis of S. aureus and C. albicans mono- and  
      dual-species biofilms 
The developed IC-MS and RPLC/HILIC methods were then applied to the 
analysis of S. aureus and C. albicans dual-species biofilms.  
The application of the IC-MS method was by the complexity of the microbial 
samples. The presence of sugar isomers resulted in poor resolution of peaks, 
making quantitation difficult. The absence of metabolites from the S. aureus 
mono-species culture also complicated comparisons as it was unclear whether 
this was as a result of metabolite concentration being below the limits of 
detection of the instrument or that they were absent as a result of the culture 
conditions. When S. aureus was removed from the comparison the metabolite 
concentrations between C. albicans and the co-culture were similar with the 
exception of fumarate and fructose 1,6-bisphosphate. 
The RPLC/HILIC method also performed poorly when applied to the analysis 
of the biofilm samples. Poor peak shapes, lower number of metabolites 
detected and issues with column backpressure compared to the routine 
pHILIC method employed in the laboratory led to the utilisation of the routine 
pHILIC method in place of the serially combined method.  
The untargeted metabolomics analysis uncovered numerous differences 
between the S. aureus and C. albicans mono- and dual-species cultures. From 
the data three pathways were chosen due to significant changes present 
between each of the cultures.  
Overall, the results obtained from this study suggest that S. aureus is unable 
to metabolise components within sera for the biosynthesis of purine and 
pyrimidines that are essential for the formation of strong biofilms (Keer et al., 
2001; D. Mack et al., 2004; Mongodin et al., 2003). Furthermore, many of the 
metabolites involved in methionine biosynthesis were detected in a higher 
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abundance in the S. aureus mono-species, with the exception of L-methionine 
and SAM. This could suggest that there is some sort of biochemical ‘block’ 
within this pathway which is affecting the production of these two key 
metabolites, which are required for the biosynthesis of macromolecules. Me-
THF which plays key roles in both methionine and pyrimidine biosynthetic 
pathways could be linked to the impairment of both of these pathways in 
mono-culture, which could lead to the formation of weak biofilms observed 
when S. aureus is cultured in sera alone. 
In contrast, the presence of the S. aureus resulted in the down-regulation of 
purine, pyrimidine and methionine biosynthetic pathways. This suggests that 
the presence of the bacteria may have a detrimental effect on C. albicans 
within the dual-species culture.  Although the fungi support S. aureus growth 
and development, the bacteria could be secreting some kind of toxin directly 
onto the fungi or into the environment that causes damage to the fungi while 
allowing the bacteria to thrive.  
From the results obtained during Chapter 3 and 6 it could be suggested that 
the presence of C. albicans within the dual-species culture either presents an 
opportunity for S. aureus to metabolise components directly from the surface 
of fungal hyphae, which could explain the presence of damaged hyphae in the 
co-culture, or C. albicans could be secreting a compound into the 
environment that S. aureus can metabolise.  
The detection of proteins related to stress response by Peters et al. (2010) 
corroborates this theory and could suggest that the increased pathogenicity 
exhibited by S. aureus and C. albicans dual infections are in fact a 
consequence of competition between these two opportunistic pathogens rather 
than a mutualistic relationship leading to increased virulence (Peters et al., 
2010c). Although the RPLC/HILIC was not robust enough for biofilm 
analysis, optimisation of the method could provide improved results. Van 
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Deemter plots could be used to determine optimum flow rates for each of the 
columns individually, which could then be adjusted to ensure the optimum 
dilution between both columns when they serially combined. Different MP 
compositions could also be examined, including the possible addition of 
buffers to one of the MPs. The back pressure of the system was unstable at 
times and often went beyond the limits of the pumps. This appeared to be an 
issue with the C18 column. Different RPLC columns could be tested to ensure 
optimum column capacity and orthogonality. Another reason for the system 
going over pressure could be the presence of particulates within the samples. 
Either the use of filtration vials or filtration of the samples before injection in 
the LC could eliminate this issue.  
The routine pHILIC method employed did detect numerous metabolites; 
however coverage of a lot of the pathways was not ideal. The lack of detected 
metabolites within pathways made data interpretation quite difficult and 
speculative. Optimisation of the serially combined method is one option to 
improve this. Another option is to carry out two optimised metabolite 
extractions; one for the polar metabolites and one for non-polar metabolites. 
These could then be run on a truly reverse phase system and HILIC system, 
respectively. The data could then be integrated and analysed. This would 
complicate sample preparation and data analysis but, through optimisation of 
each approach, coverage of the metabolome would increase which would 
ensure as many metabolites as possible were identified between the two 
separate chromatographic runs.   
The biological interpretation highlighted a number of interesting differences 
between the mono- and dual-species cultures. It could be beneficial to 
investigate the importance of different pathways within each of the 
microorganisms. S. aureus could be cultured with mutant strains of C. 
albicans which exhibit deficiencies in different regulators of purine, 
pyrimidine, methionine or cysteine biosynthesis. Strains deficient in 
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regulators of the reverse-transsulfuration pathway could also provide an 
insight into the relationship between S. aureus and C. albicans. The results 
obtained as part of this study pointed to a possible link of THF and the 
inability of S. aureus to synthesis L-methionine and SAM. To investigate this 
further metabolomics analysis could be carried out on a mutant strain 
defective in THF biosynthesis grown in a biofilm promoting medium. The 
folate and THF biosynthetic pathways could be targeted in C. albicans to 
determine how it affects the dual-species biofilm.  
7.5 Future work 
The work presented herein has made progress towards our understanding of 
the inter-kingdom interactions of S. aureus and C. albicans. The results from 
this research have highlighted a number of studies that could be carried out to 
elucidate the intimate relationship between these two pathogenic 
microorganisms. 
Gram positive bacteria often utilize small peptides as signalling molecules. 
Numerous dipeptides were putatively identified during this study (data not 
shown) but as many had the same mass they could not be distinguished from 
one another and could not be identified. Therefore peptidomics could be 
utilised in further studies in an effort to identify potential signalling 
molecules. 
In relation to peptidomics, a multi-omics approach could be employed that 
encompasses proteomics, genomics and transcriptomics. This could provide a 
more complete picture of the interaction of S. aureus and C. albicans.  
The extraction method utilised in the study of the dual-species biofilm did not 
distinguish between S. aureus, C. albicans and ECM. Method optimisation 
should be carried out prior to metabolomics to separate the bacteria from the 
fungi and both of these organisms from the ECM. Separating out the 
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organisms before analysis would enable changes within the individual 
organisms to be detected. 
The work presented here only looked at one laboratory strain of S. aureus and 
C. albicans. A natural progression from the results obtained in this study 
would be to carry-out further analyses on clinical strains of S. aureus and C. 
albicans.  
Finally, this study adopted a multi-omics approach. Unlike traditional studies 
that perhaps analyse a single organism using more than one omics approach, 
in this study multiple organisms were analysed using a single omics approach. 
The approach of analysing polymicrobial communities through analysing 
each component in isolation and then in the presence of the other provides 
greater insight into how the presence of one organism influences the other.  
Historically microorganisms have been studied in isolation to gain an 
understanding of their behaviour. It is now widely accepted that a significant 
number of infections are the product of multi-species colonisation. The 
importance of the interaction between different microorganisms within a host 
is becoming more influential in clinical thinking and it is becoming 
increasingly important in our understanding of what constitutes a normal 
flora, the changes which lead to morbidity, the changes found as a result of 
morbidity and possible interventions to the dynamic interaction between the 
microorganisms found in those circumstances. It is apparent that the 
composition of different polymicrobial communities and the interactions 
between specific microbes present within these communities play a crucial 
role in disease severity and outcomes. Although progress has been made 
towards understanding how microorganisms within these communities 
interact, there is still a very long way to go in determining the species specific 
interactions through which clinically important microorganisms influence one 
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another. Metabolomics provides a methodology with which to directly probe 
how microbial interactions influence behaviour, virulence and host response.   
Although metabolomics offers a way to directly measure the influence of one 
or more organisms on another, the incorporation of other omics techniques 
such as proteomics, genomics, peptidomics, lipidomics and transcriptomics 
would provide an explanation of these interactions on every molecular level. 
Investigating polymicrobial infections using a truly multi-omics technique 
would enable comprehensive understanding of the intricacies of these 
interactions. Uncovering specific interactions could highlight potential drug 
targets or enable clinicians to embark on novel therapeutic strategies, thus 
providing a platform with which to tackle the substantial threat posed by 
increasing antimicrobial resistance, virulence, mortality and morbidity 
exhibited by multi-species infections. 
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